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Congenital disorders (CDs) are a common, costly and critical health issue that are, as yet, 
unprioritised in South Africa (SA). Defined as abnormalities in structure or function 
present from birth, CDs are synonymous with birth defects. Although CDs are found in 
all populations, a greater proportion occur in middle and low income countries (MLIC), 
including SA, compared to industrialised countries.  
Although serious CDs can result in death or lifelong disability, there is little recognition 
in SA of the burden of disease they represent. This is despite a global call in 2010 through 
World Health Assembly (WHA) Resolution 63.17 to prioritise CDs as a health care issue 
and to respond with specific actions to improve their care and prevention. The majority 
of CDs in SA remain undiagnosed or are misdiagnosed and if lethal, the cause of death 
is incorrectly assigned leading to underreporting and an underestimate of the true 
health burden. Key challenges include a lack of skilled clinicians to diagnose, treat and 
refer CDs, competing health priorities redirecting funding and human resources, and 
inadequate empiric data collated via national surveillance and monitoring. Despite the 
trend in industrialised countries where CDs are the leading cause of death in infants and 
children, there is little awareness in SA of the increasing proportion of deaths resulting 
from CDs as the infant mortality rate (IMR) decreases.  
 
Medical genetic services offer care to those affected by CDs to reduce suffering and 
improve overall health by preventing CDs, collectively reducing the burden of disease. 
Since up to 70% of CDs can be prevented, cured or ameliorated through relevant 
interventions (including 40% that can be cured through mainly surgical correction and a 
further 30% where disability can be mitigated), medical genetic services are worthy of 
further attention.  
 
Aim and Scope of Research 
The aim of this study was to investigate the renewed need for the care and prevention 
of CDs in SA. The objectives of this PhD by publication were: 
 To evaluate epidemiological transition related to CDs for the last 25 years in SA 
including its impact upon medical genetic services. 
 Assess the existing constitutional and legislative framework relevant to CDs and 
medical genetic services in SA and its implementation. 
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 Highlight the contribution of CDs to child mortality and morbidity and the role of 
medical genetic services in obtaining significant further reductions in mortality. 
 Develop modelled birth prevalence and outcomes for CDs in SA to highlight the 
contribution of CDs to the country’s disease burden. 
 Highlight the role of the genetically trained nurse as a key component in developing 
medical genetic services in SA and potential tools to develop this workforce. 
 Demonstrate international consensus on the prevention of CDs and care of affected 
children with relevance to the Sustainable Development Goals (SDGs). 
 
Structure and overview of the thesis 
 
Paper 1 (Chapter 3) reviewed the current epidemiological context for CDs and medical 
genetic services in SA. Although the country is now back in positive epidemiological 
transition following the HIV/AIDS and concomitant TB epidemics, child mortality rates 
have stagnated since 2011 with no further significant reductions. This highlights the 
need to address other, unprioritised health issues, the first of which is CDs. With an IMR 
of 27 per 1 000 live births, SA is well past the stage of 40-50 deaths per 1 000 live births 
when countries should develop medical genetic services. SA is yet to recognise the 
growing health need represented by CDs, which will continue to rise as the country 
develops and the IMR decreases. Medical genetic services have declined as services for 
competing health priorities have developed, and SA is yet to respond to WHA 63.17 to 
prioritise the care and prevention of CDs.  
 
Paper 2 (Chapter 4) outlines the international background and SA legislative framework 
for medical genetic services and their implementation. International, regional and 
national conventions, legislation, and policy were studied for relevance to CDs and 
medical genetic services and their implementation was evaluated, including a 
comparison of sector capacity between 2001 and 2015. A key finding was the specific 
provision for genetic services in the National Health Act 61 of 2003. Although a 
comprehensive legislative and regulatory framework exists in SA for the provision of 
medical genetic services, implementation has been fragmented and unsustained. CDs 
and medical genetic services are excluded from national strategy and interventions 
combating child mortality and non-communicable diseases (NCDs). Capacity in the 
sector today is at a lower level than in 2001. The underlying reason for the shortfall in 
implementation is the failure to recognise the burden of disease represented by CDs. 
Paper 3 (Chapter 5) critiques the 4th edition of the Guidelines for Maternal Care in South 
Africa with relevance to CDs and medical genetic services. Disparate terminology is used 
for CDs throughout the guidelines and referrals to medical genetic services disregard the 
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insufficient capacity available for screening and diagnosis of CDs. This highlights the lack 
of consultation with the medical genetics sector during the development of the 
guidelines and demonstrates a lack of awareness around the growing health need and 
contribution of CDs to the disease burden in SA. 
 
Chapter 6 is a book chapter that argues for recognition of the role of CDs in child 
mortality. With the reduction of child mortality a priority in SA due to Millennium 
Development Goal (MDG) 4, the contribution of CDs to child mortality is yet to be 
realized or acted on. Despite the lack of empiric data on CDs, mortality data is beginning 
to emerge in SA, with CDs overtaking infection as the 3rd ranking cause of early neonatal 
death in the Western Cape. In the context of stagnated child mortality, CDs need to be 
addressed if child mortality is to be significantly further reduced. Priority actions 
identified include increased political will and financial commitment, improved national 
surveillance, capacity building, community education and awareness, and the role of 
patient support groups.  
Paper 5 (Chapter 7) continues with the focus on child mortality in a letter to the editor 
of the South African Medical Journal in response to published data on child mortality for 
a specific region of the Western Cape. The article data highlighted the limitations of the 
10th Edition of the International Classification of Diseases (ICD-10) and the prolific use of 
the term congenital anomalies to represent the totality of CDs while excluding up to 40% 
of CDs. This contributes to underreporting and an underestimate of the true 
contribution of CDs to the disease burden.  
In paper 6 (Chapter 8) the scale of the CD problem in SA is quantified through the 
development of modelled estimates of specific groups of early onset endogenous CDs 
for 2012. Modelled data enables informed policy making to proceed so that relevant 
services can be developed where observed surveillance is lacking. These modelled data 
provide the expected numbers of CDs, and as empiric data emerges, the need for 
modelling falls away. The Modell Global Database (MDGb) was adapted using SA 
demographic indicators to generate baseline estimates (in the absence of any care 
interventions) of CD birth prevalence. This was also a pilot of the MGDb used to develop 
national estimates based on locally sourced data in-country. Birth prevalence data for 
CDs with endogenous causes was sourced from well-established CD surveillance 
systems. Using the baseline estimates generated, the IMR was used to calculate access 
to optimal care/services. This was estimated at 30% in SA in 2012. The impact of 
services, including pre-pregnancy, pre-natal and post-natal treatment was found to 
considerably reduce mortality, and mitigate disability, dispelling the myth that nothing 
can be done for those affected with CDs. Owing to the increased number of survivors 
with disability, the number requiring care also increased. This highlighted the need for 
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a balance between the care and prevention of CDs as an integral part of medical genetic 
services.  
In paper 7 (Chapter 9) the role of the genetic nurse in medical genetic services in SA was 
investigated. Current sector capacity is inadequate and required personnel targets for 
medical geneticists and genetic counsellors cannot be reached quickly enough to meet 
the growing health need even if relevant posts are designated. The history of the genetic 
nurse in SA, current shortfalls in genetic education curricula, and their potential future 
role in rebuilding genetic services in the country are outlined. The Medical Genetics 
Education Programme and the Congenital Disorders Handbook are proposed as 
potential tools to swiftly build capacity in nurses. The importance of integrating such 
capacity building into the relevant streams of the National Health Insurance (NHI) 
scheme is emphasized, which should occur in parallel to the long-term goal of increasing 
medical geneticists, genetic counsellors and the allocation of posts countrywide. 
The final paper (Chapter 10) is a consensus document resulting from the 7th 
International Conference for Birth Defects and Disabilities in the Developing World held 
in September 2015 in Dar es Salaam, Tanzania. Developed by a core working group 
throughout the conference, it provides the global context for CDs including the 
Sustainable Development Goals (SDGs), World Health Assembly Resolution 63.17, and 
outlines a plan of action. Many of the global challenges and the subsequent priority 
actions highlighted in the paper are shared by SA.  
 
Conclusion 
The overall finding of this study is that there is an urgent need to renew medical genetic 
services in SA. Although these services have been shown to have an impact on reducing 
mortality and ameliorating morbidity, the country is well past the designated stage 
when such services should be developed. For child mortality to be significantly further 
reduced in SA, it is now a national imperative that medical genetic services in SA are 
renewed. This requires political commitment and accompanying financial resources.  
Further modelling studies are recommended at the provincial level and for specific CDs 
in SA. This could be accompanied by the development of cost estimates for specific 
interventions to illustrate the socioeconomic impact and cost effectiveness of medical 
genetic services. Developing consensus in SA on the use of standardised terminology 
and definitions for CDs is necessary to ensure accurate reporting of CDs to reduce the 
underestimation of CDs to the disease burden.  
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Glossary of Terms 
 
Birth defects: Abnormalities of structure or function, including metabolism, which are 
present from birth. Some birth defects are clinically obvious at birth while others 
manifest later in life. This term is synonymous with the term congenital disorder (1). 
Birth prevalence: The number of infants who have or will develop a congenital disorder 
per 1 000 live births. Birth prevalence rates can be compared across populations, used 
to assess changes over time and in health burden projections (2). 
Chromosomal abnormalities: Abnormalities in the number of chromosomes 
(monosomy, trisomy, mosaicism) or in the structure of chromosomes (e.g. deletions, 
translocations, duplications, inversions, insertion). Resulting loss or gain of genetic 
material causes physical and/or mental abnormalities (3). Trisomy 21 (Down syndrome) 
is one of the most common chromosomal abnormalities. 
Communicable disease: Infectious or transmissible diseases, resulting from the 
infection, presence and growth of pathogenic agents. 
Complex disorders: Congenital disorders/birth defects that develop after birth, some 
presenting in childhood but most manifesting in mid- or later life. Their aetiology 
requires an interaction between genes and, mostly postnatal, environmental factors. 
Common complex disorders include cancer, coronary artery disease, type-2 diabetes 
mellitus, hypertension, mental disorders and stroke (3). 
Congenital anomalies: Macroscopic morphological anomalies present from birth. They 
exclude functional birth defects including non-syndromic, congenital disability 
(intellectual, physical, visual and auditory disability and epilepsy), common single gene 
disorders (e.g. haemoglobin disorders, G6PD deficiency, cystic fibrosis, oculocutaneous 
albinism, spinal muscular atrophy and inborn errors of metabolism. Also excluded are 
many common teratogen induced CDs including congenital syphilis, congenital rubella 
syndrome and iodine deficiency (1). 
Congenital disorder: Any potential pathological condition arising before birth, including 
all disorders caused by environmental, genetic and unknown factors, whether they are 
evident at birth or become manifest later in life. This term is synonymous with the term 
birth defect (1, 4, 5). 
Congenital malformation: The result of abnormal embryonic development of an organ 
or body part, causing a permanent defect because the underlying tissue is abnormal. 
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May be caused by chromosomal or single gene abnormalities, multifactorial conditions 
or teratogen exposure (3). 
Genetic counselling: An education process used to inform individuals/families about the 
facts and implications of birth defects and complex disorders. The process is non-
directive but also provides psychosocial support (3). 
Genetic risk factors: Common gene variants that cause problems relatively rarely (2). 
Infant mortality rate: The number of deaths of infants under one-year of age per 1 000 
live births. 
Maternal mortality ratio: The ratio of the number of maternal deaths during a given 
time period per 100 000 live births during the same time-period. 
Medical Genetic Services: Care for those with a CD in order to reduce suffering and to 
improve health by prevention (6). 
Multifactorial inheritance: The interaction of many genes with each other and the 
environment. Certain birth defects/congenital disorders follow multifactorial 
inheritance patterns, meaning that a person’s particular genetic makeup (genotype) 
interacts with specific environmental conditions to cause the condition (3). 
Neo-natal mortality rate: The number of deaths of infants under 28 days of age per 1 
000 live births. 
Non-communicable disease: A medical condition or disease that is non-infectious or 
non-transmissible. 
Population prevalence: The number of affected individuals per 1 000 in a defined 
population. For congenital disorders this number is usually much less than birth 
prevalence because serious congenital disorders shorten life (6). 
Serious birth defect/congenital disorder: A congenital disorder that is life threatening 
or has the potential to result in disability. 
Single gene disorder: A disorder known to be caused by a single gene e.g. Cystic fibrosis. 
Teratogen: An agent that can disturb the development of the developing embryo (first 
8 weeks of life) or fetus during pregnancy. Teratogens include altered maternal 
metabolic states (diabetes mellitus, hypothyroidism, iodine deficiency), infectious 
agents, ingested substances (alcohol, illicit drugs and medications), hyperthermia, 
environmental pollutants and massive radiation exposure (3). 
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Under-five mortality rate: The number of deaths of children under the age of five years 
per 1 000 live births. 
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Congenital disorders (CDs) are a common, costly and critical health issue which occur in 
all populations globally. The term congenital disorder is synonymous with birth defects 
which are defined as abnormalities in structure or function present from birth, including 
metabolic disorders, which may be diagnosed at birth or manifest in childhood or later 
in life (1). The majority of CDs are genetic or partially genetic in origin, with the 
remainder due to factors in the fetal environmental or a combination of these (2). There 
is an unequal distribution of CDs globally, with a greater proportion occurring in middle 
and low income countries (MLIC) compared to high income, industrialised countries (3). 
Serious CDs can cause death and those who survive may be disabled for life (3). 
Although most countries worldwide are committed to reducing child mortality in 
response to the Millennium Development Goals (MDG), specifically MDG4, few 
interventions in MLIC targeted CDs specifically (4). This is despite the call in 2010 for 
World Health Assembly (WHA) member countries, including South Africa (SA), to 
prioritise CDs as a healthcare issue due to their contribution to child mortality, 
particularly neonatal deaths (5). The majority of deaths from CDs go undiagnosed or 
misdiagnosed - buried amongst mortality statistics from more obvious causes such as 
infectious diseases (eg. Diarrhea, HIV/AIDS, pneumonia, septicemia) (6, 7). It is not until 
countries control communicable diseases that mortality decreases, longevity increases 
and countries experience epidemiological transition, that the true burden of CDs is 
revealed (8). 
Today, CDs are the leading cause of infant and child death in industrialised countries 
accounting for up to 28% of deaths (9). As overall child mortality decreased in these 
countries, the proportion of deaths from CDs increased. Medical genetic services have 
developed to care for those affected, incorporating prevention to minimize the number 
of affected births. In SA, an upper-middle income country, CDs are yet to be recognised 
as a priority health care issue. This is despite a considerable body of work internationally 
highlighting the need for medical genetic services to be developed at the community 
level in primary health care (PHC) for the care and prevention of CDs. With 
communicable diseases now decreasing in SA, and a parallel burden of non-
communicable diseases (NCDs) emerging - of which CDs are the first - a greater emphasis 
must be placed upon developing medical genetic services.  
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A key reason for the neglect of medical genetic services in SA is competing health 
priorities, including HIV/AIDS and concomitant TB which have diverted political will and 
resources from CDs. The principal focus has been upon treating communicable diseases 
and other social determinants of health and it is these low-hanging fruits that are being 
responded to first, with little attention given to CDs (10). Many of these interventions 
aim at reducing the neonatal, infant and child mortality rate in SA, which has stagnated 
since 2011 (11, 12). Until CDs are tackled as a healthcare priority it is unlikely that the 
child mortality rate will be further significantly reduced.  
In SA today, the majority of CDs remain undiagnosed or are misdiagnosed due to a lack 
of genetically trained clinicians and health care professionals, and inadequate 
infrastructure (3, 6, 13). Early, accurate diagnosis can prevent, cure or mitigate up to 
70% of CDs (14). This includes curative surgical interventions for up to 40% of CDs 
(particularly congenital malformations) and in 30% of cases, the resulting disability can 
be ameliorated through rehabilitative or therapeutic treatments (6, 14). Many of the 
deaths occurring from undiagnosed and untreated CDs are preventable and the quality 
of life can be improved. Not all interventions to care and prevent CDs are expensive or 
high-tech – many are relatively low cost and can be integrated into existing health care 
programmes (3). 
For those able to afford private healthcare services in SA, estimated at 16% of the 
population benefiting from 70% of all the doctors in SA working in the private sector 
(15), diagnosis and care of CDs is more likely, although not guaranteed. With 84% of the 
South African population dependent on state health care services, relevant and 
universally accessible services for the care and prevention of CDs are non-existent in 
most of the provinces (15).  
With an infant mortality rate (IMR) of 27 deaths per 1000 live births in 2015 (16), SA is 
well below the threshold of 40 deaths per 1000 live births when medical genetic services 
should be implemented (6, 13, 17, 18). This urgently needs to be rectified. 
 
Personal Motivation 
Having lost a child due to a CD, the focus of this PhD is of personal interest and is the 
motivation for pursuing this area of study. Although we were able obtain a diagnosis 
and the best care available for our daughter prior to her death, we know that this is the 
exception rather than the rule in SA. A significant number of preventable deaths, 
unnecessary human suffering and huge socioeconomic cost are the result of the 
unethical shortfall in services. We have a responsibility to the most vulnerable of our 
society, our children and the disabled, to ensure that the most basic of human rights - 
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the right to life - is upheld by ensuring relevant, accessible medical genetic services are 
available to all South Africans. 
 
Problem Statement 
The research question asked in this study: Is there a need for renewed medical genetic 
services in South Africa for the care and prevention of congenital disorders? 
There are a number of issues that have contributed to the decline of medical genetic 
services in SA and why there is now a renewed need for these services. The lack of 
recognition of CDs as a health care priority is the underlying reason, resulting from: 
 Confusion around CD definitions and terminology: A variety of different, 
inequivalent terms are used interchangeably for CDs causing confusion, 
particularly for data reporting and comparison. Often, a sub-set of CDs is 
reported as the totality, which exacerbates underreporting.  
 Undiagnosed and misdiagnosed CDs: Many CDs remain undiagnosed or are 
misdiagnosed, especially when comorbidity occurs. The more obvious condition, 
often secondary to the CD, is usually diagnosed, preventing the patient from 
receiving appropriate care. When death occurs due to a serious CD, the cause of 
death is often incorrectly assigned leading to underreporting.  
 Competing healthcare priorities and unaddressed healthcare issues: the 
quadruple burden of disease in SA includes communicable diseases, NCDs, 
trauma and perinatal and maternal deaths. Combined with unaddressed social 
determinants of health this places a huge demand upon healthcare.  
 Lack of trained clinicians/capacity: There is a severe shortage of relevant 
capacity in the medical genetics sector in SA (19). Without increasing this 
capacity it is not possible to respond to the increasing health need of CDs.  
 A lack of empirical data: With little observed empirical data available in SA for 
CDs, there is little evidence that CDs are an issue requiring attention (20). Data 
sets held at health care facilities and registries held by patient support groups 
are currently not contributing to national surveillance.  
 Inaccurate assessment of the CD disease burden: The underreporting of CDs 
leads to an inaccurate assessment of the contribution of CDs to the disease 
burden. With deaths and morbidity due to CDs being underestimated, this 
prevents the true situation from being realised. 
 Lack of political will & resources: In the absence of an accurate estimate of the 
CD disease burden, obtaining political support and accompanying resources is a 
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challenge. This is despite global awareness and calls for prioritisation of CDs as a 
healthcare issue (5). 
 Lack of public awareness: Public education and accurate public awareness is 
required to dispel myths around CDs to counter the stigma associated with CDs 
which has led to the unethical treatment of those affected by communities.  
 
All these factors have contributed to the decline of medical genetic services in SA. Today 
medical genetic services are inadequate for the growing health need and those affected 
and at risk of CDs are not receiving the care they require and are effectively being 
marginalized, despite being, as children and the disabled, some of the most vulnerable 
of our society.  
 
Rationale 
The aim of this research project was to assess current medical genetic services at the 
macro-scale in SA to establish their relevance and adequacy in the current 




 To evaluate epidemiological transition related to CDs for the last 25 years in SA 
including its impact upon medical genetic services. 
 Assess the existing constitutional and legislative framework relevant to CDs and 
medical genetic services in SA and its implementation. 
 Highlight the contribution of CDs to child mortality and morbidity and the role of 
medical genetic services in obtaining significant further reductions in mortality. 
 Develop modelled birth prevalence and outcomes for CDs in SA to highlight the 
contribution of CDs to the country’s disease burden. 
 Highlight the role of the genetically trained nurse as a key component in 
developing medical genetic services in SA and potential tools to develop this 
workforce. 
 Demonstrate international consensus on the prevention of CDs and care of 




Structure of the thesis  
This PhD by publication was a descriptive, desktop project including in-depth studies on 
several different sub-topics of relevance to medical genetic services for the care and 
prevention of CDs.  
The literature review is included in Chapter 2 and is preliminary to the rest of the study.  
The study comprises five parts. Excluding the discussion and conclusion, each part 
contains chapters which correspond to publications which are either published, 
forthcoming, currently under review or submission ready. The approach taken for each 
part is outlined as follows: 
Part One: An overview 
 Chapter 3: This paper outlines the epidemiological transition over the past 25 
years. The impact of a counter transition upon medical genetic services related 
to the care and prevention of CDs and the increasing health need of CDs is 
highlighted. It includes an in-depth review of the literature and data collated and 
interpreted from secondary sources (demographic indicators and HIV prevalence 
of pregnant women), to demonstrate the current epidemiological context.  
 Chapter 4: This paper reviews the constitutional, legal and regulatory provisions 
relevant to CDs in SA and their implementation. It outlines the existing legislative 
framework relevant to medical genetic services. A rigorous literature review was 
undertaken for this paper and each legislative or policy document identified was 
evaluated in detail for its relevant to medical genetic services and its role in the 
legislative framework. Implementation of current services was then assessed 
against this framework. 
 Chapter 5: A critique of the 2015 guidelines for maternity care was undertaken 
with relevance to CDs and medical genetic referral services. This article was a 
response to national guidelines issued which have direct relevance to medical 
genetic services. The guidelines are compared with previous editions and the 
content evaluated against the current capacity available in the sector, 
highlighting the mismatch between what is being recommended and what may 
be possible. 
Part Two: Congenital disorders and child mortality 
 Chapter 6: This examines the role of CDs in child mortality and morbidity in SA. 
A comprehensive desktop review contextualizes the unaddressed health needs 
of CDs as a key reason for the ongoing stagnation of child mortality rates in SA. 
It reviews factors contributing to the underestimated role of CDs in the disease 
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burden, highlights gaps in medical genetic services and recommends future 
areas for development. 
 Chapter 7: This letter to the editor in response to published child mortality data 
critically evaluates the use of terminology and definitions used to rank and 
categorise causes of death in a municipality of the Western Cape. It highlights 
the pitfalls of interpreting sub-sets of CDs as a totality, which can be misleading 
for the reader and also contributes to underreporting. 
 
Part Three: Modelling data for South Africa 
 Chapter 8: National and Provincial demographic indicators are used to adapt the 
Modell Global Database (MGDb) to the SA situation. By modelling birth 
prevalence and outcomes for some specific, early onset, endogenous CDs, their 
contribution to the disease burden can be better appreciated, despite the lack 
of empirical data in SA. This includes collating relevant local demographic data 
from within SA, with several sources investigated thoroughly prior to the 
identification of optimal data. A rigorous process of tailoring the MGDb to the 
SA context was undertaken using the collated data to generate modelled data. A 
process of data extraction, analysis and interpretation was undertaken and 
presented.  
Part Four: Building capacity 
 Chapter 9: This chapter discusses the role of the genetically trained nurse in 
medical genetic services. It includes a brief history of the genetic nurse in SA and 
an overview of the current shortfalls in genetic education curricula and their 
potential future role in rebuilding genetic services in the country using two 
specific training tools in the context of the National Health Insurance (NHI) 
scheme.  
Part Five: Global consensus 
 Chapter 10: This details consensus achieved at the 7th International Conference 
for Birth Defects and Disabilities in the Developing World in the context of the 
Sustainable Development Goals (SDGs) and World Health Assembly Resolution 
63.17, and outlines a plan of action. This article required a diplomatic approach 
to ensure the balance of international and national priorities were appropriately 
merged and negotiated into an agreed format. 
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Discussion and conclusion 
 Chapter 11: The discussion and conclusions chapter provides a synthesis of the 
entire thesis, including its novel contribution to the body of knowledge, and 
outlines recommendations for the improvement of renewed medical genetic 
services for the care and prevention of CDs in SA. 
 
Limitations and Constraints 
It was not the purpose of this study to provide a detailed audit of medial genetic services 
in SA but rather to provide a broad context for this growing health need. An overview of 
the current situation of medical genetic services is provided using available data, 
scientific literature and personal communications with recognised specialists in the 
area. Constraints include the lack of available empiric data on CDs in SA, requiring the 
development of modelled estimates, and best estimates were generated for capacity 
due as these figures could not be obtained from the National Department of Health. 
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Chapter 2: Literature Review 
 
Introduction 
It is estimated that globally, 6% of live births are affected by serious congenital disorders 
(CDs) of genetic origin, and thousands more by CDs of post-conception causes (1). 
Serious CDs may result in death or disability (physical, visual, auditory, mental, 
behavioural or epilepsy) (1). CDs are caused pre-conception by genetic factors or 
partially genetic factors, or post-conception by abnormal environmental factors, 
including teratogens and by unknown factors (1-3). Although found in every population 
globally, CDs are not equally distributed and over 90% of CDs occur in middle and low 
income countries (MLIC) where 95% of CD related deaths also occur (1). The burden of 
CDs is often higher in MLIC than in high income countries, causing a heavier burden upon 
the families affected due to more limited resources available (1, 4-7). Reasons for this 
inequality include poverty, malnutrition, inadequate healthcare especially pre-and post-
natal, high risk factors including a higher percentage of mothers of advanced maternal 
age and consanguineous unions, and selective advantage of some single gene disorders 
(1, 5, 7-9). 
 
Definitions and Terminology 
A variety of terms and definitions related to CDs have been used internationally 
throughout the literature, causing global confusion (10-12). In 2006 at a joint World 
Health Organization (WHO) and March of Dimes meeting, agreement was reached on 
the use of the term CDs as synonymous with birth defects. Defined as ‘abnormalities of 
structure or function, including metabolism, which are present from birth’, these may 
be obvious at birth or only manifest later in life (2). Despite this clarification, a variety of 
non-equivalent terms continue to be used for the gathering and exchanging of data on 
CDs in the literature, both in South Africa (SA), in other countries and by internationally 
collaborating organisations (2, 13-18). The most commonly used inequivalent term is 
congenital anomalies, which are macroscopic structural abnormalities1 present from 
                                                          
1 Congenital anomalies include chromosomal abnormalities, multifactorial malformations and some 
single gene defects. Excluded are all functional abnormalities including the haemoglobin disorders, 
glucose-6-phosphate dehydrogenase deficiency and oculocutaneous albinism, some single gene defects 
and post-conception disorders due to abnormalities of the fetal environment (e.g. fetal alcohol 
syndrome and congenital rubella syndrome) (11). 
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birth. As a sub-set of CDs, the term is used often throughout the literature, incorrectly, 
to represent the totality of CDs (2, 11, 12, 19-21). 
The International Classification of Diseases 10th Revision (ICD-10) Chapter XVII 
Congenital malformations, deformations and chromosomal abnormalities, collectively 
comprises congenital anomalies and has contributed to this interchangeable use of non-
synonymous terms (2, 17, 22). Many epidemiological studies and other research groups 
report on congenital anomalies using the ICD-10 Chapter XVII. Many other CDs are found 
elsewhere in the ICD-10 system, including single gene disorders and inborn errors of 
metabolism (e.g. oculocutaneous albinism), blood disorders (e.g. haemophilia) and 
environmentally caused CDs (e.g. fetal alcohol spectrum disorder), collectively 
accounting for an estimated 40-50% of CDs (12, 18, 23). The Global Burden of Disease 
(GBD) includes six categories of congenital anomalies only (23-25). As a result, CDs are 
underestimated by the GBD according to Sitkin (2015) (25) and ‘do not feature 
prominently in the overall health burden’ as highlighted by Bittles in 2013 (23). The 
World Health Assembly Resolution 63.17 recommended widening the scope of 
congenital abnormalities in the ICD classification during the 11th revision, which is due 
for completion in 2018 (18). 
In SA, a variety of terms have been used to describe CDs. The majority of the SA scientific 
literature refers to congenital anomalies (based on the ICD-10 classification) even when 
an alternative term, such as congenital abnormalities is used (13, 16, 21, 26, 27). The 
lack of standardised CD terminology in SA has led to considerable confusion, as 
demonstrated by the 14 different terms used interchangeably in the 2015 Guidelines for 
Maternity Care (14, 28). Some programmes, such as the Child Perinatal Problem 
Identification Programme (Child PIP), are beginning to address this issue (29). 
As for many MLIC, empirical data are lacking for CDs in SA, preventing accurate birth 
prevalence and stillbirth rates being known for many conditions and requiring the use 
of modelled estimates (1, 5, 7, 18, 30-32). An estimated minimum of 1 in every 15 live 
births or 6.8% are affected by a CD in SA (33). This is double the rate reported in high 
income countries such as the USA, where 1 in 33 or 3% of live births are affected (34). 
Although less births are affected by CDs in high income countries, CDs account for a 
greater proportion of infant and child death, and disability in high income countries. In 
2013 in the USA, congenital malformations, deformations and chromosomal 
abnormalities were the top-ranking cause of death, accounting for 20% of mortality in 
infants (35). When categorised according to the World Bank levels of Gross National 
Income (GNI) classification, 28% of deaths were attributed to children under-5 due to 
CDs in high income countries in 2013 (36). In comparison, for upper middle income 
countries such as SA, 14% of under-5 deaths were attributed to CDs in the same year, 
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having risen from 9% in 2000 (36). For SA, the national figure of under-5 deaths due to 




The proportion of child mortality attributed to CDs is indicative of a country’s stage of 
epidemiological transition and development, as demonstrated by the 2015 World 
Health Statistics (36). As a population’s health status improves, the infant mortality rate 
(IMR) decreases and the contribution of CDs increases (5). The stage of epidemiological 
transition at which a country is required to develop medical genetic services has been 
designated at an IMR of between 40-50 per 1 000 live births (7, 8, 19, 37, 38). It is argued 
that this is the point at which infectious diseases are being adequately controlled, 
enabling a greater focus on non-communicable diseases (NCDs), including CDs (30, 38). 
For many MLIC this is not occurring, as outlined in the next section. 
 
Industrialised, high income countries followed Omran’s classic three-stage, linear, 
unidirectional model of epidemiological transition (39). As communicable diseases were 
controlled and eradicated, mortality and fertility decreased, life expectancy at birth 
increased, and non-communicable and degenerative diseases emerged (39). The 
eradication of communicable diseases revealed the previously hidden burden of CDs, 
which attained public health significance in these countries in the early 1960s (1, 40). 
Although Omran’s original concept included a contemporary delayed model for 
developing countries, it made several assumptions, including homogeneity in MLIC. A 
considerable body of research has shown this model to be too simplistic and inflexible 
for MLIC, which are a diverse group of countries (1, 5, 30). In these MLIC, transition 
stages often overlap, are reversible (leading to a counter transition) and are not 
completed, resulting in coexistence of different types of disease in the same population 
(41-43). This has resulted in Omran’s model being modified with two further stages 
being added, including stage five ‘the age of emergent and re-emergent infections’ (41, 
42, 44-46). 
 
Epidemiological Transition in South Africa 
Epidemiological studies in SA, including reports from the Agincourt Health and Socio-
Demographic Surveillance System, indicate that the country is undergoing a protracted 
epidemiological transition and has experienced a counter transition similar to the 
experience of other Sub-saharan African countries (43, 46-49). After steadily decreasing 
since the 1960’s (47), overall mortality began to rise again in the late 1990’s due to the 
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emergence of HIV/AIDS, the resurgence of TB and the simultaneous increase in non-
communicable disease – resulting in a double burden of disease (26, 43, 48, 50). 
Epidemiological polarisation has also been demonstrated in SA, with different social 
classes experiencing different types of disease, mortality and morbidity rates 
exacerbated by apartheid history and unaddressed social determinants of health (21, 
23, 41, 43, 46, 47, 51, 52). The impact of highly active antiretroviral therapy (HAART) 
made universally available in mid-2004, and prevention of mother-to-child HIV 
transmission (53) is outside the scope of the published Agincourt studies, for which data 
cause-specific mortality has been published up until 2004. These and other 
interventions contributed to significantly reducing infant and child mortality and 
increasing longevity from 2008 until 2011, returning the country to positive 
epidemiological transition as highlighted by the Rapid Mortality Surveillance Reports 
(54-56).  
In SA the double burden of disease has been contextualised as a quadruple burden 
which includes HIV/AIDS, injuries and violence, chronic diseases and poverty related 
diseases (26, 57). Poverty related diseases are a collective of communicable diseases, 
NCDs, trauma, and unaddressed social determinants of health (7, 57), later revised to 
perinatal and maternal deaths, most likely in response to the Millennium Development 
Goals (MDGs) (58). In SA, as for other MLIC, persisting communicable disease and 
emerging NCDs continue to bury CDs, and they are yet to be prioritised as a health care 
issue in public policy (59, 60). 
 
The first non–communicable disease 
While NCDs are now included in national priorities and strategies in parallel to a 
continued focus on communicable diseases - CDs are excluded. CDs are not being 
contextualised as an NCD in these national documents (61), despite other national (21) 
and international organisations, including WHO, categorising them as such (61-63). 
Examples include: 
 The DOH Strategic plan for the Prevention and Control of NCDs 2013-2017 (64). 
This focuses upon a healthy lifestyle which addresses the risk of tobacco use, 
physical inactivity, unhealthy diets and alcohol abuse. Genetic factors are 
specified only once in the document as a determinant of disease with no further 
details or interventions outlined.  
 The DOH Strategic Plan for Maternal, Newborn, Child and Women's Health 
(MNCWH) and Nutrition in South Africa (59). This specifies that chronic and long-
term health conditions affect 15-20% of children, highlighting current 
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inadequate services and care for these children but does not connect this to the 
8% of neonates dying in SA from congenital abnormalities also mentioned.  
 Reports of the Committee on Morbidity and Mortality in Children under-5 years 
(61, 65). CDs are included under ‘long-term health conditions’ (LTHC) which is a 
newly defined collective term to cover chronic diseases and disabling conditions, 
including both genetic and acquired conditions (61, 63). In this context, the term 
NCDs are not considered applicable for childhood, which is in contradiction to 
global consensus on the topic (61, 63). 
 
The Millennium Development Goals 
The MDGs set in 2000, specifically MDG4, initiated a global drive to reduce child 
mortality (58). A positive impact was seen in most countries, with child mortality being 
reduced globally by 53% by the deadline, annually saving 6.8 million children’s lives 
between 1990 and 2015 (66). SA experienced a poor start as one of only four countries 
globally that experienced an initial rise in under-5 mortality after the MDGs were set 
(53). Only after child mortality was integrated as a strategic health priority and various 
interventions were implemented, did child mortality began to decrease once again (53, 
67). Although MDG4 was not reached by the end of 2015, a reduction of one third in 
U5MR was achieved in SA, with dramatic reductions seen until 2011 (54, 55).  
Although the MDGS resulted in a focus upon saving the lives of babies and children in 
SA, as evidenced by the appointment of several Ministerial Committees (61, 65, 68), the 
contribution of CDs to the burden of disease is yet to be recognised. Efforts are 
underway to address social determinants of health, most notably the 11 interventions 
reported by Chola et al (69) to further reduce child mortality. These exclude specific 
interventions related to the care and prevention of CDs, which may potentially enable 
further significant reductions, particularly during the first year of life (29). An analysis of 
the contribution of CDs to child mortality in SA is needed, supplemented by evidential 
data to highlight the burden of CDs, such as empiric, observed data collected through 
surveillance and monitoring.  
 
Surveillance and Monitoring of Congenital Disorders 
Global monitoring of CDs began in the late 1960s following the thalidomide epidemic to 
prevent a repeat of this tragedy (70). In 1974, the International Clearinghouse for Birth 
Defects Monitoring Service was founded with a focus on monitoring and to ensure 
accurate counting (71). This was renamed the International Clearinghouse for Birth 
Defects Surveillance and Research (ICBDSR) in 2005 with a new emphasis on surveillance 
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– the analysis and interpretation of collected data to plan, implement and evaluate 
public health interventions in response (1, 70, 71). An analysis of the ICBDSR Annual 
Report for 2014 demonstrates that of the 42 monitoring systems contributing data that 
year, 31 were from high income countries, 9 from middle income countries (7 upper 
middle and 2 lower middle income), with no low income countries contributing data 
(72). The predominance of high income countries reflects their early commencement of 
monitoring more than 40 years ago, in parallel to their early epidemiological transition 
(70). Implementation of monitoring and surveillance by MLIC has occurred more 
recently and is still lacking in many MLIC, particularly those experiencing a protracted 
epidemiological transition (23, 41, 43). With little empiric data in MLIC, the true burden 
of disease from CDs is being underestimated and unrecognised (30). This is despite 
repeated global calls for improved surveillance and monitoring in MLIC over several 
decades (2, 4, 5, 7, 9, 18, 19). 
In SA, the first documented birth defects surveillance system was initiated in the Cape 
Peninsula in 1982 as reported by Sayed et al (73). However, data collected via this 
system was deemed unsuitable for surveillance purposes by the local health authorities 
due to gross underreporting (73). Two tools were then developed: a birth defects 
surveillance system and a genetics postnatal congenital form – the former used for 
recording CDs identified at birth and the latter for use at any age (74).  
In 2004 the decision was taken to develop a single standardised tool, and the Birth 
Defect Collection Tool (BDCT) was implemented from mid-2006, administered by the 
National Department of Health (74). Recent work by Lebese et al (75) on data collected 
via the BDCT from 2006-2014, indicates underreporting of CDs in SA by over 98%. 
Although additional CD data are collated at some facilities and for patient registries by 
patient support groups, these are not integrated into national surveillance (David 
Woods, Personal Communicaton). Without these empirical data it has not been possible 
to accurately establish prevalence rates for specific CDs in SA, or an overall estimate of 
the CD burden.  
 
Modelling 
The lack of empiric data on CDs, particularly in MLIC has led to the development of 
modelled data for CDs. In 2006 the March of Dimes Global Report on Birth Defects 
included a summary of the Modell Birth Defects Database (MGDb) with the first global 
estimates of birth prevalence data for serious genetic/partially genetic birth defects (1). 
This used data from well-established surveillance systems and registries with stable data 
over an extended period verified with other sources to generate baseline estimates of 
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country-specific birth prevalence (1). The accuracy of the modelled data is dependent 
on the quality of the available literature and demographic data inputs. For SA, the MGDb 
estimate was 53.4 genetic/partially genetic CDs per 1 000 live births, excluding post-
conception environmentally caused CDs (1). The publication of these data caused 
significant international interest resulting in a joint March of Dimes-WHO meeting a few 
months later, where these global estimates were endorsed (2). The MGDb is currently 
undergoing a process of updating and revised global estimates based on updated 
modelling (12).  
In SA there is a limited body of work on the prevalence of CDs, particularly for some of 
the priority conditions (76) including Down syndrome, albinism, fetal alcohol syndrome 
(FAS) and NTDs (77-98). Developing additional modelled estimates could provide a 
useful interim measure for these and other CDs. Provincial level estimates may also help 
overcome a current limitation of the MGDb by allowing for heterogeneity of populations 
(23).  
 
Training of Health Care Professionals 
For CD’s to be reported via a monitoring and surveillance system, they must first be 
identified and diagnosed. A key reason for underreporting in MLIC is the lack of trained 
clinicians and facilities available to accurately diagnose CDs (1, 2, 5, 27, 30, 89). 
Consequently, in MLIC, CDs are often undiagnosed or misdiagnosed resulting in the 
patient’s early death (7, 10, 25). These deaths are absorbed into mortality statistics for 
communicable diseases, malnutrition or prematurity, contributing to the 
underreporting of CDs (1, 4, 6, 7, 25, 30, 89, 99-102). There is a complex interplay 
between CDs, prematurity and other pathologies with some infections causing CDs, 
while some CDs may lead to increased risks of developing other severe infections (4, 
101). Lack of diagnosis, co-morbidity and underreporting are all acknowledged as factors 
in relation to CDs in SA (65).  
Several key factors have contributed to the lack of trained clinicians available to identify 
and diagnose CDs in SA. The global shortage of doctors, including specialists, is keenly 
felt in the country (103, 104). Only 12 medical geneticists are currently practicing in SA 
(1 per 4.6 million of the population), which is less than half the recommended number 
of 27 (1 per 2 million) based on the current population (105-108). With medical genetics 
designated a primary specialty in 2007 and requiring an additional four years of training, 
increasing capacity will take time even if the required funding and posts are made 
available (109). If SA is to take advantage of the advances in genetics and genomics and 
integrate these into health care services more rapidly, appropriate genetics training of 
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all health care professionals needs to be considered (37). Recent studies have 
highlighted the need to improve genetics content in nursing curricula in SA (110-113) 
and this sentiment is echoed in the international arena (37). The key role of genetically 
trained nurses in medical genetics services in the past (114) needs to be investigated 
once again, along with possible tools to build up the required workforce as rapidly as 
possible. Long-term measures are needed to equip all health care workers appropriately 
during training by addressing the shortfalls in medical, nursing and allied health care 
professions curricula (5) and continuing genetics education for those already in clinical 
practice (76). 
 
Medical Genetic services  
Medical genetic services are defined as health measures to ‘help people with a genetic 
disadvantage to live and reproduce as normally as possible’ (1, 4, 5, 8, 30). For 
individuals, these provide for medical and psychosocial needs of those affected or at risk 
of CDs and to maximise offspring free of genetic disease. This includes early and accurate 
diagnosis, long-term and anticipatory care, and genetic counselling and psychosocial 
care (4, 5, 10). At the population level, public health measures to reduce the burden 
imposed by CDs include primary, secondary and tertiary prevention (care) (1, 5, 8, 30).  
Medical genetic services develop when CDs are perceived as a significant health 
problem, usually when the IMR drops between 40-50 deaths per 1 000 live births (4, 7, 
8, 37, 38, 51). This mounting health burden of CDs occurs in parallel to infectious and 
nutritional diseases, which persist as the main cause of death while the IMR is still above 
25 per 1 000 live births (51). It is only once the IMR drops below 20 per 1000 live births 
that CDs emerge as the leading cause of infant death (19). Reducing the IMR to less than 
10 per 1 000 live births requires optimal medical genetic services for the care and 
prevention of CDs to be in place (4). In 2015, the SA IMR was estimated at 27 per 1 000 
live births (55, 56). 
 
Interventions for CDs 
As deaths from CDs become visible in a country’s mortality statistics, there is often a 
delay in acknowledging their proportionate increasing role in mortality and morbidity 
(13, 16, 17). In MLIC, medical genetic services, particularly surgery for those affected by 
CDs, continue to be perceived as an unaffordable luxury (4, 11, 115, 116). In some cases, 
there is blatant apartheid of providing treatment to children with communicable 
diseases above those with CDs (11, 30). As outlined by Christianson (11), this 
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marginalisation and discrimination of people with CDs, many of whom are children and 
disabled, diminishes their human dignity and denies their basic human and 
constitutional rights.  
In 1993 groundbreaking work by Czeizel (117) demonstrated that although 30% of those 
affected by serious CDs will die regardless of intervention, up to 70% of the CD burden 
can be prevented or treated (2, 10, 30, 118). For 40% this includes lifesaving or curative 
treatment - mainly through surgical intervention for conditions such as neural tube 
defects (NTDs), club foot, cleft lip and/or palate, congenital heart disorders (CHDs), 
undescended testicles, gastrointestinal tract abnormalities etc (10, 117, 119). For the 
remaining 30%, rehabilitative or long-term therapeutic treatment can mitigate disability 
enabling improved quality of life (10, 30, 37, 117). This work has gone relatively 
unheeded by many MLIC, including SA, as evidenced by the lack of prioritisation of 
medical genetic services (120). 
An overwhelming body of work has emerged in the literature highlighting the role of 
paediatric surgery as a cost effective tool in reducing the burden of surgically avertable 
CDs (mainly congenital malformations) in MLIC (25, 121-124). Work by Higashi et al 
(2013)(121) demonstrated that 12.7 million (59%) disability-adjusted life years2 (DALYs) 
are avertable with full surgical coverage for NTDs, CHD and cleft lip and/or palate. 
Paediatric surgery has been shown to be as cost-effective as vaccines and infectious-
disease treatments and thought to be cheaper than condom distribution (115, 116, 125-
127). Despite these studies demonstrating the cost effectiveness of surgical 
intervention, the lack of qualified surgeons in MLIC, including in SA, is a key stumbling 
block (25, 29). Building up local surgical expertise offers a more affordable and 
sustainable long-term solution than the high cost of repeatedly bringing in external 
expertise through vertical programmes (124). Surgical and other intervention also has 
implications for reducing morbidity, since many of those affected by CDs survive with 
disability (1). The 1997 South African Integrated National Disability Strategy (128) 
highlighted that the majority of disabilities are preventable, and that prevention must 
be a cornerstone of disability policy. However, to date there is no national prevention 
policy for disability (129) and existing policies and strategies are poorly coordinated with 
disability under-prioritised, resulting in those living with disabilities, including those 
resulting from CDs, not having access to the rehabilitative and other services they 
require (130). 
 
                                                          
2 Disability-adjusted life years (DALYs) are metrics used for measuring the disease burden in terms of 
mortality and morbidity. One DALY is one healthy year of life lost due to disability or premature death. 
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Care and prevention 
A further issue for consideration when developing medical genetic services that 
emerged during this literature review is the balance between the care and prevention 
of CDs. Although both must be implemented, the emphasis in many MLIC tends to be 
upon prevention only, as highlighted in the March of Dimes Global Report on Birth 
Defects (1). The issue of over emphasising prevention, specifically termination of 
pregnancy (TOP) for severe prenatally diagnosed CDs, was highlighted during this PhD 
study by reviewers providing feedback on submitted articles. The emphasis on TOP as 
one specific preventative intervention solely for economic reasons ignores the need for 
relevant and accessible care for those affected, which is unethical and echoes eugenic 
sentiment against the infirm seen throughout history (11, 51). The mantra of 
Christianson ‘Care is an absolute, prevention is the ideal’ (131) demonstrates the 
integrated approach required in medical genetic services – advocating that care of those 
affected must come first. This is confirmed by WHO international expert consultations 
which define the control of CDs as ‘an integrated strategy combining the best possible 
patient care with prevention by community education, population screening, genetic 
counselling and the availability of prenatal diagnosis’ (1, 4, 5, 8, 118). While care is the 
first objective, it must be balanced with prevention since the cost of care will rise as 
more patients survive (1, 30, 37). The implementation of primary prevention (ensuring 
individuals are born free of CDs through normal conception and preventing damage in 
utero)3, secondary prevention (minimizing the number of children born with CDs)4 and 
tertiary prevention (early detection, cure and amelioration of problems once a child is 
born with a CD)5 – which is essentially care, comprehensively integrates these two 
concepts (1, 30). 
Although medical genetic services in industrialised countries developed decades ago as 
these countries completed epidemiological transition, the resulting services available 
are far from ideal (1). These services were initiated by specialists in a range of disciplines, 
resulting in fragmented tertiary services with no unified strategy and little contact with 
public health or community-based services (30, 132). Medical genetic services in these 
industrialised countries are characterized as highly specialized, technical and expensive, 
focusing on ‘controversial aspects of diagnosis, treatment and prevention’ functioning 
                                                          
3 Primary prevention is achieved through family planning, optimizing women’s diets, managing maternal 
infections (e.g. rubella, syphilis, toxoplasmosis) and illnesses (e.g. diabetes mellitus and epilepsy), pre-
conception screening for common recessive disorders (1). 
4 Secondary prevention is achieved through medical genetic screening and prenatal diagnosis, genetic 
counselling. therapeutic options and the option of termination of pregnancy (1). 
5 Tertiary prevention or care interventions include early recognition and diagnosis (e.g. newborn 
screening), medical treatment of complications, surgical repair of congenital malformations, 
neurodevelopmental therapy for those with disability and palliative care for those dying as a 
consequence of their CDs.  
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from academic centres in urban centres with limited access in rural areas (30). There has 
been a tendency for MLIC to follow this model (120) although a different approach is 
recommended for developing these services in these countries (1, 4, 5, 7, 30, 118). 
Integrating medical genetic services into existing primary healthcare programmes (PHC), 
with referrals for complex cases, should be the aim for MLIC rather than vertical 
programmes (4-6, 10, 37, 118). 
 
Medical genetic services in South Africa 
Limited medical genetic services are documented as far back as the 1950’s, and were 
integrated as a part of the state funded health services through the National Health Act 
(63 of 1977) (51, 109, 114, 133). Operating from research-oriented urban academic 
centres (38, 51), these followed a similar approach to that taken by industrialised 
countries. Only a small portion of South African society was reached, mainly the affluent 
whites for whom CDs were a perceived health priority, experiencing similar 
epidemiology to that in developed countries, as outlined by Jenkins (38, 51). Although 
these services were only available for a portion of the population, budgetary constraints 
were already cited as a limitation of developing these services further (51).  
Momentum in developing medical genetic services in SA began in the mid to late 1990s, 
as mortality decreased and longevity increased and the country began to transition 
epidemiologically (38). The IMR reached a low point in SA of 46 deaths per 1000 live 
births in the 1990s (134). This prompted a committee to be established by the National 
Department of Health, chaired by Prof H.M. ‘Jerry’ Coovadia to investigate primary 
health care services for women, maternal and child health in SA, including services for 
the care and prevention of CDs (Arnold Christianson, personal communication). Soon 
after, a national task force of experts was established in collaboration with the WHO to 
investigate the need for, and implementation of, services for the care and prevention of 
CDs. Following wide consultation, the National Policy Guidelines for the Management 
and Prevention of Genetic Disorders, Birth Defects and Disabilities were published in 
2001 (76). Three years later, the National Guidelines for the Care and Prevention of the 
Most Common Genetic Disorders, Birth Defects and Disabilities followed (135). The 
Medical Genetic Education Programme was developed and began implementation in 
2003. However, the competing health priorities of HIV/AIDS and concomitant TB 
diverted attention and resources from CDs, leading to their neglect over the following 
decade. The 2013 Capability GenTEE report (120) highlighted SA as the only country out 
of eight emerging countries evaluated where positive development in improving 
medical genetic services has ceased, and has actually regressed.  
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In 2010 World Health Assembly Resolution 63.17 (18) highlighted the role of CDs in 
neonatal mortality and urged member states to address CDs as a priority health issue to 
achieve MDG4. SA is a United Nations member state and required to respond to this 
resolution, but is yet to do so. Following the appointment of a democratically elected 
government in 1994, substantial legislative and policy changes were made to redress 
past inequalities, including the Constitution of South Africa (Act 108 of 1996) (136) and 
the National Health Act (61 of 2003) (137). The HIV/AIDS and TB epidemics occurring 
simultaneously with these policy changes significantly impacted medical genetic 
services, which were integrated into PHC as part of this policy revision process (138). To 
date, no detailed study of legislation and regulation with relevance to CDs has been 




In 1990, Professor Trefor Jenkins predicted that ‘with greater emphasis on PHC and 
preventative medicine, the IMRs among the present underprivileged populations, 
including those in rural areas, will drop and the demand for genetic services will 
increase’ (51). For the reasons outlined in this literature review, more than 26 years later 
this is still to be fully realised.  
A defined approach on how to develop medical genetic services for the care and 
prevention of CDs is clearly documented in the available literature (4, 5, 7, 9, 19). These 
recommend the integration of genetic services into PHC as part of ongoing health 
programmes, an issue which many industrialised countries are now grappling to address 
through their established fragmented services. The key components of medical genetic 
services recommended for MLIC include accurate monitoring and surveillance of CDs, 
public awareness, education and training of healthcare providers; and political 
commitment including funding (1, 5, 6, 30, 37). These interventions do not need to be 
initiated simultaneously, nor are they all expensive and high-tech. There is however, a 
high societal cost of inaction both to public health (socioeconomic) and avoidable 
human suffering which is often ignored (5). The ‘best possible patient care available 
needs to be provided in the existing circumstances’ (1) which may differ within and 
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Part One: An Overview 
 
Part One provides the context for congenital disorders (CDs) in SA. General themes that 
emerge include the lack of empirical data for CDs which has prevented their true 
contribution to the disease burden from being inaccurately assessed; and as for many 
middle low income countries (MLIC), CDs have remained buried as a healthcare issue in 
SA due to other health care priorities. Although there is an existing framework of 
legislation that provides for medical genetic services in SA, there is incomplete 
implementation. This is mainly due to a lack of infrastructure and capacity – skilled 
clinicians to diagnose, refer and treat those affected to meet the current and growing 
health need. Part One is divided into three chapters: 
Chapter 3 ‘sets the scene’ and outlines the overall incidence (birth prevalence) of CDs in 
SA and reviews epidemiological transition in SA over the past 25 years. This reveals that 
SA has not followed the classical stages of Omran’s theory (1) of transition due to the 
HIV/AIDS and concomitant TB epidemics. Although the country is now back in positive 
epidemiological transition, medical genetic services are inadequate to meet the growing 
health need. It is predicted that the proportion of child and infant deaths from CDs will 
increase in SA as communicable diseases are better controlled, following the trend of 
industrialised countries. Child mortality rates have stagnated in SA since 2011 (2, 3), 
suggesting unaddressed health issues – such as CDs that need to be prioritised.  
Chapter 4 evaluates the existing framework of legislation relevant to CDs and the 
provision of medical genetic services. The idea behind this article was to find out what 
the government is doing in response to CDs through the development and 
implementation of medical genetic services. The results of a desktop review highlight 
the international protocols, national legislation and policy documents and national 
guidelines of relevance to medical genetic services. A considerable number of new laws 
were introduced post-1994 and there is provision for comprehensive genetic services, 
particularly in the National Health Act (Act 61 of 2003) (4) and the Policy Guidelines for 
the Management and Prevention of Genetic Disorders, Birth Defects and Disabilities in 
2001 (5). However, despite this theoretical provision, there has been a shortfall in 
practice and medical genetic services have declined in recent years. Capacity in the 
sector is now lower than in 2001. Key reasons for this are suggested as a lack of political 
commitment, funding, post allocation and general lack of prioritisation of human 
genetics as a health issue and the disease burden represented by CDs.  
 36 
Chapter 5 is an article in response the new edition of the 2015 Guidelines for Maternity 
Care (6) with relevance to CDs. This follows on from the previous chapter by 
demonstrating that emerging policy is disconnected from the current reality of the 
medical genetics sector. In comparison to the previous issue of the guidelines, this 
document uses a wide range of inconsistent terminology to represent CDs. This 
highlights a lack of insight and awareness of issues related to CDs. A number of 
recommendations made in the guidelines for referrals to medical genetic services are 
theoretically correct but are implausible in practice due to the lack of current capacity 
in the sector. No attempt was made during the development of the guidelines to 
collaborate with the medical genetics sector.  
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Need for services for the care and prevention of congenital 
disorders in South Africa as the country’s epidemiological 
transition evolves
The lack of prioritisation of congenital disorders 
(CDs) in health care, and the limited resources 
allocated to prevention and to the care of those 
affected, is an issue of global concern. This is 
especially true in low- and middle-income countries 
(LMICs), where over 90% of CDs currently occur, resulting in 95% of 
CD deaths worldwide.[1,2]
In 2010 the World Health Organization’s World Health Assembly 
(WHA) prioritised services for the care and prevention of CDs, 
particularly in LMICs, by passing Resolution WHA63.17.[2] This 
recognised the importance of CDs as a cause of stillbirths and 
neonatal deaths, their contribution to under-5 mortality, and their 
contribution to failure to attain Millennium Development Goal 4 
(MDG4). WHA63.17 urged member states to recognise and address 
CDs as a public health issue. It also highlighted the lack of accurate 
epidemiological data available for many LMICs.[2] CDs are often 
undiagnosed or misdiagnosed and the cause of death wrongly 
attributed. Collectively, this prevents policy decision-makers from 
correctly assessing the burden of CDs in these LMICs.[3]
In South Africa (SA), the constitutional, legal and regulatory 
framework exists to promote the development of services for the care 
and prevention of CDs. It is the government’s responsibility to provide 
such services. To understand the renewed need for these services, it 
is important to consider, contemplate and review the epidemiological 
transition that has occurred in SA over the last 25 years.
Epidemiology of CDs in SA
Modelled data of genetic causes of CDs[1] and an estimate of 
teratogenic causes (A L Christianson, personal communication, 
2014) indicate that a minimum of 6.8% of births, representing one 
in every 15 live births in SA, is affected by a CD. Of these, 80.5% 
are genetic or partially genetic in cause, while 19.5% are caused by 
teratogens. The latter is higher than the 10 - 15% expected, owing to 
the high prevalence of fetal alcohol syndrome.[1] With 26.2% of CDs 
diagnosable in the first day of life, over 18 000 cases annually should 
be identified and reported in SA.[4] However, in 2012 only 2 174 CDs 
were reported via the Birth Defects Collection Tool administered 
by the National Department of Health (NDoH) (V  Mtyongwe, 
EDITORIAL
187       March 2015, Vol. 105, No. 3
personal communication, 2013). This indicates under-reporting 
of 88%!
Although serious CDs can be life threatening or result in long-
term disability, up to 70% can be prevented, cured or ameliorated 
by appropriate care.[1,5] Many interventions are relatively inexpensive 
and low-tech, including surgery for congenital malformations and 
community-based preventive measures (e.g. iodine and folic acid 
fortification of staple foods).[1]
Epidemiological transition
Epidemiological transition is the term for the change in population 
health statistics and pattern of diseases of a country or region, 
consequent on change in socioeconomic, education, infrastructure 
and healthcare development.[1] Omran’s three-stage model of epi-
demiological transition[6] has been used extensively to describe 
this process, particularly in industrialised nations. During this 
transition, infant and child mortality rates decrease and longevity 
rises, communicable diseases are controlled and eradicated, and non-
communicable and degenerative diseases emerge.
Most high-income or industrialised countries completed the first 
two stages of epidemiological transition decades ago. Stage one, the 
‘age of pestilence and famine’, is characterised by high fluctuating 
mortality rates, a low life expectancy at birth, and epidemics, 
famine and war as the main causes of death. This is followed by 
stage two, the ‘age of receding pandemics’, when mortal ity starts to 
decrease and is accompanied by a marked increase in life expec-
tancy, although high levels of communicable disease re main.[6] 
By controlling infectious diseases, reducing malnutrition and 
improving healthcare (including maternal) services, industrialised 
countries moved into stage three, the ‘age of degenerative and 
man-made diseases’.[1,6] Deaths from CDs remain invisible during 
this process of transition  – ‘buried’ among deaths caused by 
communicable diseases – to emerge only as the latter are adequately 
controlled. CDs then become proportionately more significant in 
overall neonatal, infant and child mortality.
CDs attained public health significance in industrialised nations 
as they moved into the third stage of epidemiological transition 
in the early 1960s.[1] Since 85 - 90% of CDs have a genetic cause, 
their birth prevalence and resulting mortality remained high,[1]
causing them to emerge and persist as a leading cause of child 
death in industria lised nations. A comparative study of death 
rates in England and Wales for 1901 and 1971 demonstrates this: a 
68% reduction in non-communicable diseases occurred between 
1901 and 1971, but the number of deaths caused by CDs remained 
un changed.[1]
Epidemiological transition and CDs  
in SA
SA, like many LMICs, has not followed the classic model of 
epidemiological transition experienced by industrialised nations, 
as a result of the HIV/AIDS and TB epidemics.[7] Fig. 1 plots the 
under-5 mortality rate (U5MR), infant mortality rate (IMR) and life 
expectancy at birth (longevity) data for SA over the past 25 years. 
From 1960, a clear trend of decreasing infant and under-5 mortality 
and increasing longevity continued until 1992, when life expectancy 
at birth peaked at 62.33 years. In 1993, both the U5MR and the IMR 
were at an all-time low of 58.2/1 000 live births and 45.1/1 000 live 
births, respectively. At this point it appeared as if SA would follow 
the three classic stages of epidemiological transition, approaching 
the early phases of transition from stage two of the ‘age of receding 
pandemics’ to stage three, the ‘age of degenerative and man-made 
diseases’.[6]
As a result of this falling childhood mortality in the early 1990s, 
CDs began to emerge as a public health issue. The Policy Guidelines 
for the Management and Prevention of Genetic Disorders, Birth 
Defects and Disabilities were published by the NDoH in 2001.[8] 
These outlined goals, objectives, strategies and delivery of clinical 
and laboratory services appropriate for the care and prevention of 
CDs. In 2004, the National Guidelines for the Care and Prevention of 
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Fig. 1. Epidemiological transition in SA over the past 25 years, as demonstrated by data for childhood mortality,[18] longevity[19] and the HIV epidemic.[20]
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were published, targeting primary healthcare providers, describing 
common CDs and strategies for their care and prevention. However, 
progress in epidemiological transition was dramatically interrupted 
and reversed in the mid-1990s with the advent of the concomitant 
HIV/AIDS and TB epidemics (Fig. 1). Over a 10-year period, HIV 
prevalence in pregnant women soared from 7.6% in 1994 to 29.5% 
in 2004. Child mortality rose dramatically, with the U5MR peaking 
at 80.8/1 000 live births in 2003 and the IMR at 53.2/1 000 in 2002. 
Life expectancy dropped to 51.56 years in 2005, an all-time low 
since the 1960s. SA was no longer following the sequential stages of 
transi tion as HIV/AIDS caused the resurgence of TB, adding a stage 
to Omran’s concept known as the ‘age of emergent and re-emergent 
infections’.[7,10,11] Combined with the simultaneously increasing 
burden of non-communicable diseases in the population, this has 
led to a ‘double burden of disease’.[11]
In 2004, the prevalence of HIV infection among pregnant women 
plateaued at 30% and the U5MR started to reduce as a result of scaled-
up prevention of mother-to-child transmission and expanded roll-
out of antiretroviral (ARV) therapy.[12] The 2002 IMR of 53.2/1 000 
live births dropped to 33.5 in 2012 (Fig. 1). This is lower than the 
all-time best IMR of 45/1 000 live births in 1993 prior to the HIV/
AIDS epidemic. However, since 2011 both the IMR and U5MR have 
stagnated without significant further reductions.[13]
A major effect of the HIV/AIDS and TB epidemics was to ‘bury’ 
the issue of CDs. As services for HIV/AIDS developed, funding and 
attention were diverted away from tertiary medical genetic services. 
If child mortality, including neonatal deaths, is to decrease further, 
control of these ongoing epidemics cannot be at the expense of other 
child healthcare needs.[12]
Services for the care and prevention of CDs in SA are now at a 
lower base than in 2001. The 2003 recommendations for human 
capacity requirements to be trained and in-post by 2010 to meet 
the expected, and now increased, health needs remain unful-
filled.[14] Personnel levels are similar to, or lower than, those in 2001, 
with 11 medical geneticists today compared with four in 2001 and 
the 20 recommended by 2010.[14] Of the nine genetic counsellors in 
posts today, only four are in the state system (T Wessels, personal 
communication, 2014), compared with approximately 20 in 2001, 
and the 80 recommended.[14] Budget cuts have compromised medical 
genetic diagnostic laboratory services countrywide.
In 2013, SA was reported as the only country of eight emerg ing 
economies evaluated where positive development in improv ing med-
ical genetic service structures had ceased and indeed regressed.[3] This 
decline will take time to reverse, and the dire state of these services, 
including the lack of policy addressing childhood disability, must be 
recognised by those in authority and urgently rectified.
Conclusion
While SA has missed attaining MDG4, it has significantly reduced 
the U5MR and IMR under difficult circumstances. The previous 
negative epidemiological transition, premised on the HIV/AIDS 
epidemic, has reversed and is once again positive with an IMR of 
33/1 000 live births.[7] SA must now confront the issue of developing 
services for the care and prevention of CDs to reduce the stagnating 
child mortality rates.[13] The current IMR is now below 40/1 000 live 
births, at which point countries recognise the coming health needs of 
CDs and strive to implement appropriate services.[15] The proportion 
of deaths from CDs in SA under-5s was 4% in 2008,[3] and may be 
expected to rise as childhood deaths from CDs increasingly emerge 
as a leading cause of death in children while deaths from infections, 
particularly HIV/AIDS, decrease.
Legislation entitles those affected and living with CDs, including 
those disabled as a result, to the ‘best possible patient care’ in the 
prevailing circumstances, and provides for access to prevention by 
appropriate interventions.[16] With the global focus, including that of SA, 
shifting to non-communicable diseases, CDs must be con textualised as 
the first non-communicable disease experienced by people. CDs deserve 
to be prioritised, in accordance with WHA Resolution WHA63.17, to 
ensure the human dignity and con stitutionally and legally enshrined 
human rights of those affected and their families.[2,17]
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Post-Script to Chapter 3 
 
Following publication of this paper the PhD examiners identified specific edits that would 
further improve the quality of the paper. While we acknowledge that the version of the 
paper published by the journal will remain unchanged we would like to specify the following 
amendments: 
 
 Page 39, column 2, paragraph 1, line 9, amendment: ‘In 1993, both the U5MR and 
IMR were at the lowest point to date of 58.2/1 000 live births and 45.1/1 000 live 
births respectively.’ It was incorrect to say at an ‘all-time low’ since both the U5MR 
and IMR have dropped below these figures since then, as detailed on page 40, 
column 1, paragraph 6. 
 Page 40, column 1, paragraph 2, line 5-6, amendment: ‘This is lower than the 
previously lowest recorded IMR of 45/1 000 live births in 1993 prior to the HIV/AIDs 
epidemic.’ It was incorrect to say an ‘all-time best IMR’ since the IMR has since 
dropped to below 40/1 000 live births, see column 1, paragraph 6, line 5. 
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This article was published in the South African Journal of Bioethics and Law.  
Malherbe HL, Christianson AL, Aldous C, Christianson M. Constitutional, legal and 
regulatory imperatives for the renewed care and prevention of congenital disorders in 
South Africa. S Afr J BL. 2016;9(1 MAY):11-7. doi:7196/SAJBL.429. 
 
ARTICLE
May 2016, Vol. 9, No. 1    SAJBL     11
Congenital disorders (CDs) 
are an underestimated cri­
tical health issue. Competing 
health priorities have re­
sul ted in the neglect of 
medi cal genetic services for the care and 
prevention of CDs. While a comprehensive 
national legislative and regulatory frame­
work exists for these services, providing 
for the fundamental and socio­economic 
rights enshrined in the constitution, poor 
implementation has resulted in shortfalls in 
service for those affected by CDs, many of 
whom are living with disability.
The internationally agreed definition 
of CDs are abnormalities of structure or 
function present from birth, which may be 
evident at birth or manifest later in life.[1] 
Although CDs are a global problem, over 
90% occur in middle­ and low­income 
countries (MLIC), where 95% of those affec­
ted consequently die.[2] In South Africa (SA), 
one in every 15 live births is affected by a 
CD.[3] Modelled data indicate a minimum 
of 6.8% of SA births, of which 80.5% are 
caused by genetic factors and 19.5% by 
teratogens.[2,3] CDs are often undiagnosed, 
or misdiagnosed due to a lack of awareness 
of attending clinicians to make appropriate 
diagnoses.[2,4,5] Mortalities as a result of CDs 
are often incorrectly attributed, burying CDs 
as an issue.[2,4,5] However, up to 70% of CDs 
can be prevented, cured or the resulting 
disability ameliorated through appropriate, 
timely treatment.[2,6]  Lack of data resulting 
from poor diagnoses results in the CD 
burden being under­reported in many 
MLIC countries, where CDs are substantially 
under­reported.[3,4,5,7] In SA, only 2 174 CD 
cases were documented in 2012 via the Birth 
Defect Collection Tool administered by the 
Department of Health,[8] compared with the 
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Medical genetic services for the care and prevention of congenital disorders have declined significantly in recent years due to competing health 
priorities, with previously developed services becoming compromised. With an infant mortality rate of 28/1 000 live births, South Africa (SA) has 
passed the threshold of 40/1 000 when such services should be implemented. This article outlines the international background and SA legislative 
framework for medical genetic services and their implementation. International, regional and national conventions, legislation, and policy were 
studied for relevance to genetic services and their implementation was evaluated, including a comparison of sector capacity between 2001 
and 2015. A comprehensive legislative and regulatory framework exists in SA for the provision of medical genetic services, but implementation 
has been fragmented and unsustained. Congenital disorders and genetic services are not prominent in national strategies and excluded from 
interventions aimed at combating child mortality and non­communicable diseases. Capacity today is at a lower level than in 2001. The failure 
to recognise the burden of disease represented by congenital disorders is the underlying reason for the implementation and service shortfall. 
Child mortality rates have stagnated since 2011 and can be significantly further reduced by prioritising healthcare issues other than HIV/AIDS, 
including congenital disorders. It is now an imperative that SA responds to World Health Assembly Resolution 63.17 and prioritises congenital 
disorders as a healthcare issue, providing services to uphold the dignity and human rights of the most vulnerable members of society.












































Fig. 1. Comparison of the percentage of under-five deaths resulting from congenital anomalies for World 
Bank Country Classifications. [9]
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83 118 (6.8%) expected, indicating under­
reporting of 97%.[3,9]
As SA develops, the proportion of child hood 
deaths from CDs is increasing, as morta lity from 
com municable diseases decrea ses.[3,9] This fol­
lows the epidemiological trend in industrialised 
countries where CDs emerged and remain as 
the leading cause of child death and disability.
[2,3] Fig. 1 compares the percentage of under­five 
deaths resulting from congenital anomalies (a 
subset of CDs) between the World Bank Country 
Classifications according to Gross National 
Income (GNI) per capita.[9] The proportion of 
deaths from congenital anomalies in all GNI 
groups increased between 2010 and 2013, and 
in high­income countries they are the leading 
cause of deaths, accounting for 28% in children 
under five. 
Significant reductions in the infant mortality 
rate (IMR) and the under­five mortality rate 
(U5MR) were seen between 2008 and 2011 
from comprehensive HIV/AIDS interventions 
and the childhood Expanded Programme 
of Immunisation.[10,11] However, both the 
IMR and the U5MR have stagnated since 
2011 and the neonatal mortality rate since 
2009.[12] This indicates that health issues 
other than those being addressed, such as 
CDs, require prioritisation.[3,9,10,12] In 2013, 
congenital abnormalities (obvious structural 
abnormalities) overtook infection as the third 
leading cause of death in early neonates, 
accounting for 11.24% of early neonatal deaths 
in infants weighing >1 000 g compared with 
8.84% from infection.[13]  When the IMR falls 
below 20/1 000 live births in a country, CDs 
emerge as the leading cause of infant death.[14] 
Fig. 2 illustrates the IMR decreasing as 
countries develop and transition epi de ­
miologically, and the increasing propor­
tion of CD­related infant deaths.[9] The 
need for medical genetic services is 
usually recognised by nations when their 
IMR falls below 40/1 000 live births, as 
infant and child mortality can be signifi­
cantly further reduced through such 
measures.[4,5,14,15] Up to 40% of serious 
congenital malformations which may 
be fatal if untreated, can be cured by 
surgical intervention, and in 30% of cases 
the degree of resulting disability can be 
reduced through relevant treatment.[4,6] 
With an IMR of 28 live births in 2014[12] 
SA is beyond the point when appropriate 
services should be implemented to further 
reduce child mortality and to better care 
for those who are disabled by CDs.[3,4,9,14,15,]
Medical genetic services for the care and 
prevention of CDs ensure that people with 
CDs, or at reproductive risk of having children 
with CDs, can live and reproduce as normally 
as possible.[5,16] They are key in reducing the 
contribution of CDs to the disease burden 
and should provide the ‘best possible patient 
care’ in the prevailing circumstances for those 
affected or at risk of CDs.[9,15,16] Medical genetic 
ser vices established at human genetics 
de partments and medical schools have been 
the mainstay in SA since the 1970s.[9] Access 
to these services has been limited to urban 
areas with some rural outreach.[9] 
Services began to improve in the late 1990s 
and early 2000s, when CDs first emer ged as 
a health issue and the Policy Guidelines for 
the Management and Preven tion of Genetic 
Disorders, Birth Defects and Disabilities were 
published.[17] However, service implementation 
continued through the established framework 
of academic centres, rather than integrating 
services into primary healthcare and extending 
clinical genetic services beyond urban areas, 
as was recommended in the 2001 Policy 
Guidelines.[9,17]
Constitutional, legal and 
regulatory framework in SA
Several international treaties and reso­
lutions indicating global political com mit­
ment towards CDs are applicable to SA and 
summarised in Table 1. Notable is World 
Health Assembly (WHA) Resolution 63.17 
of 2010.[18] This recognises the importance 
of CDs as a cause of stillbirths and neonatal 
deaths, and their contribution to the U5MR 
and attaining Millennium Development 
Goal (MDG) 4 to reduce child mortality by 
two­thirds.[19] Achieving MDG4 required ‘ac­
ce lerated progress in reducing neonatal 
mor tality including the prevention and ma­
n agement of birth defects.[9,18] Although pro­
gress was made towards an U5MR of 20/1 000 
live births, MDG4 was not achieved.[9]
SA is a signatory to international pro­
tocols and conventions that have resulted 
in na tional legislation (Table 1).[9] Most 
rele vant to medical genetic services is the 
United Nations Convention on the Rights 
of Persons with Disabilities (UNCRPD).[20] 
Signed and ratified in 2007, the UNCRPD 
promotes, protects and ensures full and 
equal enjoyment of all human rights and 
fundamental freedoms by all persons with 
disabilities and promotes respect for their 
inherent dignity.[20] The United Nations 
Convention on the Rights of the Child 
(UNCRC), ratified by SA in 1995, concerns 
the rights of the disabled child without 
discrimination, while ensuring dignity, 
promoting self­reliance and community 
participation.[21]
The Constitution and 
National Legislation 
A comprehensive, national legislative 
framework exists in SA for the provision 
of medical genetic services (Table 2).[9] 
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Fig. 2. Relationship between infant mortality and percentage of infants dying from CDs, based on global 
country figures.[9]
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legislation and provides for fundamental rights to equality, dignity, 
freedom and security of the person, education and life.[22] Section 
27 provides for the socio­economic right of everyone to access 
healthcare services, including reproductive healthcare, and social 
security: women, children and people with disabilities are entitled to 
these s27 rights with the qualification that:
‘[t]he State must take reasonable legislative and other measures, 
within its available resources, to achieve the progressive realisation of 
each of these rights’.[22]
Children’s rights not subject to the concept of progressive realisation 
are listed in s28(1)(c), which states that every child has the right:[9]
‘to basic nutrition, shelter, basic health care services and social services’.[22]
Table 1. International treaties, conventions, declarations, protocols of relevance to medical genetic services[9]
Document Article/rule/overview 
World Programme of Action Concerning the Disabled (1982)[35] Prevention, rehabilitation and equalisation of opportunities
Standard Rules on the Equalisation of Opportunities for 
Persons with Disabilities (1993)[36]
Rules: 1. Awareness raising; 2. Medical care; 3. Rehabilitation; 4. Support service;  
5. Accessibility
United Nations Convention on the Rights of the Child (signed 
1993 and ratified 1995)[21]
Articles: 2. No discrimination; 6. Right to life; 23. Disabled child; 24. Healthcare;  
26. Social Security
International Covenant on Economic, Social and Cultural 
Rights (1966) (signed 1994 and ratified 2015)[37]
Article: 12. Physical and mental health
United Nations Millennium Declaration (signed 2000)[19] Goal 4: Reducing under­five mortality by two­thirds by 2015
United Nations Convention on the Rights of Persons with 
Disabilities (signed and ratified 2007)[20] 
Articles: 5. Equality/non­discrimination; 6. Women with disabilities; 7. Children 
with disabilities; 8. Awareness raising; 9. Accessibility; 10. Right to life; 19. Living 
independently; 20. Personal mobility; 23. Respect for home and family; 25. Health; 
26. Habilitation and Rehabilitation
African Charter on the Rights and Welfare of the Child 
(‘Children’s Charter’) (signed 1997 and ratified 2000)[38]
Articles: 5: Right to life;13. Protection of physically/mentally disabled to ensure 
dignity; 14. Physical/mental health and healthcare
The New Partnership for Africa’s Development (2001)[39] Healthcare provision and delivery
African Youth Charter (signed and ratified 2009)[40] Articles: 16. Health; 23. Girls and young women; 24. Mentally/physically challenged youth 
World Health Assembly Resolution 63.17 (signed and ratified 2010)[18] Urges member states to address CDs as a healthcare issue through specific actions
Table 2. Key national legislation of relevance to medical genetic services[9]
Title Overview and sections relevant to CDs
Constitution of the Republic of South Africa (108 of 1996)[22] Chapter 2: Bill of Rights. Sections: 9. Equality; 10. Human dignity; 11. Life; 27(1)(a). Access to 
healthcare services, including reproductive healthcare; 27(1)(c). Access to social security including 
appropriate social assistance; 28(1)(c). Every child has the right to basic healthcare services
Health Professions Act (56 of 1974)[28] Regulates the health professions through the Health Professions Council of South Africa
National Health Act (61 of 2003)[23] Sections: 4(3)(a). Free healthcare to pregnant/breastfeeding women, children under six 
not members/beneficiaries of medical aid schemes (c) free termination of pregnancy; 
21(2)(b)(vii). Genetic services; 21(2)(k) & 25(2)(w). Management, prevention and control 
of communicable and NCDs; 23 (1)(a)(ix) & 27(1)(a)(ix). Epidemiological surveillance/
monitoring of national and provincial trends; 21, 23, 25 & 27. Implementation of 
national/provincial policy and compliance; 39(2)(a)&(d) and 70(2)(d) Health needs of 
vulnerable groups including children and people with disabilities; 48. Development 
and provision of human resources in national health system; 52. Regulations relating to 
human resources; 70. Identification of health research priorities
Choice on Termination of Pregnancy Act (92 of 1996)[24] Sections: 2(b)(ii) and minors 5(5)(a)(ii) Termination of pregnancy (TOP) between 13 ­ 20 
weeks inclusive if substantial risk that the fetus would suffer from a severe physical/
mental abnormality
Sections: 2(c)(ii) and minors 5(5)(b)(ii) TOP after the 20th week if the continued 
pregnancy would result in a severe malformation of the fetus
The National Health Laboratories Service Act (37 of 2000)[26] Laboratory services for the public health sector
Sections 4 & 5: Cost­effective and efficient health laboratory services including training
Mental Health Care Act (17 of 2002)[25] A legal framework for mental health in SA with an emphasis on human rights
The Nursing Act (33 of 2005)[27] Regulates the nursing profession through the South African Nursing Council
Children’s Act (38 of 2005)[30] Sections: 11. Children with disability or chronic illness; 156(1)(g). Care and protection
Social Assistance Act (13 of 2004)[29] Sections: 7. Care dependency grants; 9. Disability grants
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This includes children with CDs, and those living with disability 
caused by CDs.
National Health Act
The National Health Act (NHA) 61 of 2003 provides a framework 
for a single healthcare system for the country, rectifying the socio­
economic imbalances and inequities of the health services of the 
past and provides for many of the rights outlined in the Bill of 
Rights.[23] 
The NHA is the only piece of national legislation in which genetic 
ser vices feature prominently. A clear directive is included in Chapter 3, 
under Main functions of the National Department in s21(2)(b)(vii):[9]
‘the Director-General must, in accordance with national health policy, 
issue and promote adherence to, norms and standards on health matters 
including genetic services.’[23]
Genetic services are listed among other vital services, including sterilisation 
and termination of pregnancy, and the provision of health services/
healthcare services for convicted persons and persons awaiting trial, 
highlighting the considered importance of these services.
The NHA stipulates that the national policy is executed via the 
provincial departments of health in a top­down approach. National 
and provincial health councils ensure national policy is implemented 
provincially and that provincial health plans comply with national 
policy (NHA s21, 23, 25, 27).[23] To date, no provincial policies or health 
plans for genetic services have been developed, with the exception 
of the Western Cape (Prof. Raj Ramesar and Dr Mike Urban, personal 
communication), and most provinces refer to the 2001 national 
policy[17]  
Other sections of the NHA relevant to medical genetic services 
include: 
• management, prevention and control of non­communicable disea­
ses (NCDs) through healthcare services (s21(2)(k) and s25(2)(w)) 
• epidemiological surveillance and monitoring of disease trends 
(s23(1)(a)(ix) and s27(1)(a)(ix)) 
• identification of priority health problems and research priorities 
relevant to the burden of disease (s70) 
• health needs of vulnerable groups, including children and people 
with disabilities (s39(2)(a)&(d), s70(2)(d)) 
Table 3. National policies, strategies, guidelines, charters and initiatives relevant to medical genetic services 
Document Year Overview
Integrated National Disability Strategy White Paper[41] 1997 The right of people with disabilities to play a full, participatory role in society
Policy Guidelines for the Management and Prevention 
of Genetic Disorders, Birth Defects and Disabilities[17]
2001 Goals, objectives, strategies and delivery of clinical and laboratory services for 
the care and prevention of CDs, including human capacity recommendations
Guidelines on Ethics for Medical Research. Book 2. 
Reproductive Biology and Genetic Research[42]
2002 Section 3.3: Genetic screening and testing
Department of Health. Strategic Framework for the 
Modernisation of Tertiary Hospital Services[43]
2003 Human genetics throughout document in proposed models. Appendix 4: 
Revised human capacity recommendations
National Guidelines for the Care and Prevention of the 
Most Common Genetic Disorders, Birth Defects and 
Disabilities[31]
2005 Targeting primary health care providers, describing common CDs and strategies 
for their care/prevention
National Perinatal and Neonatal Morbidity and 
Mortality Committee[45]
2008 Audit perinatal and neonatal deaths and produce annual reports and final 
report in 2011
National Patients’ Rights Charter[46] 2008 Common standard to realise, uphold, promote and protect the constitutional 
right of access to healthcare services
Section 2: Access to healthcare; 2(3)(c) Provision for special needs (newborn, 
children, pregnant women, disabled); (d) Counselling; (e) Palliative care; (g) 
Health information
Negotiated Service Delivery Agreement. Outcome 2: A 
long and healthy life for all South Africans[47]
2010 Strategic outputs: 1. Increasing life expectancy, NCDs and burden of disease; 2. De ­
crea sing maternal and child mortality; 4. Strengthening health system effectiveness
National Health Insurance in South Africa Policy 
Paper[48]
2011 To transform existing institutions/organisation in the healthcare system to 
make the system more equitable, offering universal coverage to a defined 
comprehensive package of services 
South Africa’s National Strategic Plan for a Campaign on 
Accelerated Reduction of Maternal and Child Mortality 
in Africa[49] 
2012 To rapidly reduce maternal and child mortality
Strategic Plan for Maternal, Newborn, Child and Women’s 
Health and Nutrition in South Africa 2012­2016[33]
2012 Reducing maternal and child mortality. Long­term health conditions in children 
(p24) 
Committee on Morbidity and Mortality in Children 
Under 5 Years[50]
2012 Reviews and monitors maternal, perinatal and childhood mortality and 
morbidity data in SA  
National Department of Health: Strategic Plan 2014/15­
2018/19[32]
2014 Programme 3: Maternal and child health. NCDs
Guidelines for Maternity Care in South Africa[44] 2015 Chapters: 4. Antenatal care; 9. Pregnancy problems; 10. Intrauterine, neonatal 
deaths and stillbirths; 15. Screening for congenital anomalies
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• human resources including adequate resources for education and 
training of healthcare personnel (Chapter 7).[23]
Other national legislation
Other key national legislation provides for different aspects of genetic 
services and are summarised in Table 2.[9] Notable are:
• The Choice on Termination of Pregnancy Act (1996), used as part 
of a preventive strategy when severe abnormalities are detected in 
utero (s2(b)(ii), 2(c)(ii), s5(5)(a)(ii), s5(5)(b)(ii).[24]
• The Mental Health Act (2002) provides a legal framework for 
mental health, emphasising the human rights of the mentally ill.[25]
• The National Health Laboratories Service (NHLS) Act (2000) 
provides for laboratory services as an essential component of 
genetic services.[26]
• The Nursing Act and the Health Professions Act provide for 
statutory bodies regulating these professions.[27,28] In SA, genetic 
counsellors require registration under the Health Professional 
Council of South Africa.[28]
• Social Assistance Act (2004) provides for care dependency and 
disability grants.[29]
• Matters concerning the disabled child are specified in the Children’s 
Act (2005).[30]
National policy
Two key policy documents focus solely on CDs: National Policy 
Guidelines for the Management and Prevention of Genetic Disorders, 
Birth Defects and Disabilities[17] and National Guidelines for the Care 
and Prevention of the Most Common Genetic Disorders, Birth Defects 
and Disabilities.[31] The National Policy Guidelines outline goals, objec­
tives, strategies, personnel requirements and delivery of clinical and 
laboratory services appropriate for the care and prevention of CDs. 
Despite these policies, CDs are not regarded as a healthcare issue 
in SA strategic plans (Table 3), despite the emphasis on reducing child 
mortality in response to MDG4. The Department of Health (DoH) 
Strategic Plan 2014/15­2018/19 recognises mental health disorders 
as a NCD, aiming to improve access to services through screening 
and treatment, but does not acknowledge the significant genetic 
component of many of these disorders.[32]
In the DoH Strategic Plan for Maternal, Newborn, Child and 
Women’s Health and Nutrition in South Africa 2012 ­ 2016, CDs are 
mentioned as a cause of neonatal death, contributing to 15 ­ 20% 
of children affected by a long­term/chronic health conditions who are 
‘not receiving the care they require’. [9,33] No responding interventions 
are outlined.[9] NCDs are a key strategic focus in these policies, but 
there is no cognisance that CDs are an NCD, the first experienced in 
life, contributing to the 43% of NCD related deaths annually in SA.[14,34]
A draft Disability Rights Policy, a first step to implementing the 
UNCRPD[20] was published for public comment in early 2015. A review of 
several health and disability policy documents is underway, including the 
2001 Policy Guidelines [17] and accompanying clinical guidelines proposed. 
Implementation
Despite the existence of a comprehensive legislative framework for 
the development of medical genetic services, implementation has 
fallen short and medical genetic services are in decline. 
In Table 4, personnel capacity is compared between 2001 and 2015, 
demonstrating that these services are at a lower base today than in 
2001.[3,9] 
Of over 1 000 healthcare providers, mainly labour ward nurses, 
trained through the Medical Genetics Education Programme (MGEP), 
less than 100 remain in services for care and prevention of CDs.[9] 
The lack of continued support forced trainees to discontinue their 
genetic nursing role and move to non­related fields. This has resulted 
in reduced clinical capacity to identify and diagnose CDs and has 
influenced the surveillance of CDs.[9]
SA is the only country (of eight emerging economies) where 
positive development in improving medical genetic service structures 
has ceased and indeed regressed.[3,7] 
Reasons for this decline since 2001 include competing health priorities 
that have redirected political commitment and funding.[3,9] The lack of 
investment in medical genetic services has resulted in insufficiently 
trained personnel, inadequate capacity at all levels, and severely com­
promised laboratory services.[3,9] These shortfalls make it impossible 
to uphold the constitutional rights of those affected by CDs, including 
children and those living with disability, through the practical provision 
of the services they require.
Conclusion
While the SA constitution is admired globally for its protection of hu­
man rights, there has been a failure to translate these consti tu tional 
imperatives into effective, accessible services for the care and preven­
tion of CDs. Failure to recognise the burden of disease represented 
Table 4. A comparison of medical genetic services capacity in 2001 and 2015[9]
Recommended* 2001‡ 2015
Category Number/ratio   
(Pop = 46 13 m)†
Number ‡ Ratio                 
(Pop = 44 82 m)†
Number Ratio                
(Pop = 54 96 m)§
Medical geneticists 20/1 per 2 m 4 1 per 11.2 m 12¶ 1 per 4.6 m
Genetic counsellors 80/1 per 580 000 <20 1 per 2.2 m 9∏ 1 per 6.1 m 
Medical scientists/
technologists 100/1 per 450 000 50 1 per 900 000 26** 1 per 2.1 m
* Department of Health. Strategic Framework for the Modernisation of Tertiary Hospital Services. Discussion Document. Pretoria, South Africa: Department of Health, 2003;86.
‡ Department of Health. Policy Guidelines for the management and prevention of genetic disorders, birth defects and disabilities. Pretoria, South Africa: Department of Health, 2001.
† Statistics South Africa. South African Statistics 2014. Pretoria, South Africa: Statistics South Africa, 2014.
§ Statistics South Africa. Mid-Year Population Estimates 2015. Pretoria, South Africa: Statistics South Africa, 2015.
¶ No medical geneticists are employed by the State in Gauteng. Personal communication: A. Krause, 11 February 2016. 
∏ Figure increased to 9 in April 2016 plus 6 in private practice. Personal communication: T. Wessels, 25 February 2016.
** NHLS academic medical scientists only. Personal communication: H. Soodyall, 27 July 2015.
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by CDs is the underlying cause of this unethical shortfall in services.[9] 
Despite the comprehensive legal framework remaining unchanged, 
the implementation of this legislation has declined. ‘We have the con­
stitution, the law, the guidelines and policy – but good laws are being 
lost in translation’ (Prof. Marylyn Christianson, Special Olympics Disability 
Summit, Shanghai, 2007). In the words of the 2013 GenTee Report,[7] ‘the 
continuing lack of commitment to the country’s constitutional, legal and 
regulatory framework [has resulted in] an implosion of genetic services 
in the public domain due to very limited public will, commitment and 
funding [resulting in] inequitable genetic services [impacting] the ability 
of the poorer population to utilize services according to their needs’.
It is an imperative that SA responds to WHA 63.17[18] and prioritises 
CDs as a healthcare issue by providing the required medical genetic 
services to uphold the dignity and human rights of people with CDs, 
the most vulnerable of our society.
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Post-Script to Chapter 4  
 
Following publication of this paper the PhD examiners identified specific edits that would 
further improve the quality of the paper. While we acknowledge that the version of the 
paper published by the journal will remain unchanged we would like to specify the following 
amendments: 
 
 Page 43, column 1, paragraph 4, line 16, amendement: ‘With an IMR of 28/1 000 live 
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In 2015, the 4th edition of the Guidelines for Maternity Care in 
South Africa was published by the National Department of Health 
(NDoH). [1] A manual for clinics, community health centres and 
district hospitals, these replaced the previous 2007 edition.[2]
The guidelines provide, among other things, a practical approach 
for primary healthcare to manage pregnancy, labour and delivery 
in South Africa (SA) with the ultimate aim of reducing maternal 
mortality (deaths during pregnancy or within 42 days of delivery). 
With the maternal mortality ratio (MMR) estimated as having 
quadrupled in SA due to the HIV/AIDS epidemic, the need for such 
guidelines is clear.[3] At 154 maternal deaths per 100 000 live births 
in 2011 - 2013, the MMR was reduced to almost pre-HIV epidemic 
levels, but the Millennium Development Goal target of 38/100 000 
live births was not achieved.[4,5] Sights are now set on the Sustainable 
Development Goal of a global MMR of less than 70/100 000 by 2030.[6]
Owing to the inextricable link between mother and child, poor 
maternal health and maternal death are more likely to lead to death 
of the newborn.[7] With 40% of under-5 deaths occurring during the 
neonatal period in SA, and 75% of these occurring as early neonatal 
deaths, the benefits of quality prenatal care for the child are obvious. [8] 
In SA, deaths in infants and children under-5 decreased rapidly 
between 2008 and 2011, with a more modest improvement in neonatal 
deaths from 2009 to 2011, after which all these rates stagnated.[9] Efforts 
to combat communicable diseases – including HIV/AIDS – continue, 
and interventions are underway such as those identified in the report 
by Chola et al.,[10] the childhood Expanded Program of Immunization, 
and improving social determinants of health; these will contribute to 
further reducing childhood deaths. However, for significant further 
reductions in childhood mortality and morbidity, including neonatal 
deaths, the contribution of congenital disorders (CDs) must be 
addressed.[11,12] 
The growing burden of congenital 
disorders
Data from the Perinatal Problem Identification Program (PPIP) 
in 2014 indicated that congenital abnormalities have overtaken 
infection as the third leading cause of early neonatal deaths, after 
hypoxia and immaturity.[12,13] Since congenital abnormalities (obvious 
structural CDs identified at birth) are a sub-group of CDs, the true 
death toll from CDs is likely to be much higher. CDs, which are 
abnormalities of structure or function present from birth – although 
they may only manifest later in life[14] – are estimated to affect one in 
15 live births in SA.[11] CDs have not been prioritised as a healthcare 
issue in SA, despite World Health Assembly Resolution 63.17 of 2010 
recognising their contribution to neonatal deaths and calling member 
states to action. [11,15] The lack of accurate, empirical data has led to 
an underestimate of the true contribution of CDs to the burden of 
disease. [16,17]
The purpose of this article is to evaluate the 2015 Guidelines on 
Maternity Care with relevance to the care and prevention of CDs. [1] 
Where appropriate, these will be compared with the previous edition 
of the guidelines within the current epidemiological context in SA.[1,2]
What is the aim of the Guidelines for 
Maternity Care?
Prepared by the National Maternity Guidelines Committee at the 
NDoH, the guidelines are for health workers (doctors and midwives) 
providing obstetric, surgical and anaesthetic services for pregnant 
women in primary healthcare facilities where specialist care is not 
normally available.[1] Clinics, community health centres and district 
hospitals are encouraged to use the guidelines to develop protocols 
tailored to their specific needs, for identifying, diagnosing and 
managing common and serious pregnancy and delivery problems. 
Both editions of the guidelines respond to report recommendations 
by the National Committee on the Confidential Enquiry into Maternal 
Deaths, with the overall aim to improve clinical management and 
referral to reduce pregnancy-related deaths and ill health.[5]
While the 2015 guidelines follow a similar format to that of the 
previous edition, they also include some new chapters and omit 
others. [1,2] Content of relevance to CDs is included in chapters 2: 
Levels of care; 4:  Antenatal care; 9: Problems in pregnancy; 10: 
Management of intra-uterine deaths, stillborn babies and neonatal 
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deaths; and 15: Basic ultrasound at district 
level and routine postnatal care. Additional 
chapters in the 2015 edition do not include 
new content relevant to CDs; rather, the level 
of detail and quality of information on CDs 
has been decreased. 
Confusion in 
terminology
The most notable difference in the 2015 
edition is the use of 14 different terms to refer 
to CDs, whereas the 2007 edition consistently 
used the term ‘birth defects and genetic 
disorders’. [2] The internationally agreed term 
‘congenital disorders’ itself is not used in 
the document, although the synonym ‘birth 
defects’ is used several times.[14] Unsupported 
by a glossary, the terms used include: 
congenital anomalies; congenital abnormality; 
congenital infection; chromosomal and 
congenital defect; abnormalities; structural 
and chromosomal fetal anomalies; birth 
defect; genetic or chromosomal defects; 
genetic disorder; genetic anomalies; genetic 
disease; familial and genetic disorder; fetal 
abnormalities; and fetal anomaly. Except 
for birth defects, these all refer to sub-sets 
of CDs, and some categories of CDs are 
excluded (personal communication, Berna-
dette Modell, November 2015).[14] This incon-
sistent use of disparate terms for CDs is of 
concern and causes confusion around this 
healthcare issue. 
Teratogens
In the 2015 edition, teratogens including 
alcohol, recreational drug use, maternal 
infections (rubella and syphilis), and the 
use of teratogenic medications during 
pregnancy are listed under ‘risks for genetic 
disease’. The risks associated with poorly 
controlled medical conditions are also listed, 
but diabetes mellitus is add ressed elsewhere 
in the guidelines and hypothyroidism and 
iodine deficiency are not mentioned. With 
teratogens accounting for almost 20% of 
CDs in SA and affecting 14 000 births 
annually, these need to be contextualised 
correctly, with greater emphasis placed on 
these preventable CDs.[11] 
Surveillance
An exclusion from the 2015 guidelines is the 
regular compilation of data on the number 
of babies born with genetic disorders and 
major birth defects, as specified in the 
2007 edition. In contrast, the 2015 edition 
refers only to the recording of mortalities, 
and recommends the PPIP format for data 
collation. This sole focus on deaths omits 
morbidity and the opportunity to provide 
vital data into national surveillance of CDs. 
Other content relevant 
to CDs
The majority of content relevant to CDs 
is included in chapters 4: Antenatal care 
and 10: Management of intra-uterine 
deaths, stillborn babies and neonatal deaths. 
In chapter 4, the importance of history 
taking for familial and genetic disorders 
to assess risk factors at the first antenatal 
visit is emphasised, as is 5 mg of folic acid 
daily 3 months prior to and throughout 
pregnancy for the prevention of neural tube 
defects. A concise section entitled ‘Risk of 
genetic disease’ lists categories of women 
of childbearing age potentially at risk of 
having a child with a ‘birth defect or genetic 
disorder’, but includes non-genetic CDs. 
It recommends the provision of essential 
information to all pregnant women on 
specific topics including the avoidance of 
alcohol, tobacco and recreational drugs, the 
use of medication (self-care) and genetic 
disorders and birth defects relevant to 
newborn and infant care. 
Capacity constraints in 
medical genetic services
In chapter 10: Management of intra-uterine 
deaths, stillborn babies and neonatal deaths, 
genetic counselling and relevant referral 
should be provided as part of postpartum care 
when CDs are suspected, prior to another 
pregnancy in case of reoccurrence. Steps 
outlined to obtain a diagnosis when a CD 
is suspected as the cause of death include 
undertaking a history and a basic external 
examination. When a diagnosis cannot be 
made, a postmortem or whole body X-ray/
digital photography for referral to a geneticist 
is recommended. This does not take into 
account the limited capacity available in SA 
due to there being only 12 practising medical 
geneticists, clustered around academic centres 
in urban areas (Table 1).[12] 
Capacity in the medical genetic services 
sector is further underestimated in chapter 
15: Basic ultrasound at the district level. 
While acknowledging that routine screening 
for structural and fetal anomalies is ‘not yet 
practical in the public sector’, all women of 
advanced maternal age (specified as over 
37 years) are referred to a specialist health 
facility or a maternal fetal ultrasound unit. 
This includes referral to a genetics clinic 
where consenting women should be routinely 
offered a scan, genetic counselling and inva-
sive testing to rule out Down syndrome. 
It does not specify that genetic counselling 
should be undertaken prior to the scan and 
repeated afterwards in the case of abnormal 
findings. Women with a previous history or 
family history of structural, chromosomal or 
genetic disorders are also referred to specialist 
hospitals for structural screening and man-
age ment decision. Analysis of recorded live 
births in 2013 indicates that 84 260 births 
(8.5%) were to women over 37 years. [22] As 
outlined in Table 1, current capacity falls 
far short of recommended levels, with only 
12 practising medical geneticists, fewer than 
9 genetic counsellors and compromised 
laboratory services operating almost entirely 
from academic medical genetic departments 
countrywide. This available capacity makes 
it impossible for this number of referrals 
of women of advanced maternal age to 
be implemented. Medical genetic services 
relating to the care and prevention of CDs are 
in a state of decline and at a lower base today 
than prior to the HIV/AIDS epidemic.[11,12]
Genetic counselling
In addition to referring high-risk women 
to regional and tertiary hospitals, genetic 
screen ing and counselling services are 
specified as a function of district hospitals 
in chapter 2: Levels of care. A significant 
contribution to the care of newborns is 
undertaken by nurses in these low-resourced 
primary healthcare settings, particularly 
in rural areas. These nurses, and general 
medical officers, are in the main not 
equipped with genetic counselling skills, 
and the nurses who are trained are in short 
supply. SA is also experiencing a severe 
shortage of doctors, with only 60 per 100 000 
Table 1. A comparison of medical genetics services capacity in 2001 and 2015[12]
 Recommended (2003)[18] 2001 2015
Category






Medical geneticists 20 (1 per 2m) 4 1 per 11.2m 12* 1 per 4.6m
Genetic counsellors 80 (1 per 580 000) <20 1 per 2.2m 9† 1 per 6.1m 
Medical scientists/
technologists
100 (1 per 450 000) 50 1 per 900 000 26‡ 1 per 2.1m
*No medical geneticists are employed by the state in Gauteng. Personal communication, A Krause, 11 February 2016. 
†This figure increased to 9 in April 2016, plus 6 in private practice. Personal communication, T Wessels, 25 February 2016.
‡NHLS academic medical scientists only. Personal communication, H Soodyall, 27 July 2015.
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population in 2013 compared with the global average of 152/100 000, 
and even fewer specialists (including medical geneticists).[23] This 
places a huge strain upon the system and medical practitioners are 
overworked and often unsupported. This general lack of capacity of 
healthcare professionals at all levels must be rectified before such an 
under-resourced system can respond to additional demands. 
Conclusion
As management guidelines, the 2015 edition responds to the policy 
directive to reduce maternal mortality by offering principles from 
which detailed institutional protocols can be developed. However, 
the guidelines are not cognisant of the limited infrastructure, capacity 
and resources available in the medical genetic services sector. 
The lack of investment in medical genetic services, largely due to 
competing health priorities, make it impossible for referrals in the 
guidelines to be implemented.
Consultation with the medical genetics community during the 
development of the 2015 edition could have prevented this disjoint 
and would have benefited from the ongoing review of the 2001 Policy 
Guidelines for the Management and Prevention of Genetic Disorders, 
Birth Defects and Disabilities.[20] 
With SA once again in positive epidemiological transition, the 
proportion of neonatal, infant and child deaths from CDs will continue 
to increase as the country develops and communicable diseases are 
better controlled.[11,12] Relevant, accessible and effective medical genetic 
services can prevent, cure and ameliorate CDs by up to 70% and may 
be the only way to significantly reduce child mortality further. [11,12,16,17,24] 
If SA is to respond to Sustainable Development Goal  3 to end 
preventable deaths in newborns and reduce premature mortality from 
non-communicable diseases by two-thirds by 2030, CDs must be 
addressed comprehensively and funding allocated to build capacity 
and infrastructure in the sector. [6,12] This response must permeate every 
level of implementation, to ensure no child is left behind. 
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Part Two: Congenital disorders and child mortality  
 
Moving on from Part one, Part two takes a different approach and contextualizes 
congenital disorders (CDs) as a contributing factor to child mortality in SA. This is of 
particular relevance both in SA and internationally due to the Sustainable Development 
Goals (SDG) (1) set for 2030, particularly the targets for SDG 3. If SA is to meet the goal 
of reducing the U5MR to 25 per 1 000 live births, several things need to happen. The 
current ‘invisible’ burden of CDs needs to be recognized, and the reality that with 
appropriate care, the burden of CDs can be reduced by up to 70% (2, 3). Although a lot 
of momentum was gathered as a result of the Millennium Development Goals (MDG) 
(4), specifically MDG 4 in focusing on reducing child mortality – CDs continue to be 
overlooked in SA. This chapter highlights that until medical genetic services are 
implemented – something that usually occurs when the Infant Mortality Rate (IMR) falls 
below 40-50 deaths per 1 000 live births. SA is yet to implement comprehensive services, 
despite the IMR reaching 27 in 2015 (5), and will fail to see a significant further reduction 
in child mortality until it does so. This chapter brings together all the available evidence, 
building on that provided in Part One. It highlights the need to recognize CDs as a 
healthcare issue in SA and the urgency to implement medical genetic services if child 
mortality is to be further significantly reduced. 
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The contribution of congenital disorders to  
child mortality in South Africa
In South Africa many  
congenital disorders 
go undiagnosed or are 
misdiagnosed resulting in  
the incorrect cause of  
death being reported and  
in an underestimation  
of the true burden of 
congenital disorders  
in the country.
R eduction in child mortality has been a priority issue in South Africa leading up to the Millennium Development Goals. However, the contribution of congenital disorders (CDs) to child mortality is yet to be recognised and acted upon. 
Rapid reductions in child mortality have resulted largely from comprehensive HIV and 
AIDS programmes and interventions such as the childhood Expanded Programme of 
Immunisation. However, the Rapid Mortality Surveillance System reports that since 
2011, reductions in child mortality rates “stopped abruptly”. This indicates that health 
issues other than those currently being addressed may require long-term prioritisation. 
In 2013, congenital anomalies (excluding many CDs) overtook infection as the third 
leading cause of early neonatal deaths, which account for one-third of all under-five 
deaths. 
As South Africa transitions epidemiologically, the proportion of deaths caused by 
CDs is increasing, as mortality from communicable diseases drops, revealing the 
previously hidden disease burden of CDs. In South Africa, many CDs go undiagnosed 
or are misdiagnosed, resulting in the incorrect cause of death being reported. These 
inaccurate data result in an underestimation of the true disease burden of CDs in the 
country.
As up to 70% of CDs can be prevented or ameliorated, it is essential that they 
be prioritised and that relevant, accessible services for prevention and care be 
implemented. A good legislative and regulatory framework exists in South Africa for 
the provision of services, but implementation has been poor and fragmented. Current 
services are available at a lower base than in 2001.
This chapter argues for recognition of the role of CDs in child mortality and morbidity 
and the potential advantages of medical and genetic services for the prevention and 
care of CDs.
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Introduction 
Since the Millennium Development Goals (MDGs) were set in 
2000, there has been a global drive to reduce child mortality.1 In 
order to achieve the MDG 4 target of cutting under-five mortality 
by two-thirds by the end of 2015, countries rapidly incorporated 
measures relevant to their specific healthcare challenges. As the 
MDG deadline loomed, South Africa focused on responding to 
the HIV and AIDS and concomitant tuberculosis (TB) epidemics, re-
engineering primary health care and developing a strategic plan for 
Maternal, Newborn, Child and Women’s Health (MNCWH) and 
Nutrition. Several ministerial committees were established to address 
underlying issues, including the National Perinatal Mortality and 
Morbidity Committee (NaPeMMCo) and the Committee on Mortality 
and Morbidity in Children (CoMMiC). The topic of newborn and 
child mortality and survival has also been examined in detail in 
previous editions of the South African Health Review.2,3
None of these policies or initiatives has comprehensively recognised 
the contribution of congenital disorders (CDs) to neonatal, infant 
and child mortality and morbidity. This is despite the fact that in 
industrialised countries around the world, CDs are the leading 
cause of death in infants and children, contributing up to 28% of 
under-five deaths in high-income countries.4 Like many other middle- 
and low-income countries (MLICs), South Africa is following this 
epidemiological trend and the proportion of deaths and disability 
resulting from CDs is rising, especially as communicable diseases 
are better controlled.5
This chapter provides an overview of the health issue of CDs and 
their unappreciated role in child mortality and morbidity in South 
Africa. Epidemiological transition is described in relation to CDs 
and an outline is given of the growing role of CDs in the burden 
of disease in South Africa and why it has remained hidden. The 
chapter also identifies the benefits of recognising the contribution 
of CDs in the burden of disease, including potential reductions in 
mortality and morbidity through medical genetic services for the 
prevention and care of CDs. The current status of these services 
is reviewed and compared with what is required to address this 
growing health need. Where relevant, secondary data have been 
sourced from peer-reviewed literature and globally recognised data 
sources.
Mil lennium Development Goal 4
The adoption of the United Nations Millennium Development 
Declaration in 20001 and the time-based targets set for the 
following 15 years has resulted in varying degrees of achievement 
among participating nations. MDG 4 focused on improving child 
survival, and significant progress towards this two-thirds reduction 
in under-five mortality was achieved globally. By 2015, the global 
under-five mortality rate (U5MR) had been reduced by 53%, halving 
the number of children dying annually from 12.7 million in 1990 to 
5.9 million in 2015.6 Many regions achieved or came close to the 
targeted two-thirds (66%) reduction in U5MR. In sub-Saharan Africa, 
the U5MR decreased by 54%.6 One in every 12 children still dies 
before his or her fifth birthday in sub-Saharan Africa compared with 
one in 147 in high-income countries.6 
South Africa’s progress towards MDG 4 has been varied. In 2005, 
South Africa was one of only four countries where the U5MR 
was higher than the 1990 MDG baseline due to the negative 
epidemiological impact of HIV and AIDS and concomitant TB.7 
Significant reductions were then seen in child mortality until 2011 
due to a number of factors. These included scaled-up prevention of 
mother-to-child transmission of HIV, expanded roll-out of antiretroviral 
therapy, and the addition of the rotavirus and pneumococcal 
conjugate vaccines to the childhood Expanded Programme of 
Immunisation (EPI).7–9 Despite the rate of reduction tripling since 
2000, the U5MR decreased by one-third only, to 39 per1 000 
live births,8 falling short of the South African MDG 4 target of 20 
per1 000 live births.
However, according to the Rapid Mortality Surveillance Report there 
has been no further decrease in infant and child mortality in South 
Africa since 2011.8 This stagnation indicates the need to address 
other health issues contributing to infant and child mortality, whilst 
continuing with ongoing efforts.5,7,8 Many issues related to social 
determinants of health and childhood illnesses are already being 
addressed, including malnutrition and infectious diseases associated 
with poverty such as measles, diarrhoea and malaria. A 2013 study 
identified 15 key interventions that were scaled up in South Africa 
for maximum impact on maternal and child mortality during the 
final two years of the MGDs.10 Preliminary measures to target non-
communicable diseases (NCDs), now a component of South Africa’s 
quadruple burden of disease, are also under way.11 However, CDs, 
which are the first NCD experienced by infants and children,5,12 are 
yet to be recognised for their contribution to stillbirths, and neonatal, 
infant and child mortality in South Africa. This is despite the global 
call to action by the World Health Assembly (WHA) in 2010 through 
Resolution 63.17,13 which recognised the importance of CDs as 
a cause of stillbirths and neonatal mortality. To attain MDG 4, 
WHA 63.17 called for “accelerated progress in reducing neonatal 
mortality including the prevention and management of CDs”.13
CDs are a common, costly and critical health issue. According to 
the 2006 March of Dimes report,14 serious CDs result in the death 
of 3.3 million children under the age of five globally every year. 
Although CDs are found in all populations throughout the world, 
over 90% occur in MLICs where 95% of CD-related deaths occur.14 
Reasons for this unequal distribution of CDs include less-developed 
health services and a variety of poverty-related reasons that increase 
the risk of CDs occurring, such as a higher percentage of older 
mothers and consanguineous marriages, and the survival advantage 
against malaria for carriers of some single gene disorders.14 Despite 
this higher incidence of CDs in MLICs, the contribution of CDs to 
the burden of disease is yet to be recognised by many of these 
countries. 
Definitions and terminology
CDs are defined as “any potential pathological condition arising 
before birth, including disorders caused by environmental, genetic 
and unknown factors, whether they are evident at birth or become 
manifest later in life”.15 CDs that are caused before conception are 
genetic and the result of chromosomal abnormalities or single gene 
defects, or are multifactorial in origin. Post-conception CDs are the 
result of teratogens (alcohol, prescribed and recreational drugs, 
maternal infections and illnesses, exposure to environmental toxins 
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Figure 1:  Epidemiological transition in South Africa over the past 25 years, as demonstrated by data for childhood mortality,20 longevity,21 
and the HIV epidemic22
Source:  Malherbe, 2015.5
and radiation) or abnormalities of the fetal environment that deform 
or disrupt the developing fetus (e.g. constraint and amniotic band 
disorder). Teratogens – fetal environmental factors that cause CDs – 
may be chemical substances, physical agents or infections, and are 
more common in MLICs where the potential for exposure is higher 
and there are fewer preventative measures in place.14 
The global lack of consensus on terminology related to CDs has 
plagued the medical genetics sector and resulted in lower priority 
being given to this healthcare issue. In 2006, after decades of 
uncertainty, agreement was reached by international experts on 
the use of basic terminology at a joint World Health Organization 
(WHO) and March of Dimes meeting.15 Participants recommended 
that the terms ‘CDs’ and ‘birth defects’a be used synonymously. Use 
of the term ‘congenital anomaly’ was not advised, since it excludes 
around 40% of functional CDs including non-syndromic congenital 
disabilities, common single gene disorders and inborn errors of 
metabolism.b,12,15
The limited uptake of this agreed terminology and the copious use of 
non-equivalent terms has led to confusion, fragmentation of effort and 
an inability to compare data sets.b This has diluted the visibility of the 
significant contribution of CDs to neonatal, infant and child mortality, 
and prevented CD data from being evaluated comprehensively. CDs 
are often undiagnosed or misdiagnosed and the cause of death 
is wrongly attributed, contributing to under-reporting.16 The lack of 
accurate data on CDs has led to an underestimation of the true 
contribution of CDs to the disease burden.14,16,17
Epidemiological transition
Epidemiological transition occurs when there is a change in 
population health statistics and pattern of disease in a region or 
country, resulting from changes in socio-economic, educational, 
infrastructural and healthcare development.14 The epidemiological
a Birth defects are defined as abnormalities of structure or function, including 
disorders of the metabolism, which are present from birth.15
b Personal communication: B. Modell, 19 January 2016.
transition of countries has been described extensively using 
Omran’s model,18 which defines three stages of disease. As 
mortality rates decrease and longevity increases, countries move 
from Stage 1 ‘the age of pestilence and famine’ to Stage 2, ‘the 
age of receding pandemics’ and into the third stage, ‘the age 
of degenerative and man-made diseases’ characterised by low 
mortality rates and high life expectancy at birth (over 50 years). It 
is in this third stage that communicable diseases are well controlled 
or eradicated, and NCDs and degenerative diseases emerge.18
Like many MLICs, South Africa is not following Omran’s classic 
model18 of epidemiological transition that was completed by 
industrialised, high-income nations decades ago.19 From 1960 to 
the early 1990s, infant and child mortality in South Africa declined 
steadily and longevity increased.5 Figure 1 plots the U5MR,20 infant 
mortality rate (IMR)20 and life expectancy at birth (longevity) data,21 
and the HIV epidemic (indicated by the percentage of HIV-positive 
pregnant women)22 for South Africa for the last 25 years. Life 
expectancy at birth peaked at 62.33 years in 1992, and in 1993 
both the U5MR and the IMR were at an all-time low of 58.2 per 
1 000 live births and 45.1 per 1 000 live births respectively.20,21 All 
indications were that South Africa was approaching the early phases 
of transition from Stage 2 (the ‘age of receding pandemics’) to Stage 
3, the ‘age of degenerative and man-made diseases’ and was set to 
follow the classical model of epidemiological transition.5,18
However, in the mid-1990s, epidemiological transition was 
interrupted and reversed by the HIV and AIDS and concomitant TB 
epidemics (Figure 1). As a result of these epidemics, South Africa 
has seen a counter-transition.7 HIV prevalence rates, indicated by 
the infection rate in pregnant women, climbed over the following 
decade from 7.6% in 1994 to 30.2% in 2005.22 The U5MR rose 
dramatically in response, peaking at 80.8 per 1 000 live births 
in 2003 and the IMR at 53.2 per 1 000 live births in 2002.20 
In 2005, longevity dropped to its lowest level since the 1960s at 
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51.56 years.21 The combination of a newly emerged communicable 
disease (HIV and AIDS) and the re-emergence of an old infection 
(TB) with an increasing burden of NCDs has resulted in an additional 
stage being added to Omran’s original concept, called the ‘age of 
emergent and re-emergent infections’.19,23,24
Following the roll-out of comprehensive HIV and AIDS interventions 
in 2004, the HIV and AIDS prevalence rate plateaued at around 
30% in the early part of the current decade (see Figure 1).22 The 
rapid reductions achieved in infant and child mortality between 
2005 and 2011 have resulted in both the IMR and U5MR being 
lower today than prior to the HIV and AIDS epidemic, at 28 
per1 000 and 39 per1 000 live births respectively.8 South Africa 
is now back in positive epidemiological transition. However, both 
the IMR and U5MR have stagnated since 2011, and the neonatal 
mortality rate (NMR) has stagnated since 2009 despite the continued 
implementation of HIV and AIDS interventions.8 
A significant contributor to ongoing high mortality in children are 
deaths from unnatural causes, causing just over a third (18.5%) of 
deaths in children aged 1–4 years in 2014.25 Natural deaths in 
the same age-group were attributed to intestinal infectious diseases 
(17.2%), influenza and pneumonia (9.1%) and malnutrition (8.6%), 
with TB and HIV ranked fourth and fifth.25 Some neonatal deaths, 
which contribute the bulk of under-five deaths, are preventable 
through addressing modifiable factors that are intertwined with 
social determinants of health. CoMMiC reports that modifiable 
factors are 30% home-based, including seeking medical attention 
earlier, failure to recognise severity of illness, and inadequate 
nutrition.26 The majority of health system-modifiable factors (80%) 
relate to health personnel.26
The total contribution of CDs to stillbirthsc in South Africa is unknown. 
Data from the Perinatal Problem Identification Programme (PPIP) 
2012/13 attributed 2.5% of stillbirths in non-tertiary settings and 
7.7% of stillbirths in tertiary settings to CDs.27,28 These data are likely 
to be an underestimate, especially in primary health care settings 
due to restricted diagnostics and unavailability of screening. The 
Lancet Ending Preventable Stillbirths Series Study Group estimates a 
global median of 7.4% stillbirths attributed to CDs based on reliable 
data from 18 countries.28 
However, the role and contribution of CDs to the ongoing high level 
of mortality is not visible in the available data.
Congenital disorders and epidemiological 
transition
During the process of epidemiological transition, CD deaths remained 
invisible, essentially ‘buried’ among deaths due to communicable 
diseases, and only emerging as these diseases were adequately 
controlled.16 As industrialised countries moved through the second 
stage of epidemiological transition, there was a slight decrease in 
CD birth prevalence and deaths due to fetal environmental factors, 
essentially teratogens.14 This was because of improved care and 
prevention strategies for these disorders. However, since 85–90% 
of CDs have a genetic or partially genetic aetiology, their birth 
prevalence and resulting mortality remained high.14 Deaths from 
c In South Africa, a stillbirth is defined as a fetus of at least 26 weeks’ 
gestation and born with no signs of life after complete birth. This definition 
varies between countries, making data compilation and comparison 
complex.
these CDs became proportionately greater in overall neonatal, 
infant and child mortality as deaths from communicable diseases 
reduced. As industrialised countries completed the second stage 
of epidemiological transition, CDs emerged and have remained a 
leading cause of child death in these nations today.29,30 
CDs attained public health significance in these industrialised 
nations in the early 1960s when they moved into the third stage 
of epidemiological transition.14,18 This was demonstrated in a 
comparative study undertaken by McKeown30 of death rates in 
England and Wales for 1901 and 1971, shown in Table 1. An 
overall reduction of 68% was seen in the death rate for all diseases 
over the 70-year study, including a 90% reduction in infectious 
diseases. Death rates for NCDs decreased by 45% overall, but the 
number of CD deaths remained the same.30 This was due to the 
mainly genetic cause of CDs, which cannot be changed, resulting in 
CDs contributing a greater proportion of deaths as overall mortality 
decreased.
Table 1:  Standardised death rates (per million of population) for 






Respiratory infection 2 747 603 78
Pulmonary TB 1 268 13 99
Whooping cough 312 1 100
Measles 278 0 100
Scarlet fever and Diphtheria 407 0 100
Smallpox 10 0 100
Upper respiratory tract infections 100 2 98
Sub-total 5 122 619 88
Food and Water-borne Diseases
Cholera, Diarrhoea and 
Dysentery
1 232 33 97
Non-respiratory TB 544 2 100
Typhus, Typhoid 155 0 100
Sub-total 1 931 35 98
Other Infections
Sub-total 1 415 60 96
90% Overall Reduction for Infectious Diseases
Non-communicable diseases
Birth defects 126 127 0
Perinatal problems 1 249 192 85
Heart disease 1 186 1 688 - 42
Rheumatic heart disease 487 88 92
Cancer 844 1 169 - 39
Other diseases 4 598 1 406 69
Sub-total 8 490 4 670 45
Overall reduction for non-communicable diseases 45%
Total 16 958 5 384 68
68% Overall Reduction in Death Rate of All Diseases
Source:  McKeown, 1976.30
A further example of the increasing proportion of child deaths 
from CDs is shown in Figure 2, which shows the percentage of 
deaths due to congenital anomalies using the World Bank Country 
Classificationsd according to Gross National Income (GNI) per 
capita.4 As GNI increases, the percentage of child deaths from CDs 
d South Africa is classified as an upper middle-income country.
Congen ita l d isorders















Lower middle Income Upper middle Income High Income
2010 2013
0 10 20 30 40 50 60 70 80 90 100 110 120 130

























(congenital anomalies only) increases, contributing a greater portion 
in the higher GNI classification. An increase can be seen in all 
groups between 2010 and 2013. Today, CDs account for 28% of 
child deaths in high-income countries and they are the leading cause 
of death in infants and children younger than five years.
Figure 2:  Percentage of under-five deaths resulting from congenital 
anomalies using World Bank Country Classifications
Source:  WHO, 2015.4
Figure 3 plots global IMRs for countries against the percentage 
of infant deaths resulting from CDs, demonstrating that as infant 
mortality drops, the contribution (proportion) of CDs relative to infant 
mortality increases. This is particularly noticeable as the IMR drops 
to between 40 and 50 per 1 000 live births. 
It is clear from the literature and mounting evidence that the 
contribution of CDs to child mortality increases as countries 
develop, and that MLICs, including South Africa, are following this 
epidemiological trend.5,14 The proportion of deaths resulting from 
CDs in South Africa will rise as overall infant and child mortality 
decreases.
Congenital disorders in South Africa
Prior to the HIV and AIDS epidemic in the early 1990s, CDs began 
to emerge as a healthcare issue in South Africa due to falling child 
mortality and increasing longevity. A national task force of experts 
was established in collaboration with the WHO to investigate the 
need for, and implementation of, services for the care and prevention 
of CDs. Following wide consultation, the National Policy Guidelines 
for the Management and Prevention of Genetic Disorders, Birth 
Defects and Disabilities were published in 2001.31
The 2001 National Policy Guidelines31 outlined goals, objectives, 
strategies and delivery of clinical and laboratory services 
appropriate for the care and prevention of CDs in South Africa. 
Priority disorders were designated, which included Down syndrome, 
neural tube defects, fetal alcohol syndrome (FAS), albinism, cleft-lip 
and palate, and club feet. The financial cost to society and to the 
State resulting from burden of disease was estimated at several billion 
Rand annually at the time. Personnel requirements to implement 
these services were specified in the 2001 Guidelines, based on UK 
criteria, and were later revised using more relevant criteria for South 
Africa in the Strategic Framework for the Modernisation of Tertiary 
Hospital Services.32
In 2004, the National Guidelines for the Care and Prevention of the 
Most Common Genetic Disorders, Birth Defects and Disabilities33 
were published, targeting Primary Health Care Providers (PHCPs), 
and describing common CDs and strategies for their care and 
prevention.
After this surge of policy generation, the HIV and AIDS and TB 
epidemics obscured the issue of CDs once more.5 As a result, the 
growing commitment and momentum towards CDs as a healthcare 
issue was redirected to these competing healthcare priorities along 
with the associated resources. 
Figure 3:  Relationship between infant mortality and percentage of infants dying from CDs based on global country figures 
Source:  Modell, 2015.e
e Personal communication: B. Modell, 20 August 2015.













Data modell ing of CDs
There is a lack of birth prevalence data for CDs in South Africa, 
as is the case for many MLICs.14,16 The overriding factors for this 
are the limited facilities available and the lack of skilled clinicians 
to identify and diagnose CDs.14,16,17 This is exacerbated by the 
incompleteness of vital registration data and inadequacies of other 
mortality and morbidity data sources, especially for infants and 
children.3,8 To fill this gap, country-specific prevalence estimates are 
generated using a combination of local data for specific indicators 
combined with known prevalence rates from more well-resourced 
countries.14,16 These modelled data14 of genetic causes and an 
estimate of teratogenic causesf indicate that a minimum of 6.8% 
of South African births are affected by CDs.g Of these, 80.5% are 
caused by genetic factors and 19.5% by teratogens. This translates 
to one in every 15 live births in South Africa being affected by a 
CD.5 The proportion of teratogenic CDs is more than the 10–15% 
expected in MLICs and is one of the highest documented prevalence 
rates in the world due to the high prevalence of FAS, which is 
entirely preventable.14
Reliable surveillance data provide a vital information tool for policy-
makers to plan, implement, monitor and evaluate policy accordingly 
to prevent adverse health conditions and improve public health. 
With 6.8% of live births affected by a CD in South Africa, a total 
of 83 118 live births would have been affected in 2012, based 
on vital registration data.34 However, only 2 174 cases were 
reported via the Birth Defects Collection Tool (BDCT) administered 
by the Department of Health in 2012.35 With only 2.6% of the 
expected CDs being reported, this indicates under-reporting by 
97.4% for 2012. When taking into account that only 26% of CDs 
are diagnosable during the early neonatal period,36 under-reporting 
of 90% is still unacceptably high. This is hampering the recognition 
of CDs as a key contributor to the burden of disease.
The lack of empirical data as evidence for CDs in South Africa 
prevents policy-makers from accurately assessing the contribution of 
CDs to the disease burden.37,38 Figure 4 outlines the cycle caused 
as a result of this underestimation. Underestimation leads to a lack of 
prioritisation of CDs, and to CD prevention and care services being 
neglected. The lack of CD diagnosis due to poor services leads to 
under-reporting and poor data. Under-reporting contributes to an 
underestimate of CD deaths and disability. CDs are not considered 
to be a healthcare priority and the cycle resumes. Modelling is used 
as a tool to highlight the gap between the expected health need and 
current services available.
f Personal communication: A Christianson, 15 August 2013.
g These modelled estimates are based on national figures published in 
Appendix B of the 2006 March of Dimes Report.14 These figures are 
currently under revision.
Figure 4:  The cycle caused by the underestimation of CDs
Emerging data 
Despite the lack of evidence-based data, available mortality data 
are beginning to reveal the hidden disease burden of CDs. Under-
reporting of births and deaths leading to incomplete vital registration 
data, especially for children, makes it an unsuitable source for 
monitoring and evaluating child mortality. District Health Information 
System (DHIS) data, which record deaths in public sector hospitals, 
also tend to be inadequate, as outlined by McKerrow in 2010.3 The 
PPIP is the most detailed source of information on factors contributing 
to perinatal death and hence child mortality.3 The 2012/13 PPIP 
data,27 representing 75.6% of all DHIS-recorded births in South 
Africa, indicated that congenital abnormalitiesh have overtaken 
infection as the third leading cause of death during the first week of 
life in neonates after deaths from immaturity and hypoxia. Congenital 
abnormalities accounted for 11.24% and 8.20% of early neonatal 
deaths in infants weighing >1 000g and >500g compared with 
8.84% and 7.44% of deaths respectively from infection.27 This shift, 
combined with the stagnation of neonatal mortality since 2009, 
and of infant and under-five mortality since 2011,8 speaks to the 
epidemiological transition in South Africa.
This trend continued in the Western Cape Province (WC) in 2014, 
with congenital abnormalities ranked as the third cause of early 
neonatal death in infants weighing >500g and >1 000g.i At 
10%, deaths in the under-fives from congenital abnormalities 
in the province are double that recorded in other provinces and 
nationally.4,39 The WC neonatal mortality rate is also half the 
national rate of 11 per1 000 live births,40 making the province a 
good example of what will occur in other provinces in the coming 
decade as healthcare services improve and CDs are revealed. 
Following on from the PPIP programme is the Child Healthcare 
Problem Identification Program (CHILD PIP), which audits child 
mortality from 28 days to 18 years. In 2005, deaths from congenital 
abnormalitiesj were mentioned in only 0.3% of cases from the 15 
hospitals across six provinces participating in CHILD PIP.41 CHILD 
PIP acknowledged this as an underestimate due to the lack of access 
h No formal definition is given by the PPIP programme for congenital 
abnormalities; however, it is understood to refer to obvious structural 
abnormalities only.
i Personal communication: N. Rhoda, 25 February 2016.
j Although no formal definition of congenital abnormalities is given, the 
diagnoses made include single gene, chromosomal and multifactorial 
disorders and post-conception disorders.
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to post-mortems and lack of paediatricians to assess (diagnose) the 
cases.41 Between 2005 and 2014, mortality data were submitted 
to CHILD PIP by 198 hospitals across 49 districts. Of the 44 854 
deaths recorded,k 2.2% cited congenital abnormalities as either 
the main cause or underlying cause of death. Although higher than 
the 2005 figure, this too was reported as an underestimate due 
to the lack of identification of CDs by health workers conducting 
the audit, and limitations in the cause-of-death categorisation in the 
current CHILD PIP programme, which is now being rectified by the 
development of a new data form.l
As the U5MR has decreased, the proportion of deaths in the 
perinatal period has risen.42 In South Africa, just over 40% of deaths 
among under-fives occur during the neonatal period.43 Globally, the 
contribution of neonatal deaths to under-five mortality is projected 
to rise from 45% to 52% by 2030.6 The contribution of CDs to 
these deaths should be recognised and addressed if child mortality, 
particularly neonatal mortality, is to be reduced further.
Since available data sets reported only include sub-groups of CDs, 
the true contribution of CDs to the burden of disease is likely to be 
higher than estimated. 
Congenital disorders and disabil ity
CDs are not merely a cause of child mortality but also of morbidity. 
For every child who dies as a result of a CD, many survive serious CDs 
and sustain lifelong mental, physical, auditory or visual disability.14 
The economic cost as a result of this morbidity is considerable. In 
2012, 116 000 beneficiaries – caregivers of children older than 
one year with severe disabilities or disabling chronic illnesses 
requiring permanent home-based care, including those affected by 
CDs, acquired conditions and injuries – received means-tested care 
dependency grants of R1 200 per month.44 This totals R1.6 billion 
annually, excluding inflation, adult disability grants and other costs. 
In lower-resourced countries, the majority of children born with 
serious CDs (3.3 million annually) die due to a lack of appropriate 
care, and a further 3.2 million who survive are disabled for life.14 
Early intervention and relevant care can save the life of the child from 
a life-threatening serious CD, and cure or ameliorate the degree of 
long-term disability. Many of these interventions, including one-off 
surgeries for congenital malformations, are relatively inexpensive 
compared with the cost of ongoing chronic care for untreated CDs. 
Many community-based preventative measures are both inexpensive 
and ‘low-tech’.14 Where appropriate services for the care and 
prevention of CDs are available, 30% of CD deaths in the first year 
cannot be prevented. However, 40% of the cases can be cured, 
mainly by surgery, and 30% survive with disability.45,46 In South 
Africa, specialised surgery capacity is limited and unavailable in 
some provinces, preventing widespread access to such intervention. 
Strengthening surgical capacity in all areas is required, as both 
general and specialised surgery could help to alleviate this shortfall.
Interventions must incorporate both prevention and care. As outlined 
in the 2006 March of Dimes Report,14 there are three types of 
prevention: primary prevention, in which CDs are avoided prior to 
conception through basic reproductive health approaches, including 
folic acid supplementation; secondary prevention, which aims to 
k 87.6% of these deaths occurred in children aged five and younger. Personal 
Communication: M. Patrick, 17 March 2016.
l Personal Communication: M. Patrick, 17 March 2016.
reduce the number of babies born with CDs through screening, 
prenatal diagnosis, avoidance of potentially teratogenic substances 
during pregnancy and the option of termination of pregnancy; 
and tertiary prevention, being the early detection, diagnosis, cure 
and mitigation of CDs after the child is born, including surgical 
interventions and palliative care. Tertiary prevention is equivalent 
to care that constitutes diagnosis, treatment, counselling and 
psychosocial support of those affected by CDs. 
In lower-resourced countries, prevention tends to be overemphasised 
to the detriment of care due to the misplaced myth that care 
is expensive.14,16 This may cause those affected by CDs and 
consequently living with a disability to be marginalised, which 
undermines their human dignity and human rights. Christianson’s 
mantra, “Care is an absolute. Prevention is the ideal” was coined in 
2000.47 This emphasises both care and prevention (at all levels) as 
integral components of medical genetic services, and one cannot be 
neglected at the expense of the other. 
In many MLICs, comprehensive services for the care and prevention 
of CDs are not implemented. In addition to the immense loss of 
life and suffering of those affected, there is a significant economic 
cost. Implementation of key interventions can reduce this cost and 
save lives, as outlined in Table 2. Congenital malformationsm are the 
most common type of CD and also the most treatable. Almost half 
of the congenital malformations such as cleft lip and/or palate and 
congenital heart defects can be cured through paediatric surgery, but 
without this intervention, the result is death or permanent disability. 
To date, the folate fortification of staple food (maize meal and 
bread) to reduce neural tube defects (NTDs) – an example of 
primary prevention – is the only preventative intervention being 
comprehensively implemented in South Africa. Since fortification 
began in 2003, a 30.5% reduction in NTDs has been seen.48 In 
addition to the obvious reductions in mortality and morbidity, there 
is also a considerable cost benefit. According to Sayed et al.,48 with 
the average estimated cost of treatment being R100 000 per NTD 
case for the first three years of life, averting 406 cases every year 
would render a minimum annual saving of R40.6m, offset by the 
minimal cost of R1.4m per year for the 2% fortification.
If all other interventions were implemented as outlined in Table 2, 
the burden of genetically determined CDs could be reduced by 
almost 70% and would generate sizable economic benefits due 
to the gain of almost three years of healthy life per head of the 
population.14,16,46 However, the current static child mortality rates 
in South Africa are an indication that current interventions being 
implemented fall far below this level of potential. 
m A malformation due to multifactorial inheritance.
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Table 2:  Summary of estimated potential effects of interventions for preventing genetically determined CDs
Type of CD
Birth prevalence 















36.5 Paediatric surgery  
(Tertiary Prevention/care)
17.70 48.5 1.24
Folic Acid Supplement  
(Primary Prevention)
11.50 31.5 0.81
Prenatal diagnosis  
(Secondary Prevention)
3.50 9.6 0.25
Total congenital malformations 32.70 89.6 2.30
Chromosomal 
disorderso
3.8 Family planning  
(Primary Prevention)
0.75 19.7 0.05
Prenatal diagnosis  
(Secondary Prevention)
0.5 13.2 0.04
Total Chromosomal disorders 1.25 32.9 0.09
Genetic risk 
factorsp







11.5 Genetic counselling  
(Primary Prevention)
1.73 15 0.12
Neonatal screening  
(Tertiary Prevention/care)
0.7 6.1 0.05
Prenatal diagnosis  
(Secondary Prevention)
1.15 10 0.08
Total inherited disorders 3.60 31.1 0.25
Total 54.2  39.90 73.7 2.80
Source:  Christianson and Modell, 2004;16 Christianson et al., 2006.14
Medical genetic services in South Africa 
Since the early 1970s, the mainstay of medical genetic services 
in South Africa has been the work of human genetics departments 
at major academic centres and medical schools in urban areas, 
starting in Johannesburg and Cape Town.51 Access to these services 
was limited mainly to urban areas, with some outreach into rural 
areas being conducted by the academic centres. 
Services improved following the publication of the Policy Guidelines 
for the Management and Prevention of Genetic Disorders, Birth 
Defects and Disabilities in 2001.31 The number of posts supported 
by the National Health Laboratory Service increased in response 
to the policy.51 However, implementation continued through the 
established framework of academic centres, rather than through the 
integration of services into primary health care and the extension of 
clinical genetic services beyond urban areas, as was recommended 
in the 2001 Guidelines.
As services for HIV and AIDS developed over the past decade 
to combat the epidemic, tertiary medical genetic services were 
neglected.5 By severely limiting the implementation of the 2001 
policy guidelines, the lack of investment in medical genetic services 
has resulted in insufficient trained personnel, inadequate capacity 
at all levels, and severely compromised laboratory services.5,51 
In 2013, South Africa was reported as the only country of eight 
emerging economies evaluated where positive development in 
improving medical genetic service structures had ceased, and 
indeed retrogressed.37
Medical genetic services 
Interventions to prevent, detect and care for CDs are collectively 
known as medical genetic services. The aim of genetic services 
is two-fold: to reduce suffering by offering care to those affected, 
and to improve health by preventing CDs.14 These services are 
key in reducing the contribution of CDs to the burden of disease. 
By providing the ‘best possible patient care’ in the prevailing 
circumstances for those affected by or at risk of CDs, medical genetic 
services ensure that people with CDs, or those at reproductive risk 
of having children with CDs, ‘can live and reproduce as normally 
as possible’.17,49,50
In many lower-resourced countries, the development of medical 
genetic services has been driven by epidemiological transition. 
Governments begin to see CDs as an important public health issue 
when the IMR falls below 40–50 per 1 000 live births and only limited 
reductions in child mortality can be achieved by addressing other 
health issues.12,16,17,50 With an IMR of 28 per1 000 live births in 
2014,8 South Africa is well past this threshold when medical genetic 
services should be comprehensively implemented. CDs should be 
prioritised alongside other NCDs and ongoing interventions against 
communicable diseases in order to further reduce child mortality 
and to provide better care for those who are disabled as a result of 
CDs.5 When the IMR reaches 20 per 1 000 live births (the MDG 
4 target for South Africa), CDs will emerge as a leading cause of 
death in infants.12
n Obvious structural abnormalities/malformations due to multifactorial 
inheritance.
o A structural or numerical abnormality of the chromosomes.
p G6PD deficiency and Rhesus haemolytic disease of the newborn.14
q Single gene disorders, including autosomal-dominant, autosomal-recessive, 
sex-linked inheritance and mitochondrial disorders.
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r Family planning is associated with specialist services in these secondary and 
tertiary hospitals although it is not listed as an official service.
s Mandatory iodisation of table salt (40–60ppm) was introduced in South 
Africa in 1995 to prevent iodine-deficiency disorders.
t Mealie meal and wheat flour have been fortified with folic acid in South 
Africa since 2003.
u Pre-conception screening at the level of community health centres and district 
hospitals should include screening for advanced maternal age, taking a 
family history and relevant referral.
The framework of medical genetic services across the continuum of 
health care in South Africa is shown in Table 3. This demonstrates 
how interventions to prevent and care for CDs may be integrated 
into maternal and child care (e.g. comprehensive antenatal care) 
and highlights current gaps in implementation. 
Table 3:  Overview of medical genetic services across health care in South Africa 










































































d Family planning X X X Xr Xr Xr
Optimising women’s diet:s
•	Folic acid supplementation (5mg 
daily)t
•	 Iron (200mg daily)
•	Alcohol/Smoking (education)
X X X X X X
Pre-conception screening Su Su Su X X X
Maternal infections:v  
Detection and treatment  
(primarily syphilis)
X X X X X X
Treating health conditions:
•	Diabetes mellitus X X X X X
•	Epilepsy X X X X X
•	DVT or cardiac conditions (Wafarin) X X X X
Genetic counselling  
(if required) S



































Ultrasound S S X X X
Advanced maternal age screening S S S S X X
Pre-natal diagnosis (amniocentesis, 
chorionic villus sampling, 
cordocentesis)
X X X
Genetic counselling and psychosocial 
support S






















































•	Examination of every newborn by 
trained observer (top to toe) S S X X X
•	Biochemical screening 
(Hypothyroidism) S S S S S
Care interventions:
•	Medical/therapeutic X X X X X
•	Surgery Xx Xx Xx Xx
•	Habilitationy X X X X
•	Palliative care X X X X
•	Genetic counselling and psychosocial 
support S
w Sw Xw X X
v The rubella (German measles) vaccine is available only in the private 
sector in South Africa.
w Genetic counselling for common disorders such as Down syndrome 
and spina bifida.
x This may be limited to general surgery in some provinces where 
specialised surgery (e.g. cardiac, cranofacial, etc.) is currently 
unavailable. Some CDs may require only general surgery (e.g. 
Meckel’s diverticulum), whilst others require more specialised surgical 
intervention (e.g. cleft lip and/or palate).
y For example, occupational, speech and physiotherapies.
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trained labour ward nurses, together with midwives, obstetricians 
and paediatricians, are the frontline healthcare professionals 
encountering CDs in the continuum of care.
Legislative and regulatory framework
The World Health Assembly (WHA) call in 201013 to prioritise CDs 
as a healthcare issue through Resolution 63.17 was fundamental 
for medical genetic services worldwide. WHA 63.1713 recognised 
the importance of CDs as a cause of stillbirths and neonatal deaths, 
and their contribution to under-five mortality, and it is recognised 
that for MDG 4 to be achieved, “accelerated progress in reducing 
neonatal mortality including the prevention and management 
of birth defects” was required. Although South Africa is yet to 
respond to WHA63.17,13 a number of other international treaties 
and protocols of relevance to CDs have led to the development of 
equivalent national legislation. Table 5 lists international treaties 
and conventions that included content of relevance to CDs, many of 
which are foundational for national legislation.
South Africa is well placed to respond to WHA 63.1713 since a 
comprehensive, national legislative framework already exists for the 
provision of medical genetic services for the care and prevention 
of CDs. Relevant national legislation is outlined in Table 5. 
The Constitution of the Republic of South Africa53 provides for 
fundamental rights to life, equality, dignity, freedom and security 
of the person, and education. The socio-economic right for all to 
access healthcare services, including reproductive health care, is 
provided subject to the concept of progressive realisation.ad Every 
child – including those with CDs and disabled as a result – has 
the right to ‘basic nutrition, shelter, basic healthcare services and 
social services’ (section 28, 1c), but these rights are not subject to 
progressive realisation. 
The provision of medical genetic services is specified in the National 
Health Act (NHA) 61 of 2003 through a clear directive in Chapter 
3, under “Main functions of the National Department” in section 21 
(2) (b) (vii) as follows:
The Director-General must, in accordance with national health 
policy, issue and promote adherence to, and norms and 
standards on health matters including genetic services.54
Also of relevance to CDs in the NHA are epidemiological 
surveillance, management, prevention and control of NCDs, and 
the health needs of vulnerable groups including children and the 
disabled.54 Other key national legislative instruments of relevance 
to CDs are outlined in Table 6.
ad Defined as recognising that economic and social rights can only be 
achieved over time, subject to the availability of resources.
Table 4:  A comparison of medical genetics services capacity in 2001 and 2015 
Category








Medical geneticists 20  1 per 2m 4 1 per 11.2m 12z 1 per 4.9m
Genetic counsellors 80  1 per 580 000 <20 1 per 2.2m 8aa 1 per 8.4m 
Medical scientists/technologists 100  1 per 450 000 50 1 per 900 000 26ab 1 per 2.1m
Medical genetic services are now at a lower base than in 2001, 
as outlined in Table 4. The 2003 recommended human capacity 
requirements32 to be trained and in-post by 2010 remain unfulfilled. 
Today there are 12 medical geneticists, compared with four in 2001 
and the 20 recommended by 2010. 
Of the 14 genetic counsellors practising today, only eight practise in 
State services, compared with 20 in 2001 and the 80 recommended. 
Since existing posts were frozen and no new posts were created 
to accommodate newly qualifying genetic counsellors, many have 
been forced to leave the service or the country, or to work in 
private practice. No provision was made for genetic counsellors 
in the Occupational Specific Dispensation (OSD), a government 
initiative aimed at attracting and retaining skilled employees through 
improved remuneration. Budget cuts have also reduced diagnostic 
laboratory personnel numbers to unsustainable levels and equipment 
has not been upgraded or maintained.5,51 Many practitioners have 
left, retired or emigrated due to a high service workload, limited 
opportunity to undertake research, and the inability to perform their 
tasks satisfactorily due to inadequate medical genetic laboratory 
services. To reverse this, adequate staffing and modern equipment 
are required along with the necessary training to ensure the 
translation of this technology is appropriate to the country’s needs 
and circumstances. 
The lack of access to health workers is possibly the greatest constraint 
across the health system in terms of South Africa achieving health 
goals,26 including the MDGs. Rectifying the shortfalls in specialist 
healthcare professionals in the medical genetic services sector is 
critical. 
The Medical Genetics Education Programme (MGEP) is a distance-
education postgraduate training course for nurses and rural medical 
officers. This equips in-post healthcare professionals with basic 
knowledge and skills to identify and diagnose common disorders, 
counsel patients and to refer those affected by CDs appropriately, 
providing an additional supporting capacity for medical geneticists 
and genetic counsellors. Between 2004 and 2013, over 1 000 
healthcare providers, mainly labour ward nurses, were trained 
through the MGEP course held countrywide.ac Today, fewer than 
100 remain in services for the care and prevention of CDs. The 
lack of continued government support for this training, including 
financial, trainee contact and uptake of these skills by facility 
management, has forced trainees to discontinue their genetic nursing 
role and move to other fields. This has had a direct negative impact 
on the national surveillance of CDs via the BDCT, as many MGEP-
z No medical geneticists are employed by the State in Gauteng. Personal 
communication: A. Krause, 11 February 2016.
aa Of these eight genetic counsellors, three are employed full-time directly 
by the State, three full-time by tertiary institutions, and four are employed 
part-time, plus six in private practice. Personal communication: T. Wessels, 
25 February 2016.
ab NHLS academic medical scientists only. Personal communication: H. 
Soodyall, 27 July 2015.
ac Personal communication: D. Tshikedi, 2 October 2013.
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Table 5:  International treaties, conventions, declarations and protocols of relevance to medical genetic services
Document Article/ Rule/Overview
World Programme of Action Concerning the Disabled (1982) Prevention, rehabilitation and equalisation of opportunities
Standard Rules on the Equalization of Opportunities for Persons with Disabilities 
(1993)
 1 Awareness-raising
 2  Medical care
 3 Rehabilitation
 4 Support service
 5   Accessibility
United Nations Convention on the Rights of the Child (signed 1993 and ratified 
1995)
 2 No discrimination 
 6 Right to life 
 23 Disabled child 
 24 Healthcare
 26 Social Security
International Covenant on Economic, Social and Cultural Rights (1966) (signed 
1994 and ratified 2015)
 12 Physical and Mental Health
United Nations Millennium Declaration (signed 2000)1 Goal 4: Reducing under-five mortality by two-thirds by 2015
United Nations Convention on the Rights of Persons with Disabilities (signed and 
ratified 2007)
 5 Equality/non-discrimination 
 6 Women with disabilities 
 7 Children with disabilities
 8 Awareness-raising 
 9 Accessibility 
 10 Right to life
 19 Living independently
 20 Personal mobility
 23 Respect for home and family 
 25 Health
 26 Habilitation and Rehabilitation
African Charter on the Rights and Welfare of the Child (‘Children’s Charter’) (signed 
1997 and ratified 2000)
 5 Right to life
 13 Protection of physically/mentally disabled to ensure dignity
 14 Physical/ mental health and healthcare
The New Partnership for Africa’s Development (2001) Healthcare provision and delivery
African Youth Charter (signed and ratified 2009)  16 Health 
 23 Girls and young women
 24 Mentally/physically challenged youth
World Health Assembly Resolution 63.17 (signed and ratified 2010)11 Urges member states to address CDs as a healthcare issue 
through specific actions
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Table 6:  Key national legislation of relevance to medical genetic services 
Title Overview Sections relevant to CD
Constitution of the Republic of South 
Africa (108 of 1996)53
Chapter 2 – Bill of Rights •	 9 Equality
•	 10 Human dignity
•	 11 Life
•	 27(1)(a) Access to healthcare services, including reproductive 
healthcare
•	 28 (1)(c) Every child has the right to basic healthcare services
Health Professions Act (56 of 1974) Regulates the health professions 
through the Health Professions 
Council of South Africa
National Health Act (61 of 2003)54 Framework for a structured and 
quality uniform health system
•	 4(3)(a) Free healthcare to pregnant/breastfeeding women, children 
under six not members/beneficiaries of medical aid schemes  
(c) free termination of pregnancy
•	 21(2)(b)(vii) Genetic services
•	 21(2)(k) and 25(2)(w) Management, prevention and control of 
communicable and non-communicable diseases
•	 23(1)(a)(ix) and 27(1)(a)(ix) Epidemiological surveillance and 
monitoring of national and provincial trends
•	 21, 23, 25, 27 Implementation of national/provincial policy and 
compliance 
•	 39(2)(a)&(d), 70(2)(d) Health needs of vulnerable groups including 
children and people with disabilities
•	 48 Development and provision of human resources in national 
health system 
•	 52 Regulations relating to human resources 
•	 70 Identification of health research priorities
Choice on Termination of Pregnancy 
Act (92 of 1996)
Law related to abortion •	 2(b)(ii) and minors 5(5)(a)(ii) Termination of pregnancy (ToP) 
between 13–20 weeks inclusive if substantial risk that the fetus 
would suffer from a severe physical or mental abnormality
•	 2(c)(ii) and minors 5(5)(b)(ii)ToP after the 20th week if the continued 
pregnancy would result in a severe malformation of the fetus
The National Health Laboratories 
Service Act (37 of 2000)
Laboratory services for the public 
health sector 
•	 4 and 5(1) Cost-effective and efficient health laboratory services 
including training
Mental Health Care Act (17 of 2002) A legal framework for mental health 
in South Africa with an emphasis on 
human rights
The Nursing Act (33 of 2005) Regulates the nursing profession 
through the South African Nursing 
Council
Children’s Act (38 of 2005) Protection of children and their rights •	 11 Children with disability or chronic illness
•	 156 (1)(G) Care and protection
Social Assistance Act (13 of 2004) Rendering of social assistance •	 7 Care dependency grants
•	 9 Disability grants
National policy
The National Policy Guidelines for the Management and Prevention 
of Genetic Disorders, Birth Defects and Disabilities31 and the 
National Guidelines for the Care and Prevention of the Most 
Common Genetic Disorders, Birth Defects and Disabilities33 are the 
only two policy documents that focus solely on CDs. In 2014, a 
process of revision of the 2001 Policy Guidelines was initiated and 
is due for completion in 2016. 
A new edition of the Guidelines for Maternity Care in South 
Africa was published in 2015,55 replacing the 2007 edition. This 
contains relevant content on the identification of mothers at high 
risk of having babies with a CD, as well as essential information for 
primary prevention of CDs and referral to genetic services. 
Implementation of the 2001 Policy Guidelines,31 and therefore of 
the underpinning legislation, has been fragmented, especially in the 
past decade. The lack of recognition for the contribution of CDs to 
the disease burden has resulted in the exclusion of comprehensive 
interventions from national strategies. The lack of integration of key 
interventions is noticeable in the National Department of Health’s 
Strategic Plan for Maternal, Newborn, Child and Women’s Health 
and Nutrition in South Africa 2012–2016.56 While CDs are 
mentioned as a cause of neonatal death and as contributing to 
15–20% of children affected by long-term/chronic health conditions 
“not receiving the care they require”, no responding interventions 
are outlined.56 In other documents, individual CDs or categories 
such as mental health disorders are recognised in the National 
Department of Health’s Strategic Plan 2014/15–2018/19,57 but 
with no acknowledgement of the genetic predisposition of such 
conditions. 
CDs are the first NCDs experienced by people – infants and 
children.12 However, they are not contextualised as such in national 
strategies and interventions to address the growing NCD disease 
burden. In the 2nd Triennial Report of the Committee on Mortality 
and Morbidity in Children (CoMMiC),26 CDs are included under 
long-term health conditions in children together with acquired 
childhood conditions resulting from infections. This precludes the use 
of the term ‘NCD’, effectively burying CDs beneath communicable 
disease once again. 
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Conclusions and recommendations
CDs are currently not recognised as a healthcare issue in South 
Africa. Thus, their contribution to the disease burden is currently 
underestimated, and the impact of interventions for their prevention 
and care is not considered. Instead, those born with and dying from 
CDs are largely overlooked and those surviving with disability are 
largely ignored, as care is not being provided to this most vulnerable 
group. Despite the lack of data due to poor national surveillance, 
CDs are beginning to emerge as a significant cause of mortality in 
children. Data from child mortality audit programmes indicate the 
growing contribution of CDs to neonatal death and to deaths in 
children under five years of age. Following the epidemiological trend 
of industrialised countries, the contribution of CDs to the disease 
burden will continue to increase in South Africa as the country 
develops, until they eventually constitute the leading cause of child 
death and disability. By not addressing this issue comprehensively 
now, many lives will be lost unnecessarily and others will survive 
with lifelong disability as the result of serious CDs. There is also 
a significant economic cost associated with CDs. Up to 70% of 
the deaths and the disability caused by CDs can be prevented or 
mitigated through relevant interventions.45,46
South Africa has already passed the point at which other nations 
have identified the need to develop comprehensive medical genetic 
services in order to reduce child mortality further. This is largely 
a consequence of the abating HIV and AIDS and TB epidemics 
which have buried CDs as a health issue. While the control of these 
epidemics must continue, it cannot be at the expense of other child 
healthcare needs if child mortality, including neonatal deaths, is to 
be further reduced.5,7
While a good legislative framework provides for genetic services 
in South Africa, the significant shortfall in implementation indicates 
that this intention has been lost in translation. Medical genetic 
services currently available are inadequate in terms of capacity and 
infrastructure at all levels and far from the seamless continuum of 
care required. While the implementation of accessible and relevant 
medical genetic services for the care and prevention of CDs is 
essential to contribute to reducing static mortality rates further in 
South Africa, such interventions must also plan for morbidity and 
ongoing treatment of those affected. Such interventions have major 
economic implications for South Africa, and the CD contribution to 
the burden of disease should be addressed holistically. 
If South Africa is to meet the Sustainable Development Goal (SDG) 
358 target to end preventable deaths in newborns and children, 
and to reduce the U5MR to at least 25 per 1 000 by 2030, CDs 
must be comprehensively addressed. Reducing premature mortality 
from NCDs by 2030 will require CDs to be contextualised as a 
NCD in South Africa, in alignment with the international definition 
of NCDs. The SDG goal for universal health coverage and access to 
quality essential healthcare services can only be achieved if relevant 
medical genetic services for the care and prevention of CDs are 
made available for all South Africans.58 
The re-engineering of the healthcare service and the NHI initiative59 
provide opportunities for the rebirth of medical genetic services, and 
for rectification of their currently compromised state. Their integration 
as part of services for women’s, maternal and child health would 
allow medical genetic services to develop throughout the continuum 
of care in all appropriate stages of life. Such services are vital to 
uphold the dignity and constitutionally and legally enshrined rights 
of those affected by CDs.5,60 
Priority actions include:
 ➢ Increased political will and financial commitment – This 
should be accompanied by appropriate CD-related expertise 
on ministerial and government committees dealing with the 
neonatal/infant/child mortality and the development of 
women, maternal and child health services.
 ➢ Improvement of national surveillance, patient registries and 
monitoring of CDs – Linked to existing systems for sustainability, 
these should be accompanied by ongoing training to increase 
coverage and accuracy of CD data identification and 
documentation. 
 ➢ Capacity-building – The education and training of healthcare 
professionals and the creation of related posts is required at 
all levels, especially for staff in primary health care facilities. 
 ➢ Increased community education and awareness – Such pro-
grammes are required to ensure awareness, understanding 
and knowledge of available services and how to use them. 
 ➢ Role of lay advocacy/patient support groups – These need to 
be recognised, supported and strengthened to partner with 
government and the medical genetics community.
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Post-Script to Chapter 6  
 
Following publication of this paper the PhD examiners identified specific edits that would 
further improve the quality of the paper. While we acknowledge that the version of the 
paper published by the journal will remain unchanged we would like to specify the following 
amendments: 
 
 Page 57, Figure 1, Source, amendment: Malherbe et al, 2015 instead of Malherbe, 
2015. 
 Page 58, column 1, paragraph 3, line 1-2, amendment: ‘A significant contributor to 
ongoing high mortality in children are deaths from unnatural causes, causing just 
over a third (34.3%) of deaths in children aged 1-4 years in 2014.’ The published 
percentage of 18.5% referred to children aged 5-9 years.  
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Chapter 7: Contribution of congenital disorders to under-5 mortality 
 
This article has been published in the South African Medical Journal. 
Malherbe HL, Aldous C, Christianson AL, Woods D.S. Contribution of congenital 
disorders to under-5 mortality. Afr Med J. 2016 Aug;106(8):745. 
doi:10.7196/SAMJ.2016.v106i8.11129. 
 
Chapter 7 continues the theme of CDs and child mortality with this letter to the editor 
responding to an article publishing child mortality data for a specific region of the 
Western Cape (1). The issue that is tackled in this article is terminology related to CDs 
and the use of non-equivalent terms used interchangeably. This results in sub-sets of 
CDs being reported as the totality of CDs, which further contributes to the 
underreporting of CDs and an underestimate of the true contribution of CDs to the 
burden of disease. In this specific case, the term congenital abnormalities is used, which 
relate to chapter XVII of the International Classification of Diseases (ICD-10) (2). This 
includes development structural abnormalities only and excludes a large portion of CDs 
(particularly single gene disorders and environmentally caused CDs) found elsewhere in 
the ICD-10 system (3). It is important that this incomplete reporting of CDs is 
acknowledged and uniform terminology is consistently used for reporting purposes. 
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Contribution of congenital disorders 
to under-5 mortality 
To the Editor: The article ‘Where do children die and what are the 
causes?’, which appeared in the April 2016 issue of the SAMJ,[1] 
provides an overview of the causes of death in under-5 children in 
the Metro West geographical service area of the Western Cape for 
2011. It highlights the proportion of under-5 deaths from conge nital 
abnormalities (obvious structural abnormalities), which are particu-
larly prevalent in early neonatal mortality − a close third (9.6%) of 
in-hospital deaths after hypoxia (10.0%) and immaturity (40.6%) 
according to the Perinatal Problem Identification Programme 
(PPIP) data.[1] In the Local Mortality Surveillance System in-hospital 
data, congenital abnormalities are ranked as the second (13.5%) cause 
of early neonatal death after prematurity (35.8%).[1] 
Although already prominent as a cause of death, congenital dis-
orders (CDs) may collectively contribute to a greater proportion of 
child deaths than reported. In the study, congenital abnormalities 
relate to chapter XVII: Congenital malformations, deformities and 
chromosomal abnormalities in the Inter national Classification of 
Diseases (ICD-10) and are aggregated to the Burden of Disease list 
of causes. [1-3] Limited to developmental structural abnormalities only, 
this excludes a significant portion of CDs found elsewhere in the ICD-
10 system (e.g. congenital syphilis A50; haemophilia D66 - 68; ocu-
locutaneous albinism E70.310).[3] This ICD- 10 coding fragment ation 
has exacerbated global con fusion around terminology related to CDs.
[4] In 2006, international agreement was reached on the synonymous 
use of the terms CDs and birth defects, defined as abnormalities of 
structure or function, including metabolism, present from birth and 
manifesting at birth or later in life.[5] However, use of inequiva lent 
terms, such as congenital abnormality, continues. Consequently, data 
for subsets of CDs are often interpreted as the totality of CDs when it 
is not the case. If single-gene disorders, accounting for 30.0% of CDs 
(B Modell − personal communication, 2016), were pooled with con-
genital abnormalities in the study by Reid et al.,[1] a greater proportion 
of under-5 deaths may be attributed to CDs.
CDs are also significantly underestimated, as many remain undi-
agnosed or are misdiagnosed, with the incorrect cause of death due 
to the lack of trained clini cians,[6-8] as acknowledged by the Child 
Healthcare Problem Identification Pro gramme.[4,9] Un diag nosed CDs 
may be the underlying cause of death in a number of cases assigned 
to other causes (including ‘ill-defined’) or comor bidity in the study, as 
infants born with CDs, such as congenital heart defects, may be more 
susceptible to infection.
Honein et al.[10] reported that CDs are more than five times as likely 
to occur among very preterm infants (24 - 31 weeks) compared with 
term infants (37 - 41 weeks), resulting in 16.0% of preterm infants 
having a CD. A significant portion of deaths assigned to ‘prematurity’ 
in early neonatal deaths in the study may therefore be undiagnosed 
CDs, which are predisposed to preterm birth.
The relative frequency of CDs should be noted and investigated 
in light of the above mentioned factors contributing to their under-
reporting, particularly as the majority of CD-related deaths occur 
during the first 5 years of life. As the proportion of deaths from 
CDs increases along with epidemiological transition − seen in the 
dramatic decrease in HIV- related deaths − the challenge of CDs will 
continue. [11] Possi ble areas for further study include comparison with 
other provincial populations, analyses of preventable CDs (e.g. fetal 
alcohol spectrum disorder) and prenatal diagnosis of serious CDs. 
H L Malherbe, C Aldous
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Part Three: Modelling data for South Africa 
 
In Part Three the focuses shifts to generating modelled data for SA. A finding in all 
previous parts of the study is the lack of empiric data for CDs in SA. Without these data 
there is no evidence to demonstrate the disease burden represented by CDs. In the 
interim before improved surveillance systems are available in SA, we have to consider 
modelling estimates of the expected numbers of CDs – that we should be seeing in SA. 
Modelled estimates provide a tool for measuring services until such a time when they 
are no longer necessary – when surveillance systems are collecting complete data.  
Modelled estimates for CDs have been published before as part of the March of Dimes 
Global Report on Birth Defects in 2006 (1). These national figures were based on 
demographic estimates sourced mainly from World Population Prospects. The approach 
taken in this study collates and uses local demographic data at the provincial level, using 
the revised Modell Global Database (MGDb) and its inherent improved modelling 
techniques. While these results cannot be compared with the 2006 estimates, they are 
considered more accurate and realistic. Estimates were developed for four specific 
groups of CDs with endogenous causes (single gene disorders, chromosomal disorders, 
malformations and additional conditions) and results provided at a national level. This 
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Chapter 8: Epidemiological data for congenital disorders in South Africa 
 
This article is submission ready for the Journal of Health Policy and Planning. 
Malherbe H, Aldous C, Christianson A, Darlison M, Modell, B. Epidemiological data for 
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Key Messages:  
 There is a lack of empiric data for congenital disorders (CDs) in South Africa, 
leading to underreporting and an underestimation of the CD disease burden, 
preventing the prioritisation of relevant medical genetic services. 
 Modelled data plays an important interim role in highlighting the CD burden of 
disease until surveillance systems are improved. 
 Methods from the Modell Global Database of Congenital Disorders (MGDb) were 
applied in South Africa to model baseline estimate for endogenous CDs for 2012 
in the absence of care. The 2012 actual birth prevalence was estimated to 
evaluate the effect of present interventions compared with baseline estimates.  
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 Access to relevant interventions (estimated at 30%) reduced the number of 
births affected by CDs and the number under-5 deaths, and increased the 
number of affected infants surviving to age 5.  
 
Acknowledgments: Thank you to: Professor Rob Dorrington, Centre for Actuarial 
Research (CARe), University of Cape Town for providing demographic data for use in this 
study; Professor Debbie Bradshaw, Burden of Disease Unit, South African Medical 
Research Council for conceptual and expert advice; and Statistics South Africa (StatsSA) 
for providing the 2013 data sets -although these StatsSA data were not used in the final 
modelling process they were a key component in the decision making process at the 








Monitoring and surveillance data for congenital disorders (CDs) is necessary for the 
development of targeted medical genetic services at a local, regional and national level. 
Empiric data is lacking for South Africa, with CDs underreported by over 98%. This is 
contributing to (a) underestimation of the disease burden of CDs, and (b) failure to 
prioritise services appropriately. Modelling offers a viable option to provide estimated 
figures, until improved surveillance systems can make good this shortfall. 
 
In this study, methods from the Modell Global Database of Congenital Disorders 
(MGDb), including birth prevalence data from well-established surveillance systems, 
were used with local demographic data to generate 2012 baseline country estimates for 
endogenous CDs in the absence of care. The 2012 actual birth prevalence was then 
estimated using the MGDb approach to evaluate the effect of present interventions 
compared with baseline estimates. Access to relevant health services, and so the impact 
of interventions, was quantified using the infant mortality rate (IMR) as a proxy. 
 
Baseline estimates indicated a birth prevalence of 30.5 affected births per 1 000 live 
births. Half of the 35 675 died under-5 years, with 25% (n=9 535) dying in the first month 
of life. With access to care estimated at 30%, 1 860 affected births were avoided as a 
result of pre-conception and pre-natal interventions. Birth prevalence was reduced by 
1.1 per 1 000 live births. Overall survival increased by 12% (n=3235), and 5 010 under-5 
deaths were prevented.  
 
This study highlighted the utility of modelled data in profiling the disease burden of CDs 
in South Africa, and the impact of medical genetic services in reducing mortality and 
improving the quality of life of those affected. Further study includes analyses of 
modelled estimates (a) for specific CDs, (b) in specific provinces of SA, and (c) costing of 







Health data monitoring and surveillance is crucial to enable timely and appropriate 
public health responses to reduce disease burden (1). These observed data provide a 
factual basis for rational decision making by policy makers, directing research and policy 
to address present and future needs, prioritising health issues and allocating resources 
(2). The Centers for Disease Control (CDC) defined epidemiologic surveillance in 1986 as 
“the ongoing, systematic collection, analysis, and interpretation of health data essential 
to the planning, implementation, and evaluation of public health practice” (3-5). This has 
evolved into public health surveillance, which provides an evidence-based approach to 
defining health needs, and implementing focused programmes in response. It is an 
integral part of health needs assessment (HNA) – a rational, epidemiology-assisted 
approach providing information for the planning, introduction and modification of 
health care services to benefit the health of populations (6). Public health surveillance 
includes the monitoring of communicable and non-communicable diseases (NCDs), 
health interventions, injuries, child growth and nutrition, and occupational health (2, 7). 
It is also undertaken for congenital disorders (CDs), the first NCD experienced by people 
(8). 
 
CDs, defined as abnormalities in structure or function, including metabolism, present 
from birth (9), include chromosomal disorders, congenital malformations, single gene 
disorders and disorders with multifactorial causes. Surveillance is required to target 
medical genetic services for care and prevention at a local, regional and national level 
(9, 10). Established surveillance systems monitor trends and evaluate ongoing 
programmes, with the difference between birth and population prevalence used as an 
indicator of effectiveness of care, and the number of affected births as an indicator of 
effective prevention (6). In Iran, surveillance showed a 20% reduction in births affected 
by thalassemia in 2005 compared to expected (modelled) births following 
implementation of a prevention programme (11). Expected birth prevalence rates were 
based on modelled figures, due to a lack of empiric data (6, 10). Where no interventions 
are currently available, surveillance helps prioritise and guide research (12). Clusters of 
CDs may also be identified, such as those caused by specific teratogens, to prevent a 
repeat of the thalidomide tragedy of the late 1960s, although this has become a 
secondary aim of surveillance (13). 
 
In high income countries where CDs are a leading cause of death in childhood (14), 
robust monitoring and surveillance systems have developed over the past 40 years, 
although obtaining comprehensive, standardised data remains a challenge (13). In 
middle and low income countries (MLICs), reliable epidemiological data on CDs is scarce 
due to inadequate or absent surveillance systems (10, 15, 16). This paucity of 
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information skews national and global estimates of CDs, resulting in underestimation of 
their significance as a health care issue (16, 17). This impedes policy development and 
implementation in MLICs, preventing those affected from receiving the care they 
require. Challenges faced by MLICs often include a persisting communicable disease 
burden coupled with emerging NCDs (18). This protracted epidemiological transition 
continues to mask the burden of CDs, which remain undiagnosed or misdiagnosed and 
are thus omitted as causes of deaths (15, 18). This is exacerbated by the lack of skilled 
professionals and by inadequate infrastructure (10, 15-17). Underreporting of CDs 
prevents an accurate assessment of their burden, resulting in lower funds allocated for 
surveillance, training of health care professionals and other essential medical genetic 
services (8). 
 
Lack of empiric data in South Africa 
In South Africa (SA) current modelled estimates indicate that one in every 15 births or a 
minimum of 6.8% of births, is affected by a CD1(19). Of these, 80.5% have endogenous 
(i.e. genetic or partially genetic) causes, while 19.5% are caused by teratogens2. This 
indicates that more than 70 000 live births a year are affected by a serious CD3 (20). 
However, Lebese et al (21) reported only 13 252 CD cases via national surveillance 
between 2006-2014. This is less than 20% of annual expected CDs reported over a six-
year period, and indicates underreporting of 98% compared to expected numbers (19, 
21). Datasets known not to be integrated into the national surveillance database 
administered by the National Department of Health (NDOH) include registries managed 
by patient support groups and data compiled at health facilities. Death audit 
programmes, such as the Perinatal Problem Identification Programme (PPIP) and the 
Child Problem Identification Programme (Child PIP) collate mortality data only. 
However, many of these programmes report on congenital anomalies, based on Chapter 
XVII of the International Classification of Diseases (ICD-10) system, which includes only 
chromosomal disorders and congenital malformations (22-24). Often interpreted as the 
totality of CDs, congenital anomalies are a sub-set, and exclude most single gene 
disorders and environmentally caused CDs (25, 26). This contributes further to 
underreporting of CDs.  
                                                     
1 Based on the modelled figure of 53.4 per 1 000 live births born annually with a 
serious genetic CD and estimated figures for teratogens, particularly fetal alcohol 
syndrome (10) (Professor Arnold Christianson, personal communication). 
2 Teratogens include altered maternal metabolic states (diabetes mellitus, 
hypothyroidism, iodine deficiency), infectious agents, ingested substances (alcohol, 
illicit drugs and medications), hyperthermia, environmental pollutants and massive 
radiation exposure (29).  
3 Serious birth defects are life threatening or have the potential to result in disability 
(10). 
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The role of modelled epidemiologic data 
Modelled data enables informed policy making and HNA to proceed so that relevant 
services can be developed where observed surveillance is lacking (6). These modelled 
data provide the expected numbers of CDs; as empiric data emerges, the need for 
modelling falls away (6). 
 
In 2006 baseline birth prevalence data were published in the March of Dimes Global 
Report on Birth Defects (10), to attempt to fill the gap due to inadequate birth 
prevalence data for CDs at a national and global level. A database (now known as the 
Modell Global Database of Congenital Disorders – MGDb) was used to generate baseline 
country estimates in the absence of care, for CDs with endogenous causes using birth 
prevalence data from well-established CD surveillance systems. A long-term intention 
has been to expand this method to develop sub-national estimates generated by 
individual countries using locally sourced demographic data. This study explores the 
application of MGDb methods at the national level in SA, in order to model baseline 
estimates for the birth prevalence of endogenous CDs for 2012. The actual birth 
prevalence was estimated using the MGDb approach to evaluate the effect of present 




This desktop, data analysis study was initiated in October 2014 with a consultative 
meeting at the Centre for Health Informatics and Multiprofessional Education (CHIME), 
University College London (UCL) with Professor Bernadette Modell and Dr Matthew 
Darlison of the World Health Organization (WHO) Collaborating Centre for Community 
Genetics, and Professor Arnold Christianson and Helen Malherbe from SA. Other than a 
follow-up meeting at CHIME, UCL in November 2015 the study was undertaken in 
Johannesburg, South Africa. 
 
Premise of the study 
The MGDb links reliable birth prevalence data for groups of CDs to population specific 
demographic data to generate modelled estimates of actual affected births and other 
relevant outputs. The impact of interventions through access to relevant health services 
for affected individuals is quantified using the infant mortality rate (IMR) as a proxy for 
access (26).  
 
Scope of Study 
Period of study 
Births and deaths occurring in all nine South African provinces were included for the 
2012 vital registration year. The year 2012 was the most recent for which data were 
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available with the greatest degree of certainty. It is also the year subsequent to the 
observed stagnation of child mortality rates, when no further significant reductions had 
been observed after a period of rapid reduction (27). The use of annual data for the 
South African MGDb (MGDb-ZA) is in contrast with the MGDb, which uses demographic 




Four groups of early onset CDs (presenting before the age of 20) with mainly 
endogenous causes were included in the MGDb-ZA. Several placeholder conditions are 
also priority CDs in SA (28). Specific CD groups included:  
 
 Single Gene Disorders:  
o Early onset autosomal dominant,  
o autosomal recessive (placeholder condition - oculocutaneous albinism),  
o sex-linked single gene disorders,  
o consanguinity associated disorders.  
 Chromosomal Disorders:  
o Down syndrome,  
o other trisomies (Trisomy 18 and Trisomy 13),  
o rare autosomal chromosomal disorders,  
o sex chromosomal disorders (Turner and Klinefelter syndromes). 
 Congenital Malformations: Non-syndromic isolated congenital malformations 
are divided into five sub-categories: 
o Neural tube defects (NTD) 
o Congenital heart disease (CHD)4 
o Oral facial clefts (OFC)  
o Potentially fatal (majority very severe in the absence of care) other 
malformations: Central nervous system (CNS) not NTD; eye; ear, face and 
neck; respiratory system; digestive system, abdominal wall defects; 
urinary system; other malformations; and multiple malformations. 
o Non-fatal (majority less severe in the absence of care) other 
malformations: genital and limb. 
 Additional Conditions: 
o Non-genetic CDs excluded from registries and classed elsewhere in ICD-
10 system e.g. congenital hypothyroidism due to thyroid 
                                                     
4 The MGDb category congenital heart disease is the sub-set of congenital heart 
defects which cause disease (death or disability) in the absence of care.  
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aplasia/dysplasia, or conditions with an uncertain status e.g. pyloric 
stenosis and prematurity-associated persistent patent ductus arteriosus. 
Conditions excluded 
The following conditions were excluded: 
 CDs caused post-conception due to an abnormal fetal environment, e.g. 
maternal illness or exposure to teratogens (29), since these cannot be predicted. 
 Non-genetic CDs with functional rather than anatomical effects (e.g. the 
proportion of cerebral palsy of intrauterine origin): these are usually excluded 
from congenital anomaly registries.5  
 Later-onset single gene disorders such as family cancer syndromes or 
genetically-determined neurodegenerative disorders. 
 Disorders due to genetic risk factors. MGDb includes two common early-onset 




The modelled estimates generated represent estimates only for a sub-set of the totality 
of CDs. 
 
Estimates resulting from the MGDb-ZA are not comparable with SA data from the 2006 
Modell Birth Defects Database (10) due to (a) changes in modelling methods and (b) 
different sources of demographic data.  
 
The MGDb-ZA (like MGDb) uses demographic denominators for live births only, as 
reliable stillbirth data is scarce. This leads to a modest underestimation in the annual 
affected births calculated (26).  
 
Anecdotal evidence suggests a higher incidence of consanguinity in specific regions, but 
the lack of available empiric data required a uniform consanguinity adjustment to be 
applied to the IMR across all provinces. This may lead to an overestimate of adverse 
outcomes for consanguinity associated disorders.  
 
 
Data Collated for input 
Specific data required are listed in Table 1. Where demographic data were not available 
for the smallest civil division e.g. district, the next level up (provincial or national) was 
sourced.  
                                                     
5 Neurological damage leading to cerebral palsy may occur in utero, at birth, or later 
e.g. due to meningitis or subaponeurotic/subgaleal haemorrhage.  
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Data sources 
Optimal sources of data were identified following careful consideration (see Table 1), 
due to the relationship between the quality of the demographic data used and quality 
of the estimates derived.  
 
Table 1. Details of demographic data indicators required and sourced. Unless 
otherwise specified, each indicator was used in all MGDb-ZA calculations. 
 
Data adjustment for estimating access  
In the MGDb, access to care refers to access to the typical range of services available 
when the IMR is 10 per 1 000 live births or lower (26). The IMR is the basis of the formula 
used to estimate access to care and was adjusted for the effect of the HIV/AIDS epidemic 
and for parental consanguinity, due to their disproportionate contribution to infant 
mortality in SA compared to other populations (26). Provincial IMRs, excluding HIV/AIDS 
                                                     
6 Professor Rob Dorrington, Centre for Actuarial Research, University of Cape Town, 
Personal Communication. 
7 Percentage of mothers aged 35+ is required for calculating estimates for 
chromosomal disorders. 
8 Coefficient of consanguinity and HIV/AIDS related mortality are required to adjust the 
IMR for use in the calculation of access to service.  
Indicator Data source 
Civil Division National Total or 
Rate 
Population (1 000s) CARe projection model6 Provincial 52 261 
Annual (live) births (1 000s) CARe projection model5 Provincial 1 169 
Infant mortality rate CARe projection model5 Provincial 28/1 000 LB 
Under-5 mortality rate CARe projection model5 Provincial 46/1 000 LB 
Mean life expectancy CARe projection model5 Provincial 62 (male & female) 
Total fertility rate  Dorrington & Moultrie 
2015 (30) 
Provincial 2.5 
Sex ratio at birth CARe projection model5 Provincial 1.02 
Stillbirth rate Cousens et al 2011 (31) National 20.4 /1 000 births 
Neonatal mortality rate 40% IMR5 Provincial 11.3/ 1 000 LB  
Crude birth rate CARe projection model5 Provincial 21.9 
Percentage urbanized CARe projection model5 Provincial 63% 
Percentage mothers aged 35+7 CARe projection model5 Provincial 13% 
Coefficient of consanguinity (F)8 Modell et al 2016 (26) National 0.007 
IMR adjusted for HIV/AIDS 7 Johnson et al 2016 (32)  Provincial 25  
IMR adjusted for HIV/AIDS and 
consanguinity 
Modell et al 2016 (26) &  





deaths, were sourced (32), and a further 1.4 infant deaths per 1 000 live births (based 
on coefficient of consanguinity) deducted from the IMR to adjust for consanguinity (26). 
 
Data Analysis 
The MGDb-ZA was adapted from a model of the MGDb as provided on 30 August 2016 
in a series of Microsoft Excel spreadsheets. Integrated formulae based on birth 
prevalence data updated automatically when South African demographic data was 
inputted. Formulae, data sources, birth prevalence and other rates, and methodologies 
used in the MGDb are detailed in Epidemiological Methods in Community Genetics and 
the Modell Global Database of Congenital Disorders (MGDb) available online (26). 
 
The MGDb-ZA generated a set of four outputs for 2012:  
 
1. Baseline birth prevalence and birth outcomes in the absence of any 
care/intervention. This provides a baseline to quantify the scale of the problem 
and against which to evaluate the impact of current interventions.  
2. Birth outcomes with access to available care/interventions.  
This includes effects of pre-conception and pre-natal interventions including folate 
fortification, prenatal diagnosis (PND), genetic counselling, termination of 
pregnancy (TOP) and diagnosis/care from birth.  
3. Disorder-specific survival and disability: 
a. In a baseline no-care situation  
b. With optimal care (IMR estimate of access to care) 
4. Obtaining country-specific estimates: Calculated from the proportion of the 
population estimated to have no access to care and access to optimal care  
 
Key findings of the MGDb-SA are presented below.  
 
Results 
Collated Data for input 
The demographic data collated is summarised in Table 1. Nationally, just under a third 
(30%) of the population was estimated to have access to optimal services. 
 
Baseline outcomes in the absence of intervention 
Table 2 summarizes the baseline birth outcomes without intervention. Total birth 
prevalence for all groups of CDs was estimated at 30.5 per 1 000 live births. Of the total 
live births affected, a quarter died during the first month of life (n=9 535) and half (n=16 
855) under-5. Most live births affected by NTDS (94%, n=995), autosomal dominant 
single gene disorders (97%, n=1 585) and other trisomies (99%, n=385) died under-5, 
with over 85% of NTD (n=880) and other trisomy deaths (n=335) occurring during the 
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first month of life. A high proportion (over 90%) of survivors at age 5 was seen for sex 
chromosomal disorders (Turner and Klinefelter syndromes), oculocutaneous albinism 
and usually less severe malformations.  
 
Birth outcomes with access to care  
Birth outcomes with access to care are detailed in Table 3. Compared to baseline 
outcomes, an estimated 1 860 affected births were avoided through pre-conception and 
pre-natal interventions (folate fortification, PND, genetic counselling and TOP). The birth 
prevalence was reduced by 1.1 per 1 000 live births resulting in 225 fewer stillbirths and 
1 635 fewer affected live births. Overall access to care resulted in just under a third (30% 
n=10 320) of total live births receiving care and almost two-thirds (n=23 585) receiving 
no care. Overall survival increased by 12% (n=3 235) at 5 years of age with care 
compared with baseline estimates. A reciprocal decrease was seen in deaths from CDs, 
with 37% (n=12 665) dying under-5 compared with 50% (n=17 675) without care 
(baseline). Deaths from other causes under-5 increased by 140. The proportion of 
under-5 deaths occurring during the neonate period remained at just over 50% (3% 
decrease). The overall proportion of affected stillbirths remained the same. 
Comparative results for each of the specific disorder groups are detailed in separate 
sections below. 
 
Single Gene Disorders 
The birth prevalence of single gene disorders represented just over a quarter of the total 
CD groups modelled, with consanguinity-related recessives accounting for the greatest 
proportion. Access to care for single gene disorders was 31% (n=2 960). Birth prevalence 
decreased with access to care by 0.3 per 1 000 live births due to a 0.2 reduction for 
recessive disorders and minimal reductions for consanguinity related recessives and 
genetic type unknown. 
 
Some 305 affected births were avoided by pre-conception and pre-natal intervention. 
The number of live births with baseline recessive disorders decreased by 245, 
contributing the bulk of the 3% reduction in single gene disorders affected.  
 
Affected stillbirths were estimated to account for 11% (n=210) of baseline recessive 
disorders and 17% (n=790) of consanguinity-related affected births, with access to care 
making a minimal difference. 
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5 years  
Single Gene Disorders                 
Autosomal Dominant 1.4 0 1 635 300 960 1 585 50 0 
X-Linked 0.1 0 60 10 20 25 0 35 
Baseline Recessive 1.7 215 1 940 430 760 945 70 925 
Genetic Type Unknown 1.2 0 1 355 260 465 530 50 775 
Oculocutaneous Albinism 0.3 0 290 0 0 0 15 275 
Recessive Increment/consanguinity 3.9 800 4 520 1 000 1 775 2 205 160 2 155 
Total Single Gene Disorders 8.4 1 015 9 800 2 000 3 980 5 290 345 4 165 
Chromosomal Disorders                 
Down Syndrome 1.7 100 2 010 705 900 1 370 45 595 
Other Trisomies  0.3 475 390 335 385 385 5 0 
Rare Autosomal 0.6 180 645 245 300 465 35 145 
Turner Syndrome 0.2 55 205 0 0 0 10 195 
Klinefelter Syndrome 0.7 20 820 0 0 5 35 780 
Total Chromosomal Disorders 3.5 830 4 070 1 285 1 585 2 225 130 1 715 
Malformations                  
Congenital Heart Disease3 3.6 60 4 260 1 580 2 725 2 815 105 1 340 
Neural Tube Defects 0.9 295 1 060 880 970 995 0 65 
Oral Facial Clefts 0.2 5 280 90 180 225 5 50 
Very Severe Other Malformations 7.6 260 8 900 3 610 4 325 4 890 245 3 765 
Less Severe Other Malformations 5.2 40 6 020 40 90 270 270 5 480 
Total Malformations 17.5 660 20 520 6 200 8 290 9 195 625 10 700 
Additional Conditions                 
Thyroid a/dysgenesis 0.1 0 115 0 30 60 5 50 
Prem Associated PDA 0.3 0 350 50 105 110 15 225 
Pyloric Stenosis 0.7 0 820 0 795 795 25 0 
Total Additional Conditions 1.1 0 1285 50 930 965 45 275 
Total 30.5 2 505 35 675 9 535 14 785 17 675 1 145 16 855 
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With access to care, 6% (n=445) more live births with single gene disorders survived at 
5 years than in baseline estimates, with a reciprocal decrease in deaths under-5 
(n=5010). This included 245 surviving with autosomal dominant conditions compared to 
none without intervention. Survival at 5 years of births affected by oculocutaneous 
albinism remained unchanged; survival increased by almost 10% (n=5) for x-linked 
disorders and by 5% or less each for genetic type unknown (n=50), baseline recessive 
disorders (n=40) and consanguinity-related (n=185). 
 
Chromosomal Disorders 
Chromosomal disorders accounted for 14% (n=4 900) of overall affected births, with 
Down syndrome contributing half, with minimal changes following intervention. Access 
to care for chromosomal disorders averaged at 25% due to only 14% of Klinefelter 
syndrome being diagnosed even when there is optimal care available (26).  
 
A total of 265 affected births were avoided through pre-conception and pre-natal 
intervention, specifically PND and genetic counselling. Overall, 80 fewer stillbirths and 
180 fewer livebirths were affected, including 13% less other trisomies (n=110), 11% 
(n=30) less Turner syndrome and 8% (n=65) less births affected by rare autosomal 
disorders. Of the total births affected, over half of those with other trisomies, a fifth 
with rare autosomal disorders, a further fifth with Turner syndrome and 5% with Down 
syndrome were stillborn. These proportions remained unchanged with access to care.  
 
Survival at 5 years of age rose overall for chromosomal disorders by 11% (n=335) with 
access to care, with survivors of rare autosomal disorders and Down syndrome each 
increasing by approximately 15% (n=90 and n=275 respectively). Most live births 
affected by sex chromosomal disorders (Klinefelter and Turner syndromes) survived to 
the age of 5, while none affected by other trisomies survived, and this remained 
unchanged with access to care.  
 
Overall, 500 fewer deaths under-5 occurred with access to treatment for births affected 
by chromosomal disorders. More than half of these deaths (n=280) were prevented as 
neonates, with mortality during the first month of life dropping from a third of affected 
births to a quarter. A 10% reduction in neonatal deaths was seen both for Down 
syndrome (n=190) and rare autosomal disorders (n=75). Infants affected by other 
trisomies all died within the first year of life with or without intervention, surprisingly, 
the proportion of deaths during the neonatal period increased by 9% with access to care. 
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at 5 years  
Single Gene Disorders                       
Autosomal Dominant 1.4 0 0 1 635 510 1 130 225 830 1 340 50 245 
X-Linked 0.1 0 0 60 20 40 5 20 20 0 40 
Baseline Recessive 1.5 245 210 1 700 530 1 170 305 615 750 65 885 
Genetic Type Unknown 1.1 20 0 1 335 415 920 200 395 460 50 825 
Oculocutaneous Albinism 0.3 0 0 290 90 200 0 0 0 15 275 
Recessive Increment/consanguinity 3.8 40 790 4 485 1 395 3 090 810 1 620 1 985 160 2 340 
Total Single Gene Disorders 8.1 305 1 000 9 505 2 960 6 550 1 545 3 480 4 555 340 4 610 
Chromosomal Disorders                     
Down Syndrome 1.7 60 100 1 955 610 1 345 515 700 1 035 50 870 
Other Trisomies  0.3 110 415 340 105 235 320 340 340 0 0 
Rare Autosomal 0.5 65 165 595 185 410 170 235 345 15 235 
Turner Syndrome 0.2 30 50 180 55 125 0 0 0 10 170 
Klinefelter Syndrome 0.7 0 20 820 35 785 0 0 5 40 775 
Total Chromosomal Disorders 3.3 265 750 3 890 990 2 900 1 005 1 275 1 725 115 2 050 
Malformations9                       
Congenital Heart Disease3 3.3 350 55 3 915 1 215 2 700 700 1 175 1 215 150 2 550 
Neural Tube Defects 0.6 505 185 665 165 370 325 350 390 140 135 
Oral Facial Clefts 0.2 15 5 255 80 175 55 110 140 5 110 
Very Severe Other Malformations 7.5 385 245 8 535 2 650 5 880 2 750 3 320 3 730 240 4 565 
Less Severe Other Malformations 5.2 35 40 5 990 1 860 4 125 60 95 225 270 5 495 
Total Malformations 16.9 1 290 530 19 360 5 970 13 250 3 890 5 050 5 700 805 12 855 
Additional Conditions                       
Thyroid a/dysgenesis 0.1 0 0 115 35 80 0 20 45 0 70 
Prem Associated PDA 0.3 0 0 350 110 240 35 70 75 15 260 
Pyloric Stenosis 0.7 0 0 820 255 565 0 555 565 10 245 
Total Additional Conditions 1.1 0 0 1 285 400 885 35 645 685 25 575 
Total 29.4 1 860 2 280 34 040 10 320 23 585 6 475 10 450 12 665 1 285 20 090 
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Malformations  
Non-chromosomal isolated malformations accounted for the majority of the total CDs 
modelled in this study, contributing over 50% of affected births in baseline estimates 
(n=21 180) and with access to care (n=19 890). Access to care for malformations was 
31%. Birth prevalence for malformations decreased by 0.67 following pre-conception 
and pre-natal intervention, with CHDs (0.30) and NTDs (0.34) accounting for the bulk of 
this drop. CHDs accounted for a fifth of all malformations, with potentially very severe 
other malformations (consisting of seven sub-groups of very severe malformations), 
collectively accounting for over 40% of malformation birth prevalence and less severe 
malformations for just under a third.  
 
A total of 1290 affected births were avoided through pre-conception and pre-natal 
interventions, including 39% (n=505) NTD affected births and just under a third each of 
CHDs (n=350) and very severe other malformations (n=385). Following intervention, a 
total of 130 fewer stillbirths and 1160 fewer live births were affected by malformations 
in comparison to baseline estimates, although overall proportional amounts remained 
similar for each category. The number of livebirths affected by NTDs decreased by 395 
with access to pre-conception, pre-natal intervention and care following birth. Affected 
livebirths for CHDs and OFCs also decreased by 345 and 25 respectively, following 
intervention. 
 
Intervention increased survival of births affected by malformations by 14% (n=2155). 
The greatest increase was seen for CHDs, with a third more surviving (n=1210), followed 
by OFCs with a quarter more (n=60), NTDs (14% n=70) and potentially very severe 
malformations (11% n=800). Usually less severe malformations accounted for the most 
survivors (>90%) at 5 years, both for baseline estimates and with care.  
 
With intervention, 15% (n=3495) fewer births affected by malformations died under the 
age of 5, excluding deaths from other causes. This included a third fewer deaths each 
from CHDs, NTDs, and OFCs.  
 
Additional Conditions 
The birth prevalence for additional conditions accounts for only 3.6% of total CDs 
modelled, and remained unchanged with access to care. No births were avoided through 
pre-conception or pre-natal care, with the number of affected livebirths and zero 
stillbirths remaining the same. Access to care for additional conditions was 31%. 
 
Baseline estimates indicated only 21% (n=275) of affected births survived to the age of 
5, excluding pyloric stenosis cases, which were all estimated to have died under-5. With 
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care, survival at 5 years doubled (n=575), including a third surviving (n= 245) for pyloric 
stenosis whereas none survived previously. 
 
Under-5 deaths from additional conditions decreased by 22% (n=280) with access to 
care. With access to care only those affected by prematurity associated PDA resulted in 
neonatal deaths, which decreased by 5% (n=15). 
 
Disorder-specific survival and disability (Baseline & with care) 
Proportional changes in disability and survival with access to care are detailed in Table 
4. With access to care an overall reduction of 5% (n=100 598) in years affected was seen, 
13% less years of life were lost and a slight increase in years lived with disability. As the 
result of intervention, 12% of years affected were lived cured. The number of years 
affected per person of the total birth cohort decreased by 0.08 to 1.81 with access to 





This study modelled birth outcomes for four categories of CDs in SA to supplement the 
current lack of empiric, observed data. Collated SA demographic data was used to adapt 
the MGDb to develop national birth prevalence and birth outcomes (live births, 
stillbirths, under-5 deaths, survival at 5 years) for specific early onset, endogenous CDs. 
This was undertaken for 2012, initially in the absence of any intervention to provide 
baseline estimates to indicate the scale of the problem.  
An important upfront consideration is the diversity in data sources utilised by the MGDb 
method which affects the reliability of the modelled estimates. The principle reference 
sources used for the baseline prevalence estimates in the MGDb are strongly evidence-
based and are conservative estimates to prevent overestimation (26). The evidence 
basis for the calculation of outcome estimates is less robust. While there is observed 
evidence for the impact of folic acid (26) (33), access to PND and TOP are estimates only. 
Similarly, survival data for chromosomal disorders and some malformations is reliable, 
but is outdated for CHDs and may lead to an overestimation of CHD-related early 
mortality and an under-estimation of disability (26, 34). 
The portion of the population with access to optimal care was calculated using the IMR 
and applied to the same dataset enabling birth outcomes with access. Optimal care is 
defined in the MGDb as the level of care typically available when infant mortality is 10 
per 1 000 live births or lower, although in principle it should include all interventions 
available at the relevant time (26). Survival and disability outcomes were also estimated 
to compare the impact of access to care. 
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Table 4. MGDb-ZA disorder-specific proportional changes in survival and disability for South Africa in 2012. 
  Outcomes, % of years affected per person 























































































































































































Single Gene Disorders 607 742 0.52 90% 10% 589 179 3% 0.50 82% 18% 0% 
Chromosomal 
Disorders 252 272 0.22 66% 34% 241 070 4% 0.21 64% 36% 0% 
Malformations (Non-
syndromic Isolated) 1 271 417 1.09 66% 34% 1 200 326 6% 1.03 48% 32% 20% 
Additional Conditions  79 675 0.07 88% 12% 79 934 0% 0.07 62% 13% 25% 
Total 2 211 106 1.89 73% 27% 2 110 508 5% 1.81 60% 28% 12% 
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The scale of the burden of CDs from the baseline estimates, indicates that without care, 
more than half of affected births die before 5 years of age. The 30% access to care has 
a substantial impact, preventing 5 010 of these early deaths and avoiding a further 1 860 
through pre-conception and pre-natal intervention. With half of under-5 deaths 
occurring during the neonatal period with or without care, improved access to optimal 
care, including early diagnosis and treatment, may potentially prevent more deaths 
during this high-risk period.  
 
Single Gene Disorders 
The low proportion of affected single gene disorder births that are avoided with access 
to care (n=305), is an indication of the lack of available screening as part of routine 
antenatal care. There is no mandatory national newborn screening programme in SA 
and such tests are only available in the private sector, with limited carrier screening 
available in some public health sector laboratories (17). The majority of births avoided 
are for baseline recessive and consanguinity related disorders such as thalassemia, sickle 
cell anaemia, cystic fibrosis, Gaucher disease and others, which predominate in SA (35). 
Many of these conditions are treatable, enhancing survival for affected births following 
diagnosis.  
 
The modelled estimates confirm that recessive disorders are present at a higher rate in 
births resulting from consanguineous unions, and the rarer the allele the greater the 
relative risk (36). The full potential of genetic counselling in educating families on 
potential risks to enable informed decision making regarding reproductive choices and 
PND remains constrained due to severely curtailed capacity (37) and is less immediately 
visible in a country with a low total fertility rate such as SA. Anecdotal evidence suggests 
consanguinity to be more common in specific population groups in Limpopo and North 
West Provinces (Arnold Christianson, personal communication). Due to limited 
availability of local data on the prevalence of parental consanguinity, a uniform 
consanguinity adjustment was used in the MGDb-ZA in the calculation of estimates. 
Improved data is required to better estimate nuances in the impact of this practice 
relevant for the development of services. 
 
Early-onset dominant autosomal conditions have a lower birth prevalence than 
recessive disorders. They are less likely to receive an early diagnosis and appropriate 
care due to limited facilities and lack of skilled clinicians (10, 15, 16). Owing to the 
aetiology of single gene disorders, curative interventions9 are not currently possible.  
                                                     
9 Curative interventions refer to treatments or surgeries that effectively ‘cure’ the 
disorder, i.e. enable the affected person to live a normal life with no additional medical 
surveillance or intervention – e.g. curative paediatric surgery. Where genetic disorders 
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No impact is seen for access to care for those affected by oculocutaneous albinism in 
children under-5 as this condition is not life threatening in itself. However, skin cancer 
is a major cause of death and shortens the life-span for those affected, making 
preventative treatment from an early age vital, including UV-protective clothing, 
sunscreen, encouraging an indoor lifestyle and early presentation of skin cancers (38).  
Chromosomal Disorders 
The impact of PND and genetic counselling as part of pre-conception and pre-natal 
intervention was minimal, with 265 chromosomal affected births avoided. With the rate 
of Down syndrome and other trisomies strongly related to maternal age, 
ultrasonography and amniocentesis services should be offered routinely for all 
expectant mothers over the age of 35. A scan, invasive testing and accompanying 
genetic counselling are recommended by the 2015 Guidelines for Maternity Care (39), 
but cannot occur routinely (40, 41) due a lack of infrastructure and skilled capacity (42). 
Despite being freely available in limited locations since 1994, the current system fails to 
deliver comprehensive ante-natal care for mothers of advanced maternal age, with 
frequent missed referral opportunities and the option of PND often withheld (40).  
 
This modelling exercise has demonstrated that early diagnosis and access to care can 
substantially improve survival. When a third of the population have access to optimal 
care, an additional 15% of those affected by Down syndrome survive to age 5, with 
similar outcomes for rare autosomal disorders. Diagnosis of Down syndrome after birth 
continues to be a challenge in SA, preventing early access to life-saving care, genetic 
counselling and rehabilitation to ameliorate disability, reducing survival rates (41). Many 
of those affected by Down syndrome continue to die undiagnosed, compounded by the 
lack of cardiac surgery available (41, 43, 44), and their deaths are recorded under other 
NCD-10 codes (41).  
 
With no survivors at 5-years for other trisomies, these life-limiting conditions often 
result in the withdrawal of treatment and implementation of palliative care only (45). 
The unexpected finding of a greater proportion of other trisomies dying during the 
prenatal period with access to care than for baseline estimates warrants further 
investigation. Improved services may increase survival at all stages other than for 
neonates, while Janvier et al (46) suggest that a later diagnosis confers a ‘survival 
advantage’ since full care is given up until the point of diagnosis. A more likely 
explanation in the context of this study may be an unresolved calculation error.  
                                                     
are concerned, treatment may ameliorate the disorder but at present rarely leads to 
effective cure. 
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The less pronounced impact of care for sex chromosomal disorders is because this study 
is focused on survival and these conditions are not life limiting. Only a small portion of 
affected males with Klinefelter syndrome are diagnosed, usually after puberty due to 
associated health issues (47, 48). Health issues are more severe for females affected by 
Turner syndrome and may reduce life expectancy (49). For both these sex chromosomal 
disorders, access to care has more impact on the quality of life experienced by those 
affected, than on the quantity. 
Malformations 
The greatest impact of access to care was seen in this category of CDs which contribute 
over 50% of the overall birth prevalence in the study.  
 
The MGDb includes non-chromosomal isolated early onset congenital heart disease 
caused by congenital heart defects (CHDs) that cause death or disease before the age of 
20 (26). CHDs account for a fifth of the malformations group and are the most common 
CD at birth. The lack of PND results in a low rate of TOP even for severe CHDs. Diagnosis 
after birth is also challenging for these unseen CDs, requiring examination by a skilled 
clinician which does not occur routinely before discharge of newborns in SA or for home 
births. Accurate diagnosis may be assisted by pulse oximetry pre-discharge screening, 
which is not routinely available in SA but has proven feasible (50).  
 
Folate fortification reduced CHD affected live births by 8%, accounting for the majority 
of 350 avoided CHD affected births following access to care. The high birth prevalence 
of CHDs results in a large number of unaffected births. The increased survival of affected 
births of just over a third may be largely attributed to corrective cardiac surgery. 
Although historically paediatric surgery has been perceived as prohibitively expensive 
and of little relevance for MLICs (51, 52), evidence is emerging to the contrary (51, 53, 
54). A fresh approach integrating corrective surgery into health care policy and systems 
rather than as vertical programmes and developing local paediatric surgical expertise 
and the required infrastructure, could place paediatric surgery at the forefront of 
reducing avertable suffering in children, and offer considerable socioeconomic benefits.  
 
The majority of births avoided for NTDs is attributed to the folate fortification of staple 
foods in SA (maize meal and bread) implemented since 2003. The 31% reduction in NTDs 
reported by Sayed et al (33) was the basis for the calculation in the MGDb-ZA, causing 
the reduction in birth prevalence by 0.3 per 1 000 live births. An additional small 
percentage of prenatally diagnosed NTDs were medically terminated. It must be noted 
that anencephaly contributed a fifth of the live births affected by NTDs, but all die 
shortly after birth regardless of access to care. Folate fortification also reduces OFC 
affected births but to a lesser extent due to the lower baseline birth prevalence (33). 
 98 
 
The substantial increase in survival with malformations with access to care is largely due 
to surgical intervention as outlined above. In the case of potentially lethal conditions 
such as cleft lip/palate, it can offer an effective cure and ameliorate the degree of 
disability (10). Of the 70% of CDs that can be cured, prevented or have their associated 
disability ameliorated (55), the 40% that can be cured or largely ameliorated are mostly 
malformations tackled primarily by means of surgical intervention (15). This highlights 
the need to invest more into developing surgical capacity in SA, where it could 
substantially increase survival and function for children with malformations. 
 
Additional Conditions  
The additional conditions included in this study serve largely as placeholders for more 
to be added in the future. For example, the value of therapeutic treatment and 
intervention after birth is particularly emphasised by the reduction by one third in 
under-5 deaths from congenital hypothyroidism, and the increase in survival following 
surgery for pyloric stenosis. This eclectic group of conditions highlights the tailored care 
approach required for each specific disorder that, when applied, can yield optimal 
results.  
 
Survival and disability  
The years lived cured and lives saved through access to care dispels the widely-held 
myth that ‘little can be done to treat CDs’. With the increase in survival (excluding those 
cured through surgery) comes a greater proportion living with disability resulting from 
CDs requiring therapeutic treatment -emphasizing the increased commitment, capacity 
and resource allocation needed for their care. Rehabilitation, including 
neurodevelopmental, speech, and occupational therapies to ameliorate the degree of 
disability and enhance quality of life needs to be accompanied by appropriate 
psychosocial support (10). Care of those affected by CDs should be balanced with 
prevention to ensure sustainability of care services (10). 
 
Limitations  
The use of provincial estimates for IMR, U5MR and neonatal mortality rate was 
necessary due to the incompleteness of vital registration data at the district level. 
Although registration completeness has improved over the past two decades with 
legislation (56, 57) making it compulsory, low levels of completeness persist for children 
under-5 years, especially for infants (58-61). Data for 1992-2014 from the Agincourt 
Health and Socio-Demographic Surveillance System reported death registration for 
children under-5 at only 33.7% and infants at 26.7% (59). Most deaths of rural children 
with serious CDs occur outside health facilities with traditional burial occurring at home. 
Mothers cannot afford the expense and time away from home and work to take these 
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children to hospital to die (62). (Professor Arnold Christianson, personal 
communication). This also contributes to underreporting of CDs since many of these 
unregistered deaths may be undiagnosed CDs.  
 
The development of the MGDb-ZA was instrumental in highlighting areas for 
improvement of the MGDb, and refining the modelling methods utilised as part of its 
ongoing evolution. 
 
The findings of this study have quantified the baseline scale of the burden of specific 
early onset endogenous CDs in SA for 2012. Modelled estimates for access to 30% 
available care demonstrated the proportional change in birth outcomes made possible 
by care – reducing birth prevalence, decreasing mortality, providing curative 
interventions and therapies, and ameliorating disability for the increasing number 
surviving. If improved services were more widely available, an even greater proportion 
of lives could be saved or be qualitatively improved.  
This study indicates the number of lives affected by CDs is much higher than the number 
documented by national CD surveillance (21). Current capacity is inadequate to 
accurately diagnose, refer and care for those affected by CDs. With over 40% of under-
5 deaths occurring during the neonatal period in SA (63), more needs to be done during 
this critical period of early life. Early diagnosis and appropriate care could help reduce 
these deaths, many of which are preventable, and could contribute towards achieving 
the Sustainable Development Goal 3 target of an U5MR of 25 per 1 000 live births by 
2030 (64).  
Currently capacity is lacking in the medical genetics services sector (8) and political 
commitment and accompanying resources are required if the situation is to improve. 
Without this increased capacity, the necessary primary, secondary and tertiary 
prevention and care of CDs cannot be effectively implemented for the wellbeing of those 
affected in SA.  
Conclusion 
This study has highlighted the importance of empiric data on CDs in SA. It is hoped that 
the findings of this study will stimulate policy makers to initiate informed development 
and universally accessible implementation of cogent medical genetic services, 
particularly in primary healthcare (PHC) including improved surveillance of CDs. Areas 
for further study include in-depth analyses of modelled estimates (a) for specific CDs 
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Part Four: Building capacity 
 
Part Four focuses on the need to increase capacity in the medical genetics sector in SA. 
The regression in these services is bringing the country to a crisis point as the health 
need of CDs continues to increase. The article which makes up Chapter 9 briefly outlines 
the situation in the country, as covered in Part One of this study and explains the history 
of medical genetic services and capacity development. Reasons for the decline in 
capacity are outlined and the challenges in building the required capacity quickly. The 
role of the genetic nurse is highlighted as the potential cornerstone of the sector, and 
as a means to quickly regenerate the required services.  
Two existing tools are profiled to potentially develop the large numbers needed in a 
short space of time. Collectively, the Medical Genetics Education Programme (MGEP) 
and the Congenital Disorders Course Book could be used to build up a nursing workforce 
with improved knowledge and skills in medical genetics. If implemented within the 
relevant primary healthcare streams of the National Health Insurance (NHI) scheme (1), 
this could help CDs being prioritized as a health care issue in the country. 
 
1. National Health Insurance: Towards Universal Health Coverage. White Paper on 




Chapter 9: The case for the genetic nurse in South Africa 
 
This article has been submitted to the Journal of Community Genetics. 
Malherbe HL, Christianson AL, Woods D, Aldous C. The case for the genetic nurse in 
South Africa. Journal of Community Genetics (under review). 
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The care and prevention of congenital disorders (CDs) is an emerging, but unprioritised 
health need in South Africa (SA). Inadequate empirical data and underreporting conceals 
the true burden of CDs while medical genetic services to confront the problem have 
regressed. Positive epidemiological transition in the country now demands these 
services are improved to significantly further reduce child mortality. Current sector 
capacity in SA is inadequate and required personnel targets will not be reached quickly 
enough to meet the growing health need even if relevant posts are designated. 
Historically, genetic trained nurses played a defined role in primary health care (PHC) by 
recognizing and diagnosing common CDs and counselling patients and their families, 
whilst referring complex matters to the limited tertiary medical genetic services 
available. Policy changes to redress past inequalities and other healthcare priorities 
resulted in genetic services being incorporated into PHC, with few genetic nurses 
retaining their genetic services role. While the medium to long term aim for SA would 
be to develop medical genetic services with appropriate capacity at all levels of 
healthcare, there is an urgent short term need to provide basic medical genetic services 
in PHC. Central to achieving this is the up-grading and re-implementation of the 
previously successful Medical Genetics Education Programme (MGEP). This post-
graduate distance learning, education programme is implemented with the Congenital 
Disorders course book, a distance education tool promoting independent, home-based 
learning. Together, these tools offer an approach to swiftly build up a nursing workforce 
with improved knowledge and skills in medical genetics. 
 
Keywords: congenital disorders, genetic nurses, South Africa, medical genetics 




Congenital disorders (CDs) are a common, costly and critical health issue. Defined as 
abnormalities of structure or function present from birth, this includes all disorders 
caused by environmental, genetic and unknown factors, whether evident at birth or 
manifesting later in life (1). In South Africa (SA), it is estimated that CDs affect 6.8% or 
one in 15 live births (2). As for many middle and low income countries (MLIC), the true 
contribution of CDs to the disease burden is significantly underestimated in SA, with 
national surveillance underreporting CDs by 98% (3). Many remain undiagnosed or are 
misdiagnosed and the cause of death wrongly attributed (4-6). This is largely due to the 
lack of skilled clinicians to identify and diagnose CDs, combined with inadequate 
facilities (4, 5, 7).  
 
As for many MLIC, Millennium Development Goal 4 to reduce child mortality by two 
thirds by 2015 was not reached in SA. However, rapid reductions were achieved until 
2011 (8, 9). Various interventions, including HIV/AIDS programmes and the Expanded 
Programme of Immunization, have contributed to bringing the country back into 
positive epidemiological transition (10-12). As SA develops and communicable diseases 
are better controlled, the proportion of child deaths and disability resulting from CDs is 
rising (2, 13). This follows the trend of high income countries, where CDs emerged in the 
1960’s and remain as the leading cause of death in children, accounting for up to 28% 
of deaths in the under-fives (2, 7, 14-16). 
 
Despite the lack of empirical data in SA, the previously hidden disease burden of CDs is 
beginning to emerge through mortality data (11). In 2013, congenital abnormalities (a 
sub-set of CDs) overtook infection as the third leading cause of death in early neonates 
(17). As reported by Malherbe et al in 2016, this trend in early neonatal deaths 
continued in the Western Cape (WC) in 2014, a province which serves as a healthcare 
proxy for other provinces in the future (11).  
 
With the stagnation of the SA infant mortality rate (IMR) and under-5 mortality rate 
(U5MR) since 2011 and neonatal mortality rate since 2009, efforts are underway to 
further reduce child deaths in SA (8, 11, 18). While these interventions will save child 
lives, none confront the health issue of CDs - limiting the IMR from being significantly 
further reduced. One example is the 9 469 newborn and child lives potentially saved 
annually by scaling up 11 specific interventions (18). These are overshadowed by the 47 
1201 lives that could be saved and/or disability ameliorated every year by implementing 
                                                 
1 Based on 2014 live births of 1 242 070 (Statistics South Africa. Mid-year population 
estimates 2015. Statistics South Africa, Pretoria) and a prevalence rate of 54.2 (7).  
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appropriate care and prevention for 70% of genetically determined CDs alone (19).2 
Currently, one of the only primary prevention interventions comprehensively 
implemented countrywide in SA is the fortification of maize meal and wheat flour with 
folic acid, which has resulted in a 30% reduction in neural tube defects since its 
introduction in 2003 (20).  
 
CDs have not yet been addressed in SA as a priority health care issue in terms of World 
Health Resolution (WHA) 63.17 of 2010 (21), which outlined specific actions for 
commitment and allocation of resources by member states. Implementing 
comprehensive services for the care and prevention of CDs usually begins when a 
country’s IMR is between 40-50 deaths per 1000 live births (22, 23). Despite an IMR of 
28 per 1000 live births in 2015 (8), SA is yet to comprehensively implement genetic 
services in SA. Such services could be key in significantly reducing child mortality further 
(11). While competing health priorities are contributing factors for this lack of 
prioritisation of CDs, it is now essential that medical genetic services are implemented 
for this crucial category of non-communicable disease (24). 
 
Medical Genetic Services 
Medical genetic services improve health by preventing CDs and reduce suffering by 
offering care to those affected (7). The key to reducing the contribution of CDs to the 
burden of disease, is to offer the ‘best possible patient care in the prevailing 
circumstances’, and prevention so that people affected by or at risk of having children 
with CDs ‘can live and reproduce as normally as possible’ (4, 22, 25).  
 
The completion of the Human Genome Project in 2003 highlighted the genetic 
component of disease, triggering advanced research with many new genetic screening 
and diagnostic tests becoming available (26). As a result, medical genetics is becoming 
a field of relevance to the healthcare of many (27). Genetic services are required across 
the continuum of care, but initially focus upon reducing child mortality. As countries 
transition epidemiologically, the role of genetic services widens to encompass complex 
multifactorial conditions (of later onset). In SA, the quadruple burden3 of disease and 
non-classical epidemiology are impeding CDs from being recognized as significant 
causes of mortality and morbidity. CDs are the portfolio of the Women’s Health and 
Genetics Directorate under the Women’s Maternal and Reproductive Health cluster at 
                                                 
2 Excluding lives affected by teratogens that could be potentially saved, which account 
for almost 20% of CDs in SA (2). 
3 The quadruple burden of disease in SA includes HIV/Aids and TB; violence and 
injuries; high maternal and child mortality; and non-communicable diseases. 
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the National Department of Health (NDoH). CDs are currently excluded from non-
communicable disease (NCD) strategies nationally, negatively impacting their care and 
prevention. 
 
The lack of capacity 
A key barrier to the development of medical genetic services globally is a lack of 
capacity, impacting industrialised and developing countries alike, albeit on a different 
scale of magnitude (26). Although inadequate capacity is a widespread constraint in SA 
throughout healthcare, the impact of these staff shortages in medical genetic services 
is disproportionately inhibitive on healthcare development given the epidemiology of 
CDs. In SA, comprehensive medical genetic services are currently only available at four 
academic centres4, which excludes six of the nine provinces from accessing such 
services, other than via limited outreach clinics in some areas. Even within the provinces 
where genetic services are available, access and service vary according to geographical 
location, and outreach clinics are necessary to penetrate rural areas. Only 11 medical 
geneticists are practicing full-time countrywide (one per 5 million of the population), 
and less than eight genetic counsellors are practicing in the state sector (one per 7.3 
million) (11) (Shelley McCaulay Personal Communication 12 August 2016). Laboratory 
testing facilities and capacity are also severely compromised. 
 
This capacity falls far short of national recommendations of 27 medical geneticists (1 per 
2 million) and 95 genetic counsellors (1 per 580 000) required today to provide a basic 
universal service (28). Until recognition as a primary medical specialty in 2007, medical 
genetics was a sub-specialty under which many registered under a grandfather clause in 
1999 (29). Although 17 medical geneticists have qualified since 2001 and six registrars 
are currently in training, this additional capacity has been offset by a loss of 19 to the 
sector. Seven have retired, six have emigrated, two have died, two moved to private 
practice and two are not currently practicing. Genetic counsellor numbers are similarly 
limited with many of those qualifying remaining unavailable to public service as posts 
have been closed or frozen, forcing their emigration, move to other fields or the private 
sector, where seven are currently practising.  
 
With limited posts available and few doctors choosing to specialise in medical genetics 
within the greater context of a doctor shortage in SA,5 it is unlikely that capacity targets 
                                                 
4 Comprehensive genetic services are available at the University of Cape Town, 
University of the Free State, University of Stellenbosch, University of the 
Witwatersrand.  
5 60 doctors per 100 000/population in 2013 compared to the global average of 
152/100 000 (ECONEX. Identifying the determinants of and solutions to the shortage 
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will be reached in the medium term. With only four training centres available to train 
medical geneticists countrywide6, and only two centres7 training genetic counsellors and 
a severe shortage of allocated posts, these circumstances necessitate other options to 
be considered for the more immediate expansion of services. This speaks to the role of 
allied healthcare professions, specifically nurses, who can undertake a key 
supplementary role in genetic services.  
 
History of genetic nurses in South Africa 
While the potential role of nurses in genetic services is not new, their impact continues 
to be largely unappreciated. Appropriately trained nurses can provide an initial filter for 
referrals to the geneticist and perform an educational role (30). By diagnosing, 
counselling and treating common CDs, and recognizing and referring more complex 
disorders as necessary, genetically trained nurses provide a major contribution to 
genetic services (16, 31). In low resource settings in SA, especially rural areas, nurses in 
PHC contribute significantly to antenatal, labour and delivery and newborn care. They 
live and serve locally, understand the local language and culture, and are well respected 
in the community, making them ideal candidates to be trained as point of care genetic 
nurses and genetic nurse counsellors (7, 16, 32). 
 
Nurses were identified as a key component of medical genetic services early on in SA. 
The first genetic nurse was appointed in Durban in 1974 with the mandate to ‘find cases, 
follow-up affected families, create general awareness of genetic services and coordinate 
existing facilities’ (33). By 1977 a network of 16 genetic nurses countrywide had 
developed and were linked with medical schools, provincial services and their existing 
clinics and diagnostic laboratories, based around major urban centres (33). Genetic 
nurses were senior nursing personnel who underwent intensive training to effectively 
deal with and counsel patients with common congenital disorders. During the late 
1970s, the PHC nurse cadre was established enabling nurses with the training and 
authority to assess and diagnose patients, prescribe treatment and dispense medication 
(34). Beyond the role of nursing counterparts in high income countries, this was 
necessity for countries such as SA due to the lack of medical practitioners. Ad hoc 
                                                 
of doctors in South Africa: Is there a role for the private sector in medical education? 
Hospital Association of South Africa, 2015. http://www.econex.co.za/wp-
content/uploads/2015/08/ECONEX_Doctor-shortages-and-training_FINAL.pdf. 
Accessed 1 February 2016. 
6 University of Cape Town, University of the Free State, University of Stellenbosch, 
University of the Witwatersrand. 
7 University of Cape Town and the University of the Witwatersrand. 
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training of genetic nurses spanning a few days to several weeks continued into the 1980s 
(29).  
These genetic services mainly benefited the middle class, white population in urban 
areas. In 1985 only 18% of the 4 856 patients seen at genetics clinics were black South 
Africans, despite making up 74% of the country’s population (16, 35). Efforts were made 
in 1990 to expand into more rural areas with no genetics services, but were prevented 
by budgetary constraints (35).  
 
Collectively, all these factors resulted in genetic nurses becoming the ‘back bone’ of the 
genetics service, often working in extremely challenging conditions without medically 
qualified supervisors, with only five medical geneticists in the country at the time (35).  
 
The Northern Province Experience 
The shortfall in medical genetic specialists in SA necessitated outreach programmes to 
take this expertise where it was lacking. One of the best documented programmes was 
a clinical genetic outreach in rural Limpopo (then Northern Province) (16, 23). Initiated 
in 1989, this collaborative project8 spanned seven years (1989-1996) and reached an 
estimated fifth of the population of the province (16). By 1992, week-long clinics were 
held 3-4 times annually by visiting medical geneticists, attended by patients identified 
by senior nurses trained in genetics. A total of 1 797 patients were seen of which 94.4% 
were black South Africans (16). The immense need in the Province resulted in the project 
outreach aims being revised to the development of infrastructure. Genetically trained 
nursing sisters at the seven collaborating hospitals received further training in 1993 to 
take up this responsibility. By 1994 they were so clinically adept that common disorders 
were no longer referred to the visiting medical geneticists at the outreach clinics, which 
were reserved for cases where ‘treatment was available and would significantly improve 
the prognosis’ (16). However, from 1994 commitment and funding to medical genetic 
services at the provincial level waned and eventually prevented the nurses from 
continuing in this function (Professor Philip Venter, Personal Communication, 20 May 
2016). 
 
Policy changes following the 1994 elections in SA resulted in genetic services being 
incorporated into primary healthcare countrywide. Genetic nurses were reassigned to 
PHC clinics where they were expected to provide both genetic and PHC services (31). 
                                                 
8 Involving the University of the North, the University of Pretoria, National and 
Provincial Departments of Health and trained nursing staff in seven rural hospitals in 
the Province. 
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These changes9 increased the workload for PHC nurses by an estimated 40% with no 
additional capacity (36). With an emphasis on HIV/AIDS patients, all nurses were 
required to primarily focus on providing PHC services, to the detriment of their specialist 
area (31). The restructuring of the healthcare system to address previous imbalances, 
combined with competing health needs, resulted in the depletion of posts for both 
nurse counsellors and medical geneticists (37). Many genetic nurses moved into other 
positions or emigrated (31). By 2001 only four medical geneticists, less than 20 geneticist 
counsellors and an unknown number of genetic nurses remained (38).  
  
Although the training of community based nursing staff was identified as a priority for 
the successful implementation of medical genetic services in the 2001 National Policy 
Guidelines for the Management and Prevention of Genetic Disorders, Birth Defects and 
Disabilities (38), formal training of nursing staff in medical genetics has ceased and only 
sporadic, ad hoc, self-funded genetics outreach continues in a few provinces.  
 
Medical genetics in the nursing curricula 
With the dismantling of the countrywide network of 16 genetic nurses in the mid-1990s, 
few genetic nurses and genetic nurse counsellor posts remain countrywide today.10 
With these nurses playing such a key role in genetic services their absence is keenly felt. 
Research by Phaladi-Digamela to develop a competency based curriculum framework 
for advanced midwives highlighted the call made by other nursing specialisations that 
the ‘genetic nurse must come back’ as they are ‘better empowered in addressing 
genetics problems’ (39). This reliance on the genetic nurse stems from inadequate 
genetics knowledge, skills and competencies included in basic nurse training curricula 
(38). Appropriate standardised, quality content is lacking, leaving nurses ill-equipped 
when entering clinical practice (26). Globally these inadequacies are preventing nurses 
from being prepared for their role in the new genetic era - which calls for all nurses to 
be appropriately skilled in medical genetics (40). 
 
Nursing education reform in SA is continuing as part of the post-apartheid 
transformation process with the recent incorporation of public nursing colleges into the 
higher education sector to comply with education legislation (41-43). A continuing 
Professional Development (CPD) System is also being introduced for nurses, and a Scope 
                                                 
9 The provision of free healthcare to pregnant women and children under six without 
medical aid. 
10 Official numbers of genetic nurse and genetic nurse counsellor posts were 
unavailable. Three genetic nurse counsellor designated posts are known and several 
other nurses undertake some genetic nurse functions in non-genetic nursing posts.  
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of Practice is under development for the new nurse categories. However, poor 
governance by the main institutions involved is delaying implementation and realization 
of targets outlined in the National Strategic Plan for Nurse Education, Training and 
Practice 2012/13 – 2016/17 (41, 42). However, this evolving nursing landscape may also 
be an opportune time to improve the medical genetics component in nursing training.  
 
Key genetics knowledge required by nurses should include: basic scientific principles of 
genetics; genetic risk assessment; practice and ethics of genetic counselling; accessing 
genetic information resources; and when to refer, both for appropriate testing and to 
the medical geneticists or other specialist physicians (13, 32, 44, 45). In SA, it has been 
established that genetics knowledge is lacking in nursing training (43, 46-49). Genetics 
education in SA nursing is currently considered as ‘slapdash’ with a huge variation 
between institutions according to available facilities and staffing (38, 49). Genetics 
content is often superficial with little relevance to the identification of CDs, genetic 
counselling or pre-natal diagnosis (46, 47, 49). A study by Phaladi-Digamela in 2015 
indicates that although genetics is included in the curricula of three quarters of the study 
participants, only 10 hours or less of genetics teaching were reported by 50% of 
participants, falling far short of the recommended 40 hours (49). The prediction by 
Godino and Skirton in 2012 that SA will embrace sufficient genetics in the nursing 
curricula by 2017 is unlikely to be achieved (48). Key challenges include an already full 
curriculum, nursing faculty/educators lacking genetic knowledge, and genetics 
education not being considered relevant for nurses (39, 40, 46, 50). 
 
A standardised genetic education framework for nurses is required in SA at both basic 
and post-basic training levels incorporating both theory and clinical practice 
components. Such genetic knowledge is required by all nurses, including those in non-
specialist healthcare, to translate genetic knowledge and technology to improve 
healthcare both in PHC and clinical settings (40, 49). Such an increased knowledge base 
could also serve as a pool from which nurses could then specialise as genetic nurses or 
genetic nurse counsellors.  
 
The Medical Genetics Education Programme (MGEP) 
Since developing such a standardized medical genetics framework is a long-term goal, 
an interim measure is necessary to equip nurses with genetics knowledge and skills. An 
existing option that could bridge this shortfall is the Medical Genetics Education 
Programme (MGEP). MGEP is a post-graduate distance learning, self-administered 
education programme originally developed in 2003 in response to a recommendation 
of the Policy Guidelines for the Management and Prevention of Genetic Disorders, Birth 
Defects and Disability (38). MGEP aimed to equip registered nursing staff, particularly 
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those involved in maternal, child and women’s health, with a comprehensive, primary 
healthcare medical genetic education (29, 38, 51).  
 
The MGEP programme was developed and piloted by a collaborative team of experts 
with funding from the March of Dimes (MOD) under the auspices of the Southern 
African Inherited Disorders Association (SAIDA), a patient advocacy support group 
recently relaunched as Genetic Alliance South Africa (GA-SA). It was originally intended 
that MGEP be implemented in two distinct parts over a period of five months, consisting 
of MGEP 1 and MGEP 2. MGEP 1 focused on theory, over a period of four months with 
one contact day per month including lectures and practical skills workshops. After the 
introduction of the Birth Defect Notification Tool (BDNT) in 2006 by NDOH, MGEP 1 also 
included basic training on completing and submitting BDNT notifications for national 
surveillance. Successful MGEP 1 participants could undertake MGEP 2, a two-week 
course focusing on clinical diagnosis and genetic counselling (Prof Arnold Christianson, 
Personal Communication, June 2016). Due to funding constraints for MGEP 2, in practice 
only the MGEP 1 component was taught.  
 
Associated with MGEP is a manual Birth Defects: Counselling and caring for children with 
birth defects (52). This distance learning tool promotes independent, home based 
learning for primary healthcare professionals. The manual was developed with MOD 
funds collaboratively by a team of medical geneticists, reviewed by the wider medical 
genetics community and edited and published by Eduhealthcare, as one in a series of 
self-directed learning course books [www.bettercare.co.za ]. With the use of the Birth 
Defects Manual as a companion resource, MGEP became a successful blend of distance, 
self-administered home learning and face-to-face teaching. 
 
Between 2004 and 2013 over 1 000 healthcare providers (mainly labour ward nurses) 
were trained through the MGEP courses held countrywide, with an emphasis on rural 
areas (11). Coordinated by SAIDA with funding from the NDOH and MOD, MGEP was 
taught by a team of medical geneticists, genetic counsellors and genetic nurse 
counsellors. It was intended that successful MGEP participants (nurses) could be further 
trained to assist with future MGEP teaching. This was formally piloted in Limpopo 
Province with genetic-trained nursing staff assisting as facilitators of a tele-teaching held 
MGEP course, resulting in an 86% pass rate of an MGEP 1 course (53).  
 
MGEP Evaluation and Revision 
An evaluation of MGEP was undertaken in 2007 for 96 primary healthcare nurses using 
a pre- and post-course questionnaire to test knowledge and skills (51). Pre-course 
knowledge averaged at 48% but increased to 75% post-course, and skills pre-course, (eg 
drawing/interpreting a three-generation family tree), scored an average of 4.5% which 
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rose to 86% post-course (51). The MGEP contact days of lectures and practical 
workshops clearly resulted in a significant improvement in skills and knowledge of 
participating nurses.  
 
Widespread implementation of MGEP ceased in 2014 due to the lack of allocated 
government funding and of the 1 000 nurses trained in MGEP, less than 100 continue to 
implement these skills (2). This has directly impacted national surveillance of CDs via the 
BDNT which was a key area of MGEP trained nurses responsibility. However, some 
provinces, such as KwaZulu Natal, continue to implement MGEP despite the lack of 
dedicated funds and the absence of genetic services in the province.  
 
MGEP is currently undergoing a process of revision under the auspices of GA-SA 
following a request by NDOH in 2014 for an improved medical genetics education course 
for healthcare professionals. The revised course will comply with Sector Education and 
Training Authority (SETA) requirements (6 months/six contact days) for future SETA 
registration to increase the value of the course to participants and to access funding 
avenues. The Birth Defects Manual is also being simultaneously revised as the 
Congenital Disorders course book and will be made accessible via the open-source 
Bettercare website (http://bettercare.co.za) in hard copy, e-version or for free online 
viewing. Once finalised, both the revised MGEP course and the Congenital Disorders 
course book will be piloted and evaluated. 
 
 
Future of MGEP and Birth Defects Manual 
The interim use of MGEP and Congenital Disorders course book may be critical in 
developing the required genetic capacity in nursing and other health care professionals 
for the beginnings of a universal medical genetics service. To effectively implement the 
revised MGEP and Congenital Disorders course book, these tools should be integrated 
into the PHC streams of the National Health Insurance scheme (RSA 2015) as part of the 
healthcare re-engineering process. While many of the 52 District Clinical Specialist 
Teams (DCSTs) being established countrywide still lack specialist clinicians, the majority 
of nursing staff on these teams have already been appointed (54). These PHC, advanced 
midwifes and advanced paediatric nurses, could receive MGEP training and become 
genetic ‘champions’ in each district.  
 
To successfully implement such educational programme, much may be learned from 
other MLIC facing very similar challenges of inadequate capacity and fragmented, 
heterogeneous services. The CHACO outreach project in Argentina developed a model 
to introduce genetic healthcare services into PHC in a province lacking genetic services 
by training 485 health care workers in genetics (55). The CHACO model, which was so 
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successful that it is being implemented in four additional provinces, uses content very 
similar to the MGEP course and is adding a distance learning tool (55). This experience 
highlights a number of factors to consider:  
 
 Pilot, evaluate and replicate: Pilot and evaluate MGEP courses prior to scaling 
up, with continued monitoring and feedback to optimise content. 
 Assess the local situation: Assess capacity needs in each province/district to 
identify participants and unique challenges in the area. In SA an audit of genetic 
services being undertaken by NDOH as part of the 2001 policy revision provides 
an ideal starting point. 
 Coordinated network approach: Building and strengthening coordination in each 
province/district between stakeholders and interventions. In SA this should 
include the BDNT, the Perinatal Problem Identification Programme (PPIP) and 
the CHILD Problem Identification Programme (Child PIP) etc. 
 Sustainability: Training up local trainers to ensure continuous learning 
opportunities. The education and training mandate of the DCSTs ideally equips 
them to amplify genetic skills across other PHC streams (Ward-based Primary 
Health Care Outreach Teams and the school health teams) (Voce et al. 2014). 
Linkages with human genetics academic centres could assist in ensuring quality, 
standardised training countrywide. 
 Government and provincial commitment: Both national and provincial 
government buy-in are required. Scarce specialists (medical geneticists) may be 
introduced from elsewhere on a regular basis through outreach clinics, 
permanent posts created and access to genetic technology improved. High 
turnover of government officials may be overcome by a provincial coordinator 
role. 
 Hospital management buy-in: Gaining the commitment from hospital 
management to ensure continued implementation of the skills acquired.  
 
Future options for the MGEP course include development as an electronic tool through 
teaching by application on a tablet. Use of such a device would enable an array of other 
resources to be made available for diagnostic and treatment purposes, including a 
library of anonymized images to aid diagnosis, similar to the Handbook of Genetic and 
Congenital Syndromes (56). Limited internet connectivity in rural regions could be 





If used appropriately, widespread MGEP training could swiftly build up a nursing 
workforce with improved knowledge and skills in medical genetics, as has been 
modelled by other countries. There remains a need for a formal year-long diploma for 
specialized genetic nurse counsellors requiring formal accreditation by the South African 
Nursing Council. In the longer term, SA must follow the global examples of other regions 
and develop a standardised genetics education framework for integration into the 
nursing curricula to take advantage of the advances of genetics knowledge and 
technology in healthcare. With all these tools in place, the role of MGEP could then 
transition to that of a refresher course and ongoing, in-service training, as an option in 
the nursing CPD system.  
 
MGEP training could also be implemented for other healthcare professionals to bridge 
the medical genetics capacity deficit by ensuring doctors are also equipped with the 
relevant knowledge and skills to work optimally with the MGEP trained nurses. A future 
goal could be to integrate MGEP content into medical school curricula, with an exit 
examination a requirement for clinical qualification.  
 
To ensure ‘no child is left behind’ in the new era of the Sustainable Development Goals 
(57), the potential offered by these tools must be harnessed to build up medical genetic 
services countrywide to improve the lives of those affected by CDs in the country.  
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Part Five: Global Consensus 
 
Part Five shifts the attention to the global arena and the need for renewed global focus 
upon CDs within the context of the Sustainable Development Goals (SGDs) (1). This 
paper was drafted by a core working at the 7th International Conference of Birth Defects 
and Disabilities in the Developing World held in Dar es Salaam, Tanzania in September 
2015. All the issues highlighted in this paper – the need to use standardized definitions 
and terminology for CDs, improving surveillance and monitoring of CDs, improving pre-
pregnancy and pre-natal interventions and care, pre-natal screening and diagnosis, build 
capacity in medical genetic services, public awareness and education – are also issues 
that need to be addressed at a national level in SA. Within the framework of the SDGs, 
there are specific targets that may only be met if the care and prevention of CDs is 
improved. This includes acknowledging CDs as the first non-communicable disease 
(NCD) experienced in life if NCDs are to be reduced by two thirds. Similarly, reducing the 
under-5 mortality rate and reducing preventable newborn deaths requires a renewed 
focus on CDs  
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Prevention of Congenital Disorders
and Care of Affected Children
A Consensus Statement
Gary L. Darmstadt, MD; Christopher P. Howson, PhD; Gijs Walraven, MD; Robert W. Armstrong, MD;
Hannah K. Blencowe, MBChB; Arnold L. Christianson, FRCP Edin; Alastair Kent, MPhil; Helen Malherbe, MSc;
Jeffrey C. Murray, MD; Carmencita D. Padilla, MD; Salimah R. Walani, PhD; for the Participant Working Group of
the Dar es Salaam Seventh International Conference on Birth Defects and Disabilities in the Developing World
O n September 21-24, 2015, the eve of the announcementof the Sustainable Development Goals (SDGs), stakehold-ers in adolescent, maternal, newborn, and child health and
development from 37 countries convened in Dar es Salaam, Tanza-
nia, for the Seventh International Conference on Birth Defects and
Disabilities in the Developing World (ICBD) to discuss how to accel-
erate the prevention of congenital disorders (birth defects, ie, ab-
normalities of structure or function that are present from birth) and
the improvement of care of affected children, especially in high-
burden, low-resource settings globally.1
This seventh conference, entitled Birth Defects in the Post-
MDG [Millennium Development Goals] Era: Joining Hands for Pre-
vention and Care, was organized by March of Dimes in partnership
with the Aga Khan Health Services–East Africa, the Aga Khan
University–East Africa, US Centers for Disease Control and Preven-
tion, and the Bill & Melinda Gates Foundation. Since the first ICBD
in 2001, each conference has been held in a different region of the
developing world, with the goal of bringing together experts and
stakeholders from the region and from around the world to dis-
cuss developments and highlight successes and issues to build
capacity in lower-income countries for the prevention of birth
defects and preterm birth and improvement of the care of those
affected. The conference description, call for abstracts, key dead-
lines, and related materials were sent out periodically via email
lists and the March of Dimes and Centers for Disease Control and
Prevention listservs.
The ICBDs were established to focus attention on the need to
improve the prevention and care of congenital disorders given that
the proportion of deaths in children younger than 5 years due to con-
genital disorders is rising in many low- and middle-income coun-
tries. In addition, rates of disability resulting from congenital disor-
ders are increasing in many countries where newborn survival is
improving but quality health care is lagging. Congenital disorders and
their associated disabilities result in a substantial emotional, social,
and economic toll on affected individuals, their families, and the com-
munities in which they live. The Dar es Salaam ICBD was assembled
to agree on actions to reduce this toll, especially in vulnerable, mar-
ginalized populations. A draft consensus statement was presented
and discussed by the audience on the last day of the conference, with
major changes incorporated at that time. The final document was
created by the authors and circulated to all conference partici-
pants, with 76 providing input and supporting the consensus state-
ment. A working group was also established to explore additional
ways to put this statement into action.
We support accelerating the prevention of congenital disor-
ders and improvement of care of affected individuals, recognizing
that:
• An estimated 7.9 million children are born each year with a ge-
netic or partially genetic (multifactorial) congenital disorder, and
several hundred thousand more are born with congenital disor-
ders due to in utero insults after conception, such as infections, and
exposure to teratogens, such as alcohol.2,3
As the Sustainable Development Goals are adopted by United Nations member states,
children with congenital disorders remain left behind in policies, programs, research, and
funding. Although this finding was recognized by the creation and endorsement of the 63rd
World Health Assembly Resolution in 2010 calling on United Nations member states to
strengthen prevention of congenital disorders and the improvement of care of those
affected, there has been little to no action since then. The Sustainable Development Goals
call for the global health and development community to focus first and foremost on the
most vulnerable and those left behind in the Millennium Development Goal era. To maximize
the opportunity for every woman and couple to have a healthy child and to reduce the
mortality and severe disability associated with potentially avoidable congenital disorders and
their consequences for the children affected, their families and communities, and national
health care systems, we propose priority measures that should be taken urgently to address
this issue.
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• Of the 2.7 million newborns who die annually, more than 1 in 10 die
of a congenital disorder, and, overall, there are an estimated 484 000
deaths due to congenital disorders among children younger than 5
years.4 This number is likely a gross underestimate, however, be-
cause many deaths due to congenital disorders, such as heart de-
fects and metabolic disorders, go undetected.
• It is likely that more than 192 000 of the 2.6 million annual still-
births may result from an underlying congenital disorder.5 The per-
centage of stillborn children affected by congenital disorders is likely
much higher than for live births, and many efforts to prevent still-
birth will help reduce the occurrence of congenital disorders among
stillborn children.
• Most newborns with a serious congenital disorder who survive face
a lifetime of severe disability.2,3
• An estimated 94% of newborns with 1 or more congenital disor-
ders are born in low- and middle-income countries, placing an ad-
ditional severe burden on families, communities, and national
health care systems.2,3
• Up to an estimated 70% of congenital disorders are preventable
or their effect can be substantially mitigated and quality of life im-
proved, but these preventive and mitigating actions are occur-
ring almost exclusively in high-income settings.2,3
• The fact that children with congenital disorders have been left be-
hind in policies, programs, research, and funding was recognized
by the creation and endorsement of the 63rd World Health As-
sembly Resolution,6 calling in 2010 for United Nations member
states to (1) raise awareness of congenital disorders as a cause of
child morbidity and mortality; (2) develop and strengthen birth reg-
istration and surveillance for birth defects; (3) strengthen evi-
dence on etiologic factors, diagnosis, and prevention of major birth
defects; and (4) develop national plans for implementation of ef-
fective interventions to prevent and manage birth defects. This call
by the World Health Organization, however, has gone unheeded
except in pockets such as Southeast Asia, where a strategic
framework7 is guiding efforts to prevent and control congenital dis-
orders in 12 countries of the region.
The conference participants agreed that, with the advent of the
SDGs, greater emphasis must be placed on more holistic ap-
proaches, including preventive care and, beyond survival, optimi-
zation of childrens’ developmental potential. This emphasis aligns
with the SDGs’ call for equality in social inclusion and in opportuni-
ties for education, employment, and the ability for all human beings
to fulfill their potential and enjoy prosperous, productive lives. Fur-
thermore, the SDGs call for giving priority in policy and action to the
most vulnerable, specifically including those with disabilities, and
those currently most left behind.8 Congenital disorders can be con-
sidered the first chronic disease experienced in life and are encom-
passed in SDG goal 3 that calls for a reduction, by 2030, by one-
third in premature mortality from noncommunicable diseases
through prevention and treatment and the promotion of mental
health and well-being.7
Call to Action
To maximize the opportunity for every woman and couple to have
a healthy child; to reduce the consequences of potentially avoid-
able congenital disorders for those affected, their families, the health
care system, and the wider society; and to promote the well-being
of children who have a congenital disorder, there are many mea-
sures that should be taken urgently to address this issue. In this con-
text and in order that no child is left behind, we pledge an initial fo-
cus that supports the following:
Improving data quality:
1. Building consensus on and widespread use of a standardized defi-
nition of congenital disorders, such as “abnormalities of struc-
ture or function, which are present from birth,”3(p2) to facilitate
data comparison and ensure that the contribution of congenital
disorders to the burden of disease is comprehensively repre-
sented.
2. Establishing registries and surveillance systems and their integra-
tion, where possible, into existing data platforms to monitor the
toll and risks of congenital disorders and evaluating the outcome
of interventions for prevention and care. Consideration should also
be given to the collection of pertinent data available from existing
registries and surveillance systems in other countries.
Reducing risk:
1. Promoting family planning, allowing women and couples to choose
when they have their first child, space their pregnancies, plan fam-
ily size, define the ages at which they wish to complete their fam-
ily, and reduce the proportion of unintended pregnancies.
2. Ensuring a healthy, balanced diet for girls and during a woman’s re-
productive years through an adequate intake of macronutrients
(protein, carbohydrates, and fats) and a broad range of micronu-
trients. Special attention should be given to adding 400 μg of syn-
thetic folic acid daily to the diet through fortification and supple-
mentation while also promoting a diet rich in food folates,
correcting iodine deficiency through fortification, and ensuring iron
sufficiency through fortification, supplementation, and therapy for
those with deficiencies.
3. Removing teratogenic substances from the diet, the most im-
portant of which is alcohol, and minimizing environmental con-
taminants in foods.
4. Controlling infections in women of reproductive age, including
rubella and syphilis, and optimizing maternal health through de-
tection and management of chronic illnesses associated with an
increased risk of congenital disorders, such as type 2 diabetes
mellitus and epilepsy, which require teratogenic medications.
Improving care:
1. Training physicians, nurses, allied health care professionals, and
workers in the fundamentals of the recognition, causes, and care
of children with congenital disorders and ensuring physical ex-
aminations of all newborns by trained health care professionals
before discharge from the hospital or clinic.
2. Aligning medical and social services to provide timely treat-
ments for congenital disorders, including surgery, medications,
dietary modifications, and rehabilitation services when needed.
3. Providing emotional and practical support for parents to enable
them to understand and manage their risk of congenital disor-
ders and to help families in supporting the growth and develop-
ment of children with congenital disorders.
Empowering the public and civil society:
1. Educating the public about congenital disorders and the steps
mothers and fathers can take with their health care profession-
als to maximize the chances of a healthy pregnancy.
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2. Strengthening civil society—including patient and parent sup-
port groups, faith-based groups, and nongovernmental organi-
zations—to advocate for improved prevention of congenital dis-
orders and access to high-quality, family-centered patient care,
including facilitating community and professional awareness and
education and advocating for increased funding for research on
the causes of congenital disorders.
The following additional actions should be taken by countries as pri-
orities and circumstances allow:
1. Training physicians, nurses, and allied health care professionals in
the essentials of medical genetics. This training should include di-
agnosis of common congenital disorders before and at birth; means
of treatment where possible in the primary health care setting;
knowing when to refer a patient for more specialized treatment;
basic genetic counseling, including best practices in communicat-
ing unfavorable health information to parents; and support for fami-
lies who have a child or are at risk of having a child with a congen-
ital disorder. Genetic counseling aims to empower those who are
counseled to make autonomous decisions regarding their health
in ways that are consonant with their religious and ethical beliefs
and circumstances and to support them in their decisions.
2. Establishing periconception medical services to assist women and
their partners in attaining optimal physical and mental health and
well-being and to facilitate a healthy pregnancy and delivery of
a healthy infant. These services include rubella immunization;
screening for the risk of genetic, partially genetic, and terato-
genic congenital disorders; and mental health counseling, includ-
ing identification and support for depression.
3. Implementing preconception or prenatal medical screening to
identify women and couples at risk of having a baby with hemo-
globin disorders; Down syndrome; blood type incompatibility;
congenital sexually transmitted infections such as syphilis, hu-
man immunodeficiency virus, and herpes simplex virus; and struc-
tural malformations, particularly neural tube defects.
4. Establishing newborn screening to identify congenital hypothy-
roidism, phenylketonuria, galactosemia, sickle cell disease, glu-
cose-6-phosphate dehydrogenase deficiency, and other meta-
bolic disorders.
5. Supporting research into the diagnosis, prevention, etiologic fac-
tors, and treatment of congenital disorders to enable improved
outcomes for children into the future.
The conference participants call for concerted action by inter-
national government policymakers and donor organizations to ex-
plore how these recommended actions can be funded through more
cost-effective and rational integration of policy, funding, and inter-
ventions across the reproductive, maternal, newborn, child, and ado-
lescent continuum. Systems are required that encourage more ef-
fective partnership among the many existing organizations and
agencies whose missions address common risk factors and out-
comes and who would benefit financially and programmatically from
better integration of policy, research, and action at international and
national levels.
Conclusions
The Seventh ICBD in Dar es Salaam, Tanzania, was a pivotal oppor-
tunity to build consensus and commitment for accelerated preven-
tion of congenital disorders and improvement of care of affected chil-
dren in low- and middle-income countries. In conjunction with the
newly launched SDGs and building on the 63rd World Health As-
sembly resolution calling on United Nations member states to
strengthen prevention and care for congenital disorders, immedi-
ate action on the plan outlined above will save newborn and child
lives, reduce disability rates and improve quality of life in survivors,
and substantially lessen the current emotional and economic toll of
these conditions on affected individuals, their families, and the com-
munities in which they live.
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Chapter 11: Discussion 
 
 
Rational and Aim of Study  
Congenital disorders (CDs) are a common, costly and critical health issue. In South Africa 
(SA) and many other middle and low income countries (MLIC), they remain unprioritised, 
their contribution to the health burden underestimated, and services for their care and 
prevention are neglected. This results in often preventable human suffering, impacts 
the human rights and dignity of those affected or at risk of being affected, and comes 
with significant socioeconomic effects. Medical genetic services for the care and 
prevention of CDs in SA require measured consideration and strategic planning to meet 
the growing health need in the current epidemiological and socioeconomic context.  
On the basis of this rationale, this PhD study aimed to investigate the renewed need for 
the care and prevention of CDs in SA. This was undertaken through a series of in-depth 
studies on specific sub-topics to evaluate the overall requirement for medical genetic 
services in the country. This followed a logical step-wise process including: why these 
services are needed (epidemiology); how these services are provided for legislatively 
(legal framework); how CDs relate to other health priorities (child mortality); quantifying 
the health burden of CDs (modelled data); responding to the challenge (capacity 
building); and, the global context for the health issue of CDs (global consensus).  
 
Synthesis of Findings  
 
Collectively, these individual studies have built up an overall picture of the situation of 
CDs in SA and the current state of medical genetic services. As outlined in the first paper 
in Chapter 3, the impact of the HIV/AIDS and TB epidemics on epidemiological transition 
in SA was substantial and to the detriment of the developing medical genetic services. 
The data presented indicated that the country is back in positive transition once again, 
a finding which is consistent with other studies (1). Chapter 3 also highlighted the 
current infant mortality rate (IMR) in SA, of 27 per 1 000 live births (2) as being well 
under the threshold of 40-50 per 1 000 live births, when medical genetic services are 
usually developed (3-7). Despite the extensive literature supporting this concept of a 
designated stage for developing these services, this is yet to be recognised by SA and is 
an important finding of this study.  
The protracted epidemiological transition SA is experiencing describes the persisting 




(NCDs) (1, 8-10). This has contributed to the delay in developing medical genetic services 
in SA, which is confirmed in the literature most recently by Sitkin et al (11). Although the 
burden of CDs remains largely obscured by communicable disease, the growing 
proportion of deaths from CDs as the country develops and IMR decreases is an 
irrefutable trend already in progress in SA (12). While this may be a more extended 
process in SA and other MLIC due to the persisting burden of infectious disease in 
comparison to the classic transition experienced by industrialised countries, the same 
end results.  
Within this context, Chapter 4 aimed to identify the legislative framework relevant to 
medical genetic services for the care and prevention of CDs. There seems to be little 
awareness by policy makers of the key international document, World Health Assembly 
Resolution 63.17 (WHA 63.17) of 2010 (13), to which SA is a signatory as a United 
Nations member state. The WHA 63.17 call to prioritise the care and prevention of CDs 
has gone largely unheeded in SA, as evidenced by the lack of inclusion in national 
strategy (14, 15), the lack of implementation of existing policy (16), and delays in revising 
policy relevant to CDs. 
A surprising finding of the desktop review of legislation in Chapter 4 was the specific 
provision for genetic services in the National Health Act (NHA) 61 of 2003 (17). Prior to 
this study, the widely-held view of the literature indicated the most relevant content of 
the NHA as the provision of free health services for pregnant and breastfeeding women 
and children under the age of 6 (that are not members of medical aid schemes) (17). 
This NHA directive to provide genetic services is crucial, and holds together the 
provisions in all other legislation.  
Although a comprehensive legislative framework exists in SA for the provision of medical 
genetic services there is a shortfall in the implementation of these services. The 
underlying reason for this shortfall is the lack of recognition of the burden of disease 
represented by CDs. This finding is an issue shared by many MLIC, a fact borne out in 
the literature, with the lack of empiric data in SA on CDs from surveillance systems a 
major contributing factor (3, 6, 13, 18-23). 
 
The lack of awareness of the status of medical genetic services by policy makers 
prompted a critique of the 2015 Guidelines for Maternity Care (24) in Chapter 5. While 
the inclusion of referral services in these guidelines for advanced maternal age and other 
high-risk categories is relevant, there was little cognisance of the insufficient capacity 
available to provide these services in practice. The disconnect between the developers 
of these guidelines and the medical genetics community was in stark contrast to the 
consultative process undertaken to compile the 2001 Policy Guidelines for the 





Inadequate capacity of the medical genetic services sector was an issue highlighted in 
many of the Chapters of this study. A comparison of capacity available in the sector 
today compared with 2001 was included in Chapters 4 and 6. The finding that capacity 
today is at a lower base than in 2001, despite the increased population, is consistent 
with the work by Kromberg et al (25) who indicated that current limited capacity is only 
enabling 10% of the country’s genetic needs to be met. Without an adequate workforce, 
the implementation of basic medical genetic services, including the diagnosis, care and 
prevention of CDs will continue to decline.  
 
The contribution of CDs to child mortality in SA is an issue that warranted further 
investigation and was the focus of Chapter 6. This was prompted by the stagnation in 
neonatal, infant and child mortality rates in the country since 2011, despite continued 
interventions to treat communicable diseases (26, 27). This suggests other, unaddressed 
health issues contributing to child mortality, and CDs were presented as the first of 
these. This is consistent with the literature, which clearly demonstrates an increasing 
proportion of deaths from CDs as the IMR decreases (12, 28-30). A key finding of Chapter 
6 was the emergence of CDs as a leading cause of death in SA, with CDs having overtaken 
infection and ranking 3rd as a cause of death in early neonatal deaths in the Western 
Cape (31). This is of particular significance as the Western Cape province leads the 
country in health service provision and serves as a proxy for where the rest of the 
country will follow in the future. Surprisingly, although this change in rankings was 
reported in the public sphere, its significance does not appear to be fully appreciated 
(31). This is indicative of the lack of cognisance of the contribution of CDs to child 
mortality and the potential significant reductions that may be achieved by improving 
medical genetic services. Instead, efforts to reduce child mortality are focused on other 
interventions, termed ‘low hanging fruits’, such as those outlined by Chola et al (32). 
The most important finding of Chapter 6, is that for child mortality to be further 
significantly reduced in SA, medical genetic services for the care and prevention of CDs 
must be comprehensibly implemented. This is consistent with the literature (3-7). 
A theme emerging throughout the course of this study is the issue of terminology and 
definitions of CDs. A lack of clarity has led to the use of disparate and non-synonymous 
terms by stakeholders both globally and locally. This issue is highlighted in several 
Chapters of this study, but is of most relevance in Chapter 7. The letter to the journal 
editor in response to mortality data published in a specific region of the Western Cape 
demonstrated the inadequacies of the current 10th edition of the International 
Classification of Diseases (ICD-10) (33) with relevance to CDs. The prolific use of the term 
congenital anomalies (and equivalent terms) to represent the totality of CDs, despite 




other published work (13, 34, 35). If only a portion of CDs are being reported, this 
contributes to underreporting and prevents an accurate estimate of the true disease 
burden – since not all CDs are represented. This has implications for ranking in overall 
mortality assessments and cause of death studies both nationally and globally. 
A further issue related to terminology is the exclusion of CDs from specific NCD policies 
and interventions (14, 15, 36). The reluctance to contextualize CDs as an NCD in SA is at 
odds with the global classification of CDs as an NCD as reported in the literature (37) 
(38). Instead, the promotion of a newly coined term long-term health conditions (39, 40) 
in children combines CDs with acquired conditions, and states that the NCDs 
classification is not applicable for children. This further diminishes the issue of CDs and 
has implications for the development of and access to cogent medical genetic services, 
including multifactorial (complex) CDs which tend to manifest later in life. 
The lack of empiric data for CDs in SA, as highlighted by Lebese et al (18), has been an 
issue that has dominated this study. Without these data there is little evidence to 
persuade policy makers of the burden of disease represented by CDs, preventing the 
required commitment for services to be developed. Chapter 8 aimed to rectify this by 
quantifying the scale of the problem represented by CDs using modelled estimates. The 
resulting estimates clearly demonstrate the impact of care and preventative 
interventions on reducing mortality and mitigating morbidity. This dispels the myth that 
nothing can be done for those affected by CDs. This key finding demonstrated that even 
with a national average of only 30% access to optimal services, a substantial number of 
lives can be saved and degree of disability reduced. This was consistent with studies by 
Czeizel et al (41) and Christianson and Modell (19), which indicate that up to 70% of CDs 
can be prevented, cured or disability ameliorated. With the increase in survivors comes 
an increase in the cost of care, due to a greater number living with disability. This finding 
was consistent with the literature, most notably Christianson et al (29), which highlights 
the importance of balancing care and prevention.  
The issue of capacity is revisited in Chapter 9 with the suggestion of a potential solution 
for rapidly increasing capacity in the sector. The shortcomings of genetic education of 
health care professionals (HCP) in SA is similar the world over, as confirmed by the 
literature (42). The key finding of this Chapter is the availability of two genetic education 
tools that may be used to swiftly train large numbers of nurses as a short-term measure 
to up-skill the medical genetics sector. The proven track record of the Medical Genetics 
Education Programme (MGEP) and the Congenital Disorders Handbook, and the 
experience of similar tools in other countries is borne out in the literature (43, 44). It is 
imperative that this capacity building is undertaken within the context of the PHC 
streams of the National Health Insurance (NHI) initiative (45) to ensure full integration, 




Chapter 10 provides the global context for CDs and the need for improved medical 
genetic services against the backdrop of the Sustainable Development Goals (SDGs) (46). 
For SA, the SDG 3 target to reduce the current under-5 mortality rate (U5MR) from 39 
to 25 deaths per 1 000 live births (26, 46) will require the comprehensive development 
of medical genetic services to tackle the burden of CDs. SA has already reached the SDG 
3 target for neonatal deaths of 12 per 1 000 live births (26, 46). However, with over 40% 
of under-5 deaths occurring during the first month of life in SA (47), this highlights the 
need for further study and the potential contribution of undiagnosed CDs to these 
deaths. If the SDG 3 target to reduce NCDs by two-thirds by 2030 (46) is to be reached 
in SA, it may require an adjustment of the classification of CDs as an NCD. Remarkably, 
the challenges highlighted globally in the consensus document were found to be the 
same as those faced nationally by SA. This was consistent with the literature, which has 
been making the same call to action to policy makers for decades (3, 6, 19-23, 29). 
In the words of WHO (21) ‘It appears that one of the main problems in delivering 
genetics services is the difficulty of informing the profession and the community of the 
real significance of genetic problems.’ The first step in this process is the realisation of 
the true burden of CDs. This is necessary to generate the required political commitment 
in SA for the further development of medical genetic services. Without this commitment 
and renewed, comprehensive services streamlined across the continuum of care (48), 
SA will remain ill-prepared for the growing health need of CDs.  
 
 
Contribution to Knowledge 
 
This study has made the following original contributions to the literature and the 
advancement of knowledge: 
 A macro-scale situational analysis of CDs in SA, that is to date, unprecedented. The 
specific data, concepts and perspectives presented are drawn from the international 
and national scientific literature, and world-renowned experts to provide the 
current South African context regarding medical genetic services.  
 The identification of the national legislative and regulatory framework relevant to 
CDs is a blueprint for future monitoring of policy implementation and a point of 
reference for new policy development. It may also serve as a key advocacy tool for 




 This study has highlighted the contribution of CDs to child mortality, and 
demonstrated the lack of cognisance around the growing proportion of CD related 
deaths as the country transitions epidemiologically.  
 The lack of empiric data on CDs in SA is a major factor contributing to the inaccurate 
assessment of the CD disease burden in SA. By quantifying the burden of CDs in SA 
through modelled data, the findings of this study provide a baseline for further 
studies to measure the impact of care and prevention interventions, and serve as a 
target for future surveillance systems.  
 By quantifying the diminished capacity in the medical genetic sector, this study has 
documented the lack of investment in the sector and the urgent need to rectify this 
situation through capacity building. By proposing a means to achieve this, the study 
has also offered a potential solution for increasing capacity in the sector. 
 
Study Limitations 
It is acknowledged that as a desktop study this PhD is limited to theoretical knowledge.  
The methodologies used to develop epidemiological estimates in this study are subject 
to the limitations of the Modell Global Database (MGDb). These methods are detailed 
in a forthcoming series of articles in a special edition of the Journal of Community 
Genetics (49). 
Study Implications 
It is hoped that relevant government organisations will respond to the arguments 
presented in this study, including the proposal to improve the quality of genetic 
education in nurse training as an integral part of the NHI.   
Conclusions  
This study investigated the need for renewed services for the care and prevention of 
CDs in SA. The overall finding of this study is that there is an urgent need to renew 
medical genetic services in SA since: 
 There is a lack of recognition of the contribution of CDs to the burden of disease in 
SA and to child mortality. 
 SA is beyond the designated stage at which genetic services are developed (IMR of 
40-15 deaths per 1 000 live births). 
 Currently stagnated child mortality in SA will only significantly be further reduced by 
addressing CDs through developing improved medical genetic services.  





 Modelled estimates of CDs provide a baseline estimate in the absence of accurate 
empiric data, and demonstrate that intervention can save lives and mitigate 
disability, although the cost of care may increase.  
 Current capacity in the medical genetics sector is inadequate. Use of the MGEP and 
the Congenital Disorders Handbook within the context of the re-engineering of PHC 
are potential tools that could be used to swiftly increase capacity by training nurses.  
 Confusion around terminology and definitions related to CDs needs to be clarified 
and the usage of appropriate terms agreed to minimize underreporting to enable 




Policy Recommendations  
The key policy recommendation emerging from this study is the need for 
increased political commitment to medical genetic services for the care and 
prevention of CDs in SA. This needs to be accompanied by appropriate allocation 
of resources with actionable tasks related to improving surveillance and 




Areas for future research prompted by this study include further modelling 
studies at the provincial level and for specific CDs in SA. A further phase of this 
work could include the development of cost estimates for specific interventions 
to illustrate the socioeconomic impact and cost effectiveness of medical genetic 
services. 
Developing consensus in SA on the use of standardised terminology and 
definitions for CDs is necessary to ensure accurate reporting of CDs to reduce 
the underestimation of CDs to the disease burden. This needs to be evaluated 
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Executive Summary  
The current state of genetic services in South Africa (SA) related to the care and prevention of 
congenital disorders (CDs) are in decline due to competing health priorities. Currently available 
services are inadequate to service the population and this must be rectified to meet the increasing 
health need as CDs emerge as a leading cause of death in children in SA,.  Many of those born with a 
CD remain undiagnosed or are misdiagnosed and die as a result, with the cause of death incorrectly  
assigned, while others survive with lifelong disabilities due to inadequate care. 
This project will investigate CDs and the required services in SA, providing a comprehensive, 
evidence based evaluation of this neglected health issue that contributes significantly to the disease 
burden. Undertaken as seven distinct  tasks, the first of these will describe epidemiological transition 
over the past 25 years in SA and contextualise CDs demonstrating their contribution to child 
mortality and  morbidity. The lack of comprehensive data on CDs in SA will be supplemented by the 
second task of modelling data and mapping the burden of birth prevalence and outcomes of CDs in 
the country. The third will investigate the legal, constitutional and regulatory imperatives, 
highlighting the rights of those affected by CDs, and evaluate the existing legal framework in place 
and its current implementation inluding any shortfalls. Tasks four and five focus on the need to build 
medical genetics capacity in clinical staff to improve diagnose, care and prevention of CDs. 
Educational frameworks based around core genetic competencies will be developed for both doctors 
and nurses to serve as resource for curricula and skills development. To be reported, CDs must first 
be recognised and diagnosed accurately and this can only be achieved if clinicians primary health 
care providers are trained adequately. Medical genetics education in SA with the UK will be 
compared in as a sixth task, aiming to identify gaps in current training in SA and to learn from the 
UK, an industrialised nation in later stages of epidemiological transition where CDs emerged and 
remained as a leading cause of mortality in children.The final task will draw together the findings of 
the seven tasks and outline potential steps forward that are required to renew genetic services in SA 
related to CDs. 
The outputs of this project will include seven peer-reviewed publications reflecting the seven tasks 
outlined above and a number of presentations at relevant national, regional and international 
conferences. A concise report outlining the findings and recommendations for the renewal of 
genetic services will be submitted to the National Department of Health. The educational 
frameworks developed will also be distributed to medical training institutions as relevant.  
By providing an evidence-based evaluation, this study can contribute to CDs being once again 
prioritized as a health care issue in accordance with World Health Assembly (WHA) Resolution 
WHA63.17, and influence policy and decision makers to leverage political commitment, support, and 
the required resources to develop and implement the required genetic services. The ultimate impact 
should be the provision of relevant, effective services for the care and prevention of CDs, to achieve 
the human dignity, and constitutionally and legally enshrined human rights of people affected and 
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1) Defining the Research Problem 
 
As South Africa (SA) undergoes epidemiological transition and non-communicable diseases are 
better controlled and cause less deaths overall, the proportion of deaths caused by congenital 
disorders (CDs) is increasing and they are emerging as a leading cause of mortality and morbidity in 
children [1].  
As services for the competing health priorities of HIV/AIDS and concomitant TB developed over the 
past 10-15 years, this diverted funding and attention from CDs. Tertiary medical genetic services 
required for the care and prevention of CDs declined [2] are now severely compromised in SA. Many 
of those born with serious CDs in SA remain undiagnosed or are misdiagnosed and die with the 
cause of death incorrectly assigned [3] or survive with severe disabilities due to inadequate care. 
Currently, less than 4 % of CDs are reported via the Birth Defect Collection Tool administered by the 
Department of Health (Ms V Mtyongwe, personal communication). This lack of accurate data has 
contributed to an underestimation of the contribution of CDs to the burden of disease and a lack of 
political will in prioritising their care and prevention, further exacerbating the problem [4]. 
Up to 70 % of serious CDs can be prevented, cured or ameliorated by appropriate care, [5] but CDs 
must first be recognised, referred and diagnosed [1]. Existing clinical expertise to enable this in the 
health care system is inadequate and training is required in medical genetics to equip healthcare 
providers throughout the continuum of care. This capacity is a necessay componant of developing 
comprehensive genetic services to counter the burden of disease resulting from CDs.   
 
 
2) Literature Review and Motivation  
 
A congenital disorder (CD) is "any abnormality affecting body structure or function, including 
metabolism, which are present from birth, whether recognised at birth or later" [1,6]. The causes of 
CDs are diverse. Some are caused pre-conception by genetics, and others are caused post-
conception by maternal exposure to environmental agents (radiation, methyl mercury), teratogens 
including alcohol and drugs, maternal illness including diabetes and epilepsy and maternal infections 
such as cytomegalovirus, herpes, HIV/AIDS, rubella, toxoplasmosis, varicella virus etc, which affect 
the developing fetus [1]. Others are thought to be a combination of genetics and the environment 
although the exact cause is unknown.    
The March of Dimes Global Report on Birth Defects [1] estimates that globally 9 million infants (7 % of 
live births) are born annually with a serious CD leading to death or lifelong disabilities. Births 
affected by these disorders are not equally distributed around the world, with over 90 % born in 
middle or low Income countries. This imbalance is attributed to poverty and differences in maternal 
health, including a greater frequency of consanguineous marriages, a high percentage of older 
mothers and the survival advantage against malaria for carriers of sickle cell, thalassemia, and 
glucose-6-phosphate dehydro-genase (G6PD) deficiency genes [1]. As a result of inadequate care in 
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these MLIC, 95 % of these die including 3.3 million children under the age of five  - and a further 3.2 
million survive and are disabled for life [1,7]. 
 
Historically, the significance of CDs has long been underestimated and neglected, especially in MLIC 
where they continue to be a 'serious, unappreciated health problem causing a significant health 
burden’ [1]. Many MLIC, including SA, have not achieved significant progress in controlling CDs and 
are in the midst of epidemiological transition, a process that industrialised countries completed 
decades ago [8]. During this transition, infectious diseases are contained, and malnutrition and poor 
healthcare (including maternal) services are reduced, resulting in lower mortality and less 
“unnecessary” deaths. Deaths from CDs usually remain invisible - “buried” among deaths caused by 
communicable diseases and only emerge as these diseases are adequately controlled. As 
industrialised countries moved through the early stages of epidemiological transition, the birth 
prevalence and deaths from CDs due to fetal environmental factors, essentially teratogens, 
decreased slightly, due to improved care and prevention strategies, such as education and screening 
[1]. However as 85 -90% of CDs have a genetic or partially genetic aetiology, their birth prevalence 
and resulting mortality remained high.[1] In these industrialised countries, deaths from these 
disorders became proportionately greater in overall neonatal, infant and child mortality as deaths 
from communicable diseases reduced as they were contained and eventually eradicated. CDs 
emerged as a leading cause of child mortality and remain a leading cause of child death in these 
nations today [9]. 
In SA, modelled data of genetic causes of CDs [1] and an estimate of teratogenic causes (Prof AL 
Christianson, personal communication) indicates a minimum of 6.8 % of births, representing one in 
every 15 live births, is affected by a CD. Of these, 80.5 % are genetic/partially genetic in cause while 
19.5 % are caused by teratogens. The latter is more than the 10-15 % expected owing to the high 
prevalence of Fetal Alcohol Syndrome (FAS) [1]. With 26.2 % of CDs diagnosable in the first day of life, 
over 18 000 cases annually should be identified and reported in SA [10]. However, in 2012 only 2 174 
CDs were documented via the Birth Defects Collection Tool (BDCT) administered by the National 
Department of Health (NDoH) (Ms V Mtyongwe, personal communication). 
 
CDs contribute significantly to the under-five mortality rate (U5MR) which indicates the probability 
of dying between birth and five years of age per 1000 live births of the population. Globally, the 
U5MR has almost halved since 1990, decreasing from 90 deaths per 1000 live births to 48 in 2012 
which translates to 6.6 million children under five dying in 2012 compared to 12.6 million in 1990 [11]. 
However, as the overall U5MR declines, the proportion of deaths occurring during the neonatal 
period (the first 28 days of life) is increasing and is now over 40 %, of which 9 % is attributed to CDs 
[11] . However, with many CDs remaining undiagnosed and the cause of death often misdiagnosed in 
MLIC due to inadequate clinical expertise available, it is likely that the 9 % attributed to CDs as cause 
of death is an understimate. 
 
Global efforts are underway to reduce the number of child deaths. Efforts include the Millennium 
Development Goals (MDG) set in 2000, especially MDG4 which commits to reducing the number of 
the U5MR by two thirds between 1990 and 2015.  The SA target U5MR of 20/1000 live births will not 
be met, although much has been done to counter the initial rise in child mortality in the 2000’s 
caused by HIV/AIDS [12]. Since their implementation in the mid-2000’s, scaled-up prevention of 
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mother-to-child transmission and expanded roll-out of antiretroviral therapy saw rapid and 
significant reductions in both the U5MR and infant mortality rates, [12] which dropped from 74/1000 
live births and 52/1000 live births in 2000 to 44/1000 and 33/1000 respectively by 2012/13 [13]. 
However, since 2011 these child mortality rates have stagnated [14] indicating other health issues 
that need to be addressed to further reduce child mortality, such as the care and prevention of CDs. 
The current IMR of 33/1000 live births [13] is below the range of between 40-50 deaths per 1000 live 
births when countries recognise the coming health need of CDs and services for their care and 
prevention and well below 40 per 1000 live births when these services should have been 
implemented. [15] 
For CDs, one of the most significant global political shifts was in 2010 when the World Health 
Organization’s (WHO) highest decision making body – the World Health Assembly (WHA) - prioritized 
services for the care and prevention of CDs, particularly in MLIC, by passing Resolution WHA63.17.[16] 
This Resolution recognised the importance of CDs as a cause of stillbirths and neonatal deaths, their 
contribution to under-five mortality and contribution to failure to attain Millennium Development 
Goal 4 (MDG4). WHA63.17 urged member states (including SA) to recognise and address CDs as a 
public health issue. The Resolution also highlighted the lack of accurate epidemiological data 
available for many MLIC which prevents policy/decision makers from correctly assessing the burden 
of CDs in these MLICs.[4, 16]    
 
Genetic services were initiated in the 1950s and 60s financed by the State under the Health Act (Act 
63 of 1977) including laboratory services, community screening for specific conditions, community 
education and training programmes and the establishment of several academic centres [2].  However, 
it was only in the early 1990’s due to falling childhood mortality, that CDs began to emerge as a 
public health issue. In 2001, Policy Guidelines for the Management and Prevention of Genetic 
Disorders, Birth Defects and Disabilities were published by the DoH, aiming to “deliver a 
comprehensive genetic service equitably to all South Africans” [17] .  Developed through wide 
consultation and input by national, provincial DoH representatives and academics, the Guidelines 
outlined goals, objectives, strategies and delivery of genetics services for the prevention and care of 
genetics services relevant for SA [17]. Personnel requirements to implement these services were also 
specified in the Guidelines, based on UK criteria, and were later revised using more relevant criteria 
for SA in the Strategic Framework for the Modernisation of Tertiary Hospital Services. [18] Four years 
later, In 2004 the National Guidelines for the Care and Prevention of the Most Common Genetic 
Disorders, Birth Defects and Disabilities were published, targeting Primary Health Care Providers 
(PHCP), and described common CDs and strategies for their care and prevention [19]. 
 
The HIV/AIDS epidemic then buried CDs as a health care issue, and a consequence, funds and 
attention were diverted from the care and prevention of CDs to this competing health priority. As 
services for HIV/AIDS developed over the past decade, tertiary medical genetic services have been 
simultaneously neglected. In 2013, SA was reported as the only country of eight emerging 
economies evaluated where positive development in improving medical genetic service structures 
had ceased and indeed retrogressed [4]. 
Although reducing maternal and child mortality is a key strategic outcome for the SA health sector, 
as specified in the Negotiated Service Level Agreement and tackled in relevant strategies, policy and 
by relevant established bodies, including the Strategic Plan for Maternal, Newborn, Child and 
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Women's Health (WNCWH) and Nutrition in South Africa 2012-2016 [20], the Department of Health 
Strategic Plan 2-14/15 to 2018/19 [21] The Committee on Mortality and Morbidity in Children 
(CoMMiC),  South Africa’s National Plan for The Campaign on Accelerated Reduction of Maternal and 
Child Mortality in Africa (CARMMA) [22], and the Child Perinatal Problem Identification Programme 
(Child PPIP). However, although several include a CD statistic, none of these initiatives include CDs as 
a health issue or relevant strategies for their care and prevention. Nor do they respond to the 
Resolution WHA63.17 [16],  legally required as a WHO member country. 
The purpose of this study is to investigate the renewed need for services for the care and prevention 
of CDs in SA. Epidemiological transition in SA will be examined over the past 25 years. Data will also 
be modelled in more detail to indicate the scale of CDs as a health care issue in SA. Genetic 
education needs of relevant health care professionals will also be evaluated and a competence 
based education framework developed. Collectively, the papers published from this research will 
provide a comprehensive and evidence based overview of the issue of CDs and the current situation 
of genetic services in SA, including needs in medical genetics education. 
 
3) Aim and Objectives 
Aim 1: The renewed need for care & prevention of CDs in SA: Epidemiological transition 
Objectives:  
 To provide an overview of CDs in SA and their significant contribution to mortality and 
morbidity. 
 To explain the process of epidemiological transition in SA over the last 25 years using 
relevant national demographic data. 
 Demonstrated the impact of the counter epidemiological transition on medical genetic 
services, including examples of current inadequate services available. 
 Highlight what is required to develop and implement relevant services in the community. 
 
Aim 2:  The renewed need for care & prevention of CDs in SA: Constitutional, legal and regulatory 
imperatives 
Objectives: 
 A desktop study will be undertaken to identify all relevant constitutional, legal and 
regulatory documents relating to the provision of medical genetic services in SA. 
 The specific extracts of these documents will be evaluated in the context of the current 
services available to identify the legal and ethical shortcomings of the current services being 
provided.  
 




 South African demographic data will be obtained from Stats SA for a discrete time interval 
(one year period). Where possible, provincial and district data will be used to enable 
regional variations to be identified. 
 The Modell Global Database of CDs will be used and adapted to model this data to map the 
birth prevalence and outcomes of CDs for SA. This will include a variety of different 
scenarios, i.e. with and without adequate intervention to demonstrate the best and worst 
case scenarios possible for SA. 
 The findings of this exercise will be made public to highlight the contribution of CDs to the 
country’s disease burden. 
 
Aim 4:  The renewed need for care & prevention of CDs in SA: Educational framework for 
undergraduate and post-graduate nursing genetic education. 
Objectives:  
 Existing core competencies for nurses developed elsewhere in the world (e.g. UK) will be 
evaluated for use and cross-referenced with other relevant content identified in recent SA 
fora. The resulting list will be used as the starting document for evaluation. 
 A rigorous consultation process will evaluate and refine the starting document and will 
involve wide consultation with relevant role players, including the Council of Nurses and 
other relevant educational bodies, through a multi-step process.  
 The resulting framework of core competencies and learning areas on medical genetics (CDs) 
will be published and used as a resource for developing curricula for undergraduate and 
post-graduate nurse training. 
 
Aim 5:  The renewed need for care & prevention of CDs in SA: Educational framework for 
undergraduate medical genetic education. 
Objectives: 
 Existing core competencies for doctors (non-genetic specialists) developed elsewhere in the 
world (e.g. Uk) will be evaluated for use and cross-referenced with other relevant content 
identified in recent SA fora. The resulting list will be used as the starting document for 
evaluation. 
 A rigorous consultation process will evaluate and refine the starting document and will 
involve wide consultation with relevant role players through a multi-step process.  
 The resulting framework of core competencies and learning areas on medical genetics (CDs) 
will be published and used as a resource for developing curricula for medical schools. 
 




 The genetics/genomics content of medical school curricula will be evaluated and assessed 
for relevance to providing adequate genetic services related to CDs at key medical schools in 
the UK and in SA. 
 Commonalities and differences in content and format will be identified and discussed, and 
the relevance of the resulting education to the provision of genetic services related to CDs.  
 
Aim 7:  The renewed need for care & prevention of CDs in SA: A way forward 
Objectives: 
 All the work undertaken as part of this project will be taken into account and an article 
written to give an overview of the findings and the potential steps forward that are required 
to renew genetic services in SA related to CDs. 
 
4) Methods  
4.1 Study Design for Research Aim 1: Epidemiological transition 
This is an observational study. The systematic review of literature on epidemiological transition in 
MLIC and industrialised countries, as well as research of child mortality, life expectancy at birth 
(longevity) and HIV/AIDS prevalence in pregnant women will be conducted by accessing research 
from journal articles published in peer-reviewed journals and relevant publicly available 
international data sets will be downloaded for evaluation.  
4.1.1 Setting 
Data relevant to epidemiological transition in SA will be reviewed, although statistics maybe sourced 
from other countries as relevant to enable comparisons.  
 
4.1.2 Research Object Selection 
The timeframe of the past 25 years has been selected for this study, specifically from 1988 – 2013. 
The start of this timeframe falls immediately prior to the start of the HIV/AIDS epidemic, when 
childhood mortality was decreasing and longevity increasing.  
4.1.3 Measurements 
The Infant mortality rate, under-five mortality rate, longevity (average for males and females) will be 
used for the past 25 years in SA. Figures of HIV infected pre-natal women will be used as an as an 
indicator of HIV/AIDS prevalence over the same period. 
 
Online data sources will include:  
 UN Inter-agency Group for Child Mortality Estimation (www.childmortality.org);  
 World Bank longevity data (http://data.worldbank.org/indicator/SP.DYN.LE00.IN)  
 HIV data from the 2012 National Antenatal Sentinel HIV and Herpes Simplex type-2 prevalence 
Survey, National Department of Health, SA.  (www.hst.org.za/publications/2012-national-




4.1.4 Data Analysis 
The data sets will be represented graphically to demonstrate the process of epidemiological 
transition in SA over the past 25 years. Descriptive statistics and analysis will be used to describe the 
changes in mortality and longevity over this period and the interplay with the HIV/AIDS epidemic 
and treatment.   
 
4.2 Study Design for Research Aim 2: Constitutional, legal and 
regulatory imperatives 
This is an observational study and aims to describe the constitutional, legal and regulatory context in 
SA relevant to services for the care and prevention of CDs. The systematic review of literature on 
constitutional, legal and regulatory imperatives and the current state of medical genetic services in 
SA will be conducted by accessing research from journal articles published in peer-reviewed journals. 
Where required, additional information will be supplemented via personal communication with key 
individuals and relevant experts. 
4.3 Study Design for Research Aim 3: Mapping the burden of CDs 
in SA 
 
This is an observational, cross sectional study modelling the birth prevalence and outcomes of 
genetic CDs nationwide in SA over a one-year period. This will demonstrate the national toll of CDs 
and their contribution to the burden of disease in the country. 
The Modell Global Database (MGD) of CDs will be utilised and adapted for the South African context. 
The MGD was orginally developed in response to a lack of reliable data on national and global birth 
prevalence of CDs, which is especially lacking in MLIC. It relates known CD prevalence data from well 
established CD surveillance systems and registries to generate baseline estimates of country-specific 
birth prevalence [1]. This study develops the MGD a step on from national prevalence estimates by 
using provincial and district data, when available. This will enable the the regional variations of birth 
prevalence and outcomes of CDs to be mapped in SA.  
4.3.1 Setting 
This is a desktop, data analysis study to be undertaken in SA and will involve close collaboration with 
the originator of  the MGD, Prof Bernadette Modell, Emeritus Professor of Community Genetics, 
University College London and Director, WHO Collaborating Centre for Community Control of 
Hereditary Disorders.  
 
Demographic data from Statistics SA will be sourced at district and provincial level throughout the 
country for the latest year it is available (2012 TBC). Due to late registration of births and other 






The key outcome variable of this study is birth prevalence of early onset genetic CDs. This is the 
number of infants affected by a CD per 1000 live births in a population and is different from 
population prevalence, which is the number of individuals affected by a CD in a specific population. 
Since serious CDs shorten life, population prevalence is usually lower than birth prevalence for CDs, 
especially in MLIC. Birth prevalence is a more accurate and enables CD rates to be compared across 
populations and time [1]. The MGD includes CDs causing death or disability in the absence of 
intervention, namely chromosomal disorders, congenital malformations, single gene disorders and 
two genetic risk factors, rhesus negativity and G6PD deficiency. 
South African provincial and district demographic data will be integrated into the MGD. These 
demographic data will include: population, annual births, crude birth rate, sex ratio at birth, IMR, 
U5MR, total fertility rate, mean life expectency, maternal age distribution (% mothers over 35), 
proportion of the population urbanised, estimated population coefficient of consanguinity and 
adjusted IMR (if relevant), and population age and sex distribution (Prof. B. Modell, personal 
communication). Relevant HIV/AIDS data may also be obtained and the IMR adjusted to isolate 
infant deaths caused by CDs. 
4.3.3 Data Analysis 
South African demographic data for a specific year will be inputed into the adapted MGD which is in 
Microsoft Excel.  The MGD uses a set of defined methods (using formulae) to relate the demographic 
data to known birth prevalences of CDs (Prof Bernadette Modell, personal communication). 
Assistance will be sought from Prof Modell to develop a new formula to adjust the IMR for HIV/AIDS 
deaths using relevant data sourced from the Health Systems Trust in SA. 
 
Once data input is complete and formulae updated, the MDG will calculate potential (baseline) birth 
prevalences for which there are a number of possible outcomes. In the absence of any services (i.e. 
primary prevention and termination of pregnancy), there are four possible outcomes : fetal 
death/still birth or live birth, which includes death or varying degrees of disability. (primary 
prevention, termination of pregnancy, fetal death/stillbirth, livebirth, death, disability, and cure). 
Minimum estimates will be generated for a five year interval.  
 
The results will be described graphically where relevant and published in a relevant peer reviewed 
journal.   
 
4.4 Study Design for Research Aim 4 & 5: Educational frameworks 
for undergraduate and post-graduate nursing genetic education 
and undergraduate medical genetic education.  
 
Development of these educational frameworks are interventional, qualitative studies. A nominal 
group approach will be employed during a consultative process to achieve consensus on a list of 
medical genetic competency statements. This approach takes all participants views into account and 
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can be used for groups of all sizes for decision making while allowing everyone’s viewpoints to be 
taken into consideration. Following consultation with the research group in the UK, this study is 




Development of both of these two frameworks will involve a separate series of meetings of expert 
panels of a maximum of 40 relevant stakeholders from various health care specialties i.e. South 
African Nursing Council, South African Medical and Dental Council, HPCSA etc. These meetings will 
be undertaken at a location/venue to be determined. 
 
4.4.2 Research Object Selection 
The project and process will be explained to the potential partner organizations and specific key 
individuals will be invited to participate, and relevant individuals will be nominated by their 
organizations to participate. A maximum of 40 stakeholders will participate in each meeting. 
 
Preliminary information will be sent to invited participants explaining the purpose of the study and 
the role of the educational framework to be developed in contributing to developing capacity 
required for genetic services in SA.  
 
A list of core competencies developed elsewhere (UK & Europe) will be used as a starting point for  
discussion. These will be discussed over a 1-2 day meeting to consider the genetics competence 
required by the healthcare professionals. Where relevant, scenarios may be used within a structured 
programme and anonymous voting will be undertaken in iterative rounds. 
 
4.4.3 Data Analysis 
After the meetings, the agreed statements will be validated against appropriate professional 
frameworks and refined further, through wider consultation and discussion. The finalized statements 
will be placed in a framework with proposed learning and practice outcomes. Both the final 
frameworks and reports will be published in relevant, peer-reviewed journals.   
 
4.5 Study Design for Research Aim 6: A review of medical genetic 
education in SA- a comparison with the UK  
 
This is an observational, descriptive study. The systematic review of literature on medical genetic 
education in the UK and SA will be conducted by accessing research from journal articles published 
in peer-reviewed journals. Descriptions of genetics/genomics content in medical school 
undergraduate curricula obtained from in-person, informal interviews of relevant teaching staff at 
key London Medical schools in 2008 and 2014 will also be evaluated. The choice of the UK as a 
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comparable country is due to the foundations of the SA healthcare system on the UK. As an 
industrialised country, the UK also completed the epidemiological transition many decades earlier 
and has had to confront the issue of CDs and develop genetic services and the corresponding 
genetics education. The study will look at how the state of medical genetics in the UK compared to 
that of SA when at a similar stage of epidemiological transition, how they transitioned to the current 
status of education, and what medical genetics education in the UK looks like today.  Possible 
approaches, gaps, lessons learned and a way forward for SA will be evaluated in light of this 
comparison. 
4.6 Study Design for Research Aim 7: The renewed need for care & 
prevention of CDs in SA: A way forward 
 
This is an observational study. Based on the findings of the previous six papers (Research Aims 1-6) 
combined with wider desktop research conducted via desktop study of peer reviewed articles, CDs 
as a health issue in SA and the required services will be contextualized, including genetic education 
of relevant professionals, will be evaluated. Collectively, this research will provide an evidenced 
based foundation for generating political will in support of renewed genetic services for the care and 
prevention of CDs in SA. 
 
5) Ethical Considerations 
Informed consent will be obtained from all participants in future interventions of the study. The 
Biomedical Research Ethics Committee (BREC) at the University of KZN will also be consulted and 
relevant ethics approval applied for. 
6) Time Lines and Project Management 
The outputs of this study consist of seven scientific papers that will be submitted for peer review 
(see Gant Chart attached for further details on timeline):  
1. End 2014: Paper 1: Epidemiological transition (BMJ in press, March 2015) 
2. First Quarter 2014: Constitutional, legal and regulatory imperatives 
3. Second Quarter 2015: The burden of congenital disorders in South Africa (Modell DB) 
4. Third Quarter 2015: A review of medical genetic education in SA compared with elsewhere (e.g. 
the UK) 
5. End 2015: Educational framework for undergraduate and post-graduate nursing in SA 
6. End 2015: Educational framework for undergraduate medical genetic education in SA 
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Helen Louise Malherbe 
School of Clinical Medicine 
University of Kwa-Zulu Natal 













Re: Modell Global Database – Permission to Use 
 
This letter is to place formally on record that you have my permission to use and adapt data, 
data structures, techniques and approaches from the Modell Global Database of Congenital 
Disorders (MGDb) for the purposes of modelling the circumstances prevailing within a 
country (i.e. South Africa), as outlined in your PhD protocol and discussed with me in detail 
when we met in London in Autumn 2014. 
 
I wish you every success in this endeavour and look forward to a productive collaboration! 
 






Professor Bernadette Modell MA PHD MB BCHIR FRCP FRCOG 
Director, WHO Collaborating Centre for the Community Control of Hereditary Disorders 


